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Abstract 
Droplet microfluidics has emerged as a branch of microfluidics with 
tremendous potential for high-sensitivity and high-throughput biomolecular 
analysis, leading to its adaptation for a variety of applications. However, 
commonly used biosample analysis schemes using droplet-based systems are 
limited, due to the need for multiple devices per analysis, integration with 
low-sensitivity detection techniques as well as the need of barcodes for 
droplet identification. This thesis will focus on sample-to-answer droplet 
microfluidic devices I have developed in collaboration with colleagues at the 
Johns Hopkins University to overcome these limitations. Integration of novel 
microfluidic design with highly sensitive confocal fluorescence spectroscopy 
technique has enabled these devices to achieve ultra-sensitive analysis of 
individual biosamples at single-molecule levels as well as high throughput 
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Conventional microfluidic systems designed to miniaturize biochemical 
experimentation done on bench top equipment typically use single phase fluid 
flow. However, past few years have seen the emergence of the term ‘Droplet 
Microfluidics’ in the microfluidic community. Droplet Microfluidics employs 
two immiscible phases i.e. the dispersed or droplet phase and the continuous 
or carrier fluid phase to rapidly generate millions of discrete reaction 
chambers(i.e. droplets)(1). Droplet microfluidics offers distinct advantages 
over conventional microfluidic systems including shorter heat and mass 
transfer times (due to high surface area to volume ratio), rapid mixing and 
massive parallel processing (1).  
Although, microdroplet generation is possible through application of a 
variety of non-microfluidic methods, the application of microfluidics for 
droplet generation allows highly monodisperse droplet generation with 
significant reduction in droplet size(2). Most common microfluidic 
configurations used for droplet generation are the ‘T-junction’ and ‘Flow 
focusing’ configurations. T-junction configuration involves side shearing of 
the dispersed phase by the continuous phase, whereas the flow focusing 
configuration involves forcing the dispersed phase and the continuous phase 
through a narrow region in the microfluidic chip for droplet generation. Flow 
focusing configuration allows for more symmetric shearing of the dispersed 
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phase with reduced size and polydispersity(2). Droplet generator chips can 
routinely approach kHz generation rates with peak rate of 20 kHz reported in 
literature (3). As a result, a simple droplet generator chip can set up millions 
of reactions in a matter of minutes. Furthermore, the size of the reaction 
containers i.e. droplets can be reduced to as low as fL volumes (1) resulting in 
orders of magnitude savings in reagent volume over microfluidic large scale 
integration systems (4). Reduced reaction volumes and fast generation rates 
allow droplet microfluidic platform to be used for running large number of 
reactions without the need for increasing device size (1). Furthermore, highly 
monodisperse droplet generation is further supplemented with development 
of sophisticated droplet manipulation techniques. Basic operations required 
for performing chemical reactions including droplet fusion, droplet fission, 
droplet sorting, droplet mixing etc have been demonstrated with a variety of 
active as well as passive methods(1).  
Inspired by nature’s way of performing biochemical operations within 
confined discrete individual units i.e. cells, performing chemistry and biology 
in droplets is rapidly becoming a prominent research theme. Droplet 
microfluidics has been utilized for a variety of applications including single 
cell screening(5, 6), digital PCR (7-9), protein engineering and directed 
evolution(10) ,protein crystallization condition screening(11) and shape and 
structure controlled particle synthesis (12-14) 
3 
However, droplet microfluidics being still in its early stages still 
suffers from a few limitations which need to be addressed to expand the 
applicability of this elegant technology to a wider range of applications. To be 
specific, 1) Readout techniques like fluorescence imaging (15, 16) used with 
droplets lack the sensitivity required for detecting low abundance 
biomolecules of interest at single molecule level. As a result amplification 
schemes are typically required for detection of a nucleic acid sequence of 
interest, increasing the droplet platform complexity. 2) The PCR based 
droplet platforms used for precise nucleic acid/pathogen quantification from a 
biological sample require a complicated multi-device and multi-instrument 
workflow and 3) Although droplet microfluidics can be used to set up millions 
of reactions in minutes, the T-junction and flow focusing droplet generator 
chips commonly used for various applications (1) cannot generate droplets 
with arbitrary compositions by mixing many different reagents in different 
proportions, limiting the true high-throughput potential of droplets. 
This thesis will attempt to overcome all the limitations of the droplet 
microfluidic technology mentioned above. The limitations mentioned above 
are broken down into individual problems in each chapter of this thesis. Each 
chapter begins with the description of a specific problem being addressed 
followed by a proposed solution to the problem as well as discussion of 
experimental results showing the efficacy of that solution. Towards the end of 
each chapter, a ‘supplementary section’ is included, which lists details of 
4 
experimental conditions for the experimental results discussed earlier in the 
chapter.  
Overall I believe that all the solutions proposed in this thesis combined 
together will contribute to the repertoire of tools available with droplet 
microfluidic technology for ultra-sensitive and high-throughput biomolecular 
analysis, thus, expanding the applicability of this elegant technique to a 
broader range of applications. 
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Chapter 2: Counting single molecules within droplets 
Rane, T. D., et al. "Counting single molecules in sub-nanolitre droplets." Lab 
on a Chip 10.2 (2010): 161-164. Reproduced by permission of The Royal 
Society of Chemistry 
2.1 Introduction 
Droplet-based microfluidic platforms offer the distinct advantages of fast 
sample mixing, limited reagent dispersion, and lower sample loss or 
contamination when compared to traditional microfluidic devices.(1)(2) In 
addition, simple control strategies for kHz frequency droplet generation, 
transportation, storage, and sorting give the platform a propensity for high 
throughput analysis. While initial applications have been shown in a range of 
research disciplines, including biochemical analysis,(17) chemical and 
material synthesis,(18) and chemical reactions,(19) more recent applications 
have emerged that seek to expand this high throughput capability to the 
analysis of individual biological entities, such as single cells(20-22) or 
biomolecules.(23, 24) 
In single cell experiments, in vitro compartmentalization in droplets 
enables rapid accumulation of secreted cellular factors,(25) and provides both 
chemical isolation and a unique means of cell selection and control.(26) 
Alternately, single molecule compartmentalization enables nucleic acid 
analysis through single-copy DNA PCR, extending the high throughput 
capacity of droplet-based microfluidics to digital PCR assays.(21, 23, 24) 
However, the current dependence on amplification techniques (e.g. PCR or 
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fluorogenic substrate)(1) for detection of low concentration biomolecules 
presents limitations in droplet-based platforms; these include decreased 
throughput and added complexity involved with enzymatic amplification. 
These limitations point towards the need for integration of a highly sensitive 
detection platform for amplification-free detection of low-abundance 
biomolecules. 
2.2 Solution 
Confocal Fluorescence Spectroscopy (CFS) has traditionally been used 
for fluorescence based single molecule detection (SMD).(27-32) Resolution of 
single fluorophores is accomplished through reduction of a laser-illuminated 
probe volume to femtolitre size, thus minimizing background noise. Although 
well suited for SMD in continuous sample streams, CFS is ill-suited for low 
abundance analyte detection in discrete volumes (e.g. droplets).(33, 34) Fig. 
2.1A depicts the challenges associated with SMD in droplet platforms. A 
single pass of the droplet through the laser illuminated volume results in low 
intra-droplet detection efficiencies (i.e. detection of only a small fraction of 
encapsulated molecules), as most biomolecules pass around the detection 
volume. In addition, even at nominal flow speeds the sub-nanolitre droplets 
pass by the detection volume in milliseconds, making it difficult to resolve 
tens to hundreds of molecules encapsulated within each single droplet. 
In this report, we overcome challenges involved with biomolecular 
quantification in droplets, including short intradroplet signal acquisition 
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times and droplet–illumination volume size mismatches. In our platform, one 
dimensional beam shaping using cylindrical optics (Cylindrical Illumination 
Confocal Spectroscopy, CICS)(35) produces a sheet-like illumination volume, 
maximizing intra-droplet detection efficiency (Fig. 2.1B). Furthermore, 
droplet confinement through a microfluidic constriction extends droplet 
duration through the illumination volume, providing the spatial and 
temporal resolution necessary to detect single biomolecules. 
Controlled droplet confinement and passage through the illumination volume 
was accomplished using a microfluidic constriction channel patterned into a 
retractable PDMS valve (Fig. 2.1C). In the open valve state the constriction 
was not part of the fluidic path and presented no unnecessary challenge to 
droplet generation due to the increased fluidic resistance of the narrow 
channel. Water-in-oil droplets were generated using a flow-focusing 
configuration and transferred to a downstream storage chamber within the 
multilayered (36) PDMS device (details in section 2.4.1). Upon valve 
actuation droplets were driven through the constriction using the continuous 
phase at a controlled pressure, while the occasional clogging of the narrow 
constriction was averted by pulsing the retractable channel to remove debris. 
The microdevices were coupled to a custom confocal fluorescence 
spectroscopic system as described previously, (33-35) by loading the chip onto 
a stage capable of sub-micron positioning of the chip relative to the 
illumination volume (details in section 2.3). Two separate optical 
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configurations were used with two different cylindrical lenses (f = 200 mm or 
f = 300 mm) to expand the illumination volume laterally across the 
constriction width, while remaining diffraction limited in the other 
dimensions to maximize signal to noise ratio (SNR).(35) These two 
configurations created detection volumes with 14.3 or 64.6 µm2   cross-sections, 
respectively (details in section 2.4.2). Four separate microdevices were 
fabricated with constrictions ranging from ~50-400 µm2  sized cross-sections, 
yielding a range of maximum possible molecular detection efficiencies (i.e. 
ratio of the cross sectional areas of the laser illumination and the constriction 
channel) in traversing droplets from 3.5% to 100%. 
Fig. 2.2A shows that droplets from pL to nL sizes were stretched through the 
constrictions without droplet break-up. In the initial experiments, TOTO®-3 
stained Lambda DNA was used as a model biomolecule. Varying 
concentrations of DNA were loaded in ~40 pL droplets and run through the 
64.6 µm2 illumination volume held within the 200 µm2 constriction. The raw 
data trace in Fig. 2.2B shows the outline of two control droplets (no DNA) 
running through the constriction (red trace – Fluorescence signal from Alexa 
488 droplet indicator dye, black trace – Fluorescence signal from TOTO®-
3/DNA; details in section 2.4.3). Fig. 2.2C shows the encapsulation and 
detection of the DNA at 37 pM concentrations. At these higher concentrations, 
droplet stretching through the constriction becomes increasingly essential as 
the ~1000 DNA molecules per droplet (37 pM within 44.5 pL) must be 
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resolved within the droplet’s transit time through the CICS volume. Fig. 2.3A 
shows the effect that droplet transit times had on single molecule counting at 
37 pM. Burst counts per droplet approach a maximum value of 312 (red line – 
average of last three datapoints) at ~280 ms. Droplets that traverse the 
constriction at a faster pace yield decreasing burst rates. The lost information 
is a result of non-digital molecular occupancy in the illumination volume and 
decreased SNRs at faster speeds. However, the 312 average fluorescence 
bursts per droplet in the plateau region agree well with the expected value 
(320 bursts for the maximum possible detection efficiency of 32.3%). The 
small discrepancy from the expected value is attributable to molecular loss 
into the continuous phase and experimental variation in laser and 
constriction alignment (details of single molecule data analysis and 
thresholding in section 2.4.4). 
In all subsequent experiments, pressures that yielded equal droplet durations 
through the constriction were selected, yielding equal drop-to-drop 
acquisition times. This constraint enabled molecular quantification through 
the expected linear increase in single molecule fluorescent bursts with 
increasingmolecular concentrations (Fig. 2.3B). In addition, the ability to 
mold intradroplet detection efficiencies via alterations in the constriction 
channel to laser illumination cross-section ratio is apparent in Fig. 2.3C. As 
shown, the average fluorescent bursts per droplet show a linearly increasing 
trend with decreasing constriction size at equivalent DNA concentrations 
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(maximum possible detection efficiencies of 16.15, 32.3, 64.6, and 100%; 
details in sections 2.4.1 and 2.4.2).  
The results so far, indicate the effectiveness of the droplet-SMD platform in 
quantifying low abundance fluorescent biomolecules encapsulated within 
droplets. However, the utility of the droplet-SMD platform can also be 
extended to sequence specific nucleic acid assays using common single 
fluorophore nucleic acid probes.(27, 29-31, 34, 37) As shown in Fig. 2.3D, a 
smaller CICS illumination volume (14.3 µm2) was used to increase SNR for 
single fluorophore studies. At 40 pM concentrations (~1000 molecules per 
44.5 pL droplet), Cy5 molecular beacons (MB) (34) for E. coli rRNA sequences 
show few background peaks due to thermal fluctuation of the hairpin probe 
(Fig. 2.3D top panel; average peaks per droplet 0.282 ± 0.11). However, the 
presence of target is detectable upon target hybridization as an increase in 
fluorescence peak counts per drop (Fig. 2.3D bottom panel; average peaks per 
droplet 9.075 ± 0.76). These single fluorophore studies were performed using 
a 200 µm2 constriction; however, the smaller constriction sizes used above 
demonstrate the ability to mold intradroplet detection efficiencies to meet a 
variety of experimental requirements. 
2.3 Conclusion 
In conclusion, for the first time we have demonstrated direct and 
amplification-free single molecule detection of biomolecules in subnanolitre 
droplets. As shown, biomolecular quantification using SMD requires only a 
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microfluidic constriction channel for droplet confinement and elongation. 
Thus, the droplet-SMD microdevice presents a unique alternative to the 
complex PCR devices currently used for intra-droplet detection. Furthermore, 
by applying homogeneous probes for single molecule counting we were able to 
detect nucleic acids using a sequence specific probe. Future integration of the 
droplet-SMD platform with existing in-drop cell control and lysis 
techniques(1, 2) or single molecule probe schemes(27, 29-31, 37) presents a 
general method for high-throughput single cell analysis. 
2.4 Supplementary section 
2.4.1 Device Fabrication and Operation 
As discussed in the text, all devices were fabricated using multilayer 
soft lithography. Two layers of polydimethylsiloxane (PDMS) were 
constructed, one for droplet generation and transport and another for the 
pneumatic valve. The mold for the device was made using three separate 
photoresist layers. First, a 10 μm tall pad of SPR220-7.0 (Shipley) was used 
to create the portion of the valve that would close tight against the 
underlying glass coverslip. After development, a reflow process at 200 °C for 
120 minutes resulted in the semi-circular cross-section necessary for effective 
valve closure. SU-8 was then used to pattern a small constriction channel (20 
μm wide with varying heights of 2.5 – 20 μm) on top of SPR220-7.0 pad that 
would remain open while the valve is in the actuated state. Finally, the 35 
μm tall layer containing the droplet generator module was patterned to 
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connect the constriction to the rest of the device. A separate mold for the 
pneumatic valve (control) layer was made at a 40 μm height, again using SU-
8 3025 photoresist (See Fig. 2.4 for a cross-section of the constriction within 
the retractable valve).  
PDMS prepolymer (SYLGARD® 184, Dow Corning) was prepared at 
1:7 mixing ratio and cast onto the control layer mold to result in a final 
thickness of ~ 3 mm upon curing at 80 °C for 10 minutes. The fluidic layer 
molds were silanized using vapor deposition of chlorotrimethylsilane (Sigma-
Aldrich) before spin coating with PDMS prepolymer at a mixing ratio of 1:15 
(1300 rpm for 60 seconds). The excess curing agent in the thick control layer 
(1:10 is the standard mixing ratio) was added to ensure fusion with the 
second PDMS layer. The thin PDMS layer was then partially cured at 80 °C 
for 5 minutes before the thick PDMS sheet containing the mechanical valve 
was peeled off its mold and aligned to the fluidic layer. The two layers were 
fused together upon curing at 80 °C for 30 minutes. During these steps holes 
for fluidic and valve access were punched using gauge 20 syringe needles 
(McMaster-Carr). Finally, the entire chip was bonded to a coverglass 
(Fisherfinest, 12-548-5R, 35x50-1) after activation of the PDMS surface via 
plasma oxidation. Samples were delivered to the microfluidic chip using 0.02 
inch I.D. Tygon tubing (Cole-Parmer) fitted with 23-gauge needle tips 
(McMaster-Carr). A mixture of Mineral oil (20% v/v), Tegosoft DEC (73% v/v), 
and ABIL WE09 (7% w/v)(38) was used as the continuous phase for droplet 
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generation. Upon generation drops were carried to a large volume (~2 uL) 
storage channel, where droplets could be collected for downstream analysis. 
During on-chip single molecule detection (SMD), the continuous phase was 
used to force drops through the constriction at a controlled speed. The 
discrete phase always consisted of high concentration of Alexa488 dye, which 
served as an indicator dye to monitor droplet edges on the fluorescence 
spectroscopy platform. The signal from the indicator dye also provided 
feedback to control the speeds at which droplets traversed the constriction. 
2.4.2 Experimental Setup for Single Molecule Detection 
Spectroscopy data was acquired using a custom-built, dual laser 
excitation, dual emission channel, single molecule spectroscopy platform, as 
described previously (Fig. 2.5).(39) The system was capable of Cylindrical 
Illumination Confocal Spectroscopy (CICS) with 488 nm (Melles Griot) and 
633 nm (Thorlabs) laser illumination and detection in narrow wavelength 
bands centered on 560 nm and 670 nm (Fig. 2.5). The two laser beams used in 
the setup were spatially aligned using beam steering mounts (Newport) and 
combined using a dichroic mirror (z633RDC, Chroma Technology). The joint 
laser beam was coupled with an optical fiber to isolate the laser optics from 
rest of the setup. The beam emerging from the optical fiber is collimated and 
expanded before hitting a cylindrical lens (f = 200 mm), which was used to 
shape it in the form of a sheet and focus it into the back focal plane of a 
microscope objective (100X, oil-immersion, 1.3 NA UPlanFl, Olympus). The 
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objective tightly focused the beam into the microfluidic device, and collected 
emitted fluorescence in an epi-fluorescence configuration. The collected 
fluorescence signal was spectrally separated from the excitation light using a 
second dichroic mirror (z488/633RPC, Chroma Technology). Upon passing 
through a confocal aperture, the collected fluorescence was separated into 
two emission bands by a third dichroic mirror (XF2016, Omega), passed 
through bandpass filters (560AF55 and 670DF40, Omega Optical), and 
finally imaged on Silicon Avalanche Photodiodes (SPCM-AQR-13 and SPCM-
CD2801, PerkinElmer Optoelectronics) using f = 30 mm doublet lenses 
(Thorlabs). The slit-like confocal aperture used in this configuration 
measured 750 μm by 50 μm. The actual size of the CICS illumination volume 
for the 633 nm laser in this configuration was estimated using the 
experimental data shown in Fig. 2.6. The 633 nm laser beam was focused on 
a reflective silicon wafer surface and the reflected laser beam was imaged on 
a CCD camera (Allied Vision Technologies GmbH), after passing through the 
confocal aperture. The intensity profile of the image thus obtained was 
analyzed to estimate the width of the illumination volume (20.13 μm). This 
was followed by a z-scan to estimate the size of the illumination volume along 
the axis of the laser beam. During the z-scan, the reflective silicon wafer 
piece was moved along the axis of the laser beam, with respect to the laser 
beam focus and the reflected laser beam intensity was collected using the 
APD corresponding to the 670DF40 bandpass filter (Red APD). The variation 
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of the reflected laser intensity with changing position of the reflective surface 
respective to the laser beam focus is shown in the right panel in Fig. 2.6. A 
Lorentzian function was fit to the data and 1/e2 radius of the illumination 
volume was estimated to be 3.2 μm. Hence, the overall cross section of the 
illumination volume corresponding to the 633 nm laser was found to be ~64.6 
μm2. The CICS setup in this configuration was used for the Lambda DNA 
experiments. In a second configuration for single fluorophore experiments, a 
separate cylindrical lens (f = 300 mm, Thorlabs) was used to shape the laser 
beam into a sheet and to focus it into the back focal plane of the objective 
(same as above). An aperture of size 600 μm by 150 μm was used in this 
configuration to obtain a smaller observation volume. The size of the actual 
illumination volume was estimated as described above and was found to be 
~14.3 μm2 in cross section. The single molecule burst data was collected from 
the APDs by a PC using a PCI 6602 counter DAQ card (National 
Instruments), controlled using a custom software written in LabView 
(National Instruments). The microfluidic devices were positioned using a 
combination of a piezo stage (BPC203, Thorlabs) and a manual XYZ stage 
(Newport), allowing focusing of the CICS illumination volume at desired 
positions on the devices. 
2.4.3 Sample Preparation 
For the Lambda DNA experiments, Lambda DNA (37 pM; Invitrogen) 
was stained with TOTO®-3 dye (Invitrogen) at a concentration of 1 μM for at 
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least 30 minutes before droplet generation. The indicator dye Alexa 488 was 
then added to the stained DNA and the sample was diluted to achieve the 
concentration of DNA required for a particular experiment. Final 
concentration of indicator dye in the discrete phase was kept to a constant of 
100 nM in all the experiments with Lambda DNA. The single fluorophore 
experiments were conducted using a DNA molecular beacon (MB; 5’-Cy5-
CATCCGCTGCCTCCCGTAGGAGTG- BHQ2-3’; Integrated DNA 
Technologies) with the probe sequence complementary to a conserved region 
of the 16S rRNA in a wide-range of bacteria.(34) Complementary DNA 
oligonucleotides were hybridized in 10 mM phosphate buffer (pH 7.8) and 900 
mM NaCl at 100X of the MB concentration to saturate available probe. The 
MB-target mixture was heated to 95 °C and then gradually cooled to room 
temperature for 1 hour to ensure adequate hybridization, prior to loading into 
the microdevice for droplet generation. The final concentration of molecular 
beacons in the discrete phase was 40 pM, both in the ‘MB only control’ and 
the ‘MB hybridized with target’ experiment. The concentration of the 
indicator dye Alexa 488 in the discrete phase was kept to a constant of 10 nM 
in each case. 
2.4.4 Single Molecule Data Analysis 
An image of the droplets generated on each chip was taken prior to 
obtaining single molecule burst data using a custom stereoscope interface for 
the single molecule spectroscopy platform (Nikon SMZ1000). The average 
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droplet size was estimated from a minimum of ten droplets for each 
particular experiment. This data allowed the droplet counts per droplet to be 
normalized to an average droplet size (44.5 pL for all experiments), so that 
slight experimental variation in droplet size did not affect overall results. 
Data analysis was performed using custom software written in MatLab. 
Briefly, the leading and falling edge of each droplet were identified as the 
location in a data trace where the signal from the Alexa488 indicator dye 
reached three standard deviations above the background fluorescence of the 
continuous phase. A size filter was used to remove small satellite droplets 
from the analysis, while single molecule data from the Red APD (TOTO-
3/Cy5 channel) was analyzed at each droplet location, as identified by the 
indicator dye signal (from the Green APD). Integration time for photon 
binning was set at 0.1 ms for all peak counting experiments. 
For each sample, three data traces were analyzed with each trace 
containing at least 10 droplets visible in the form of fluorescence signal from 
indicator dye. For each droplet analyzed, the number of fluorescent peaks 
from the Red channel was normalized with the average droplet volume 
estimated from the picture, as described earlier. The number of peaks per 
unit volume, thus obtained, was converted to number of peaks per drop of a 
standard size (44.5 pl). The peak counting algorithm introduced by Huang et. 
al. (40) was adopted to minimize thresholding artifacts. Traditionally, in 
single molecule counting experiments threshold values for fluorescent burst 
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detection are set around three standard deviations from the mean 
background signal. Setting a lower threshold for detection in discrete volume 
droplets would result in lower false negatives, but cause a subsequent 
increase in false positive fluorescent bursts from background noise. However, 
as shown in Fig. 2.7 the same data trace can be analyzed with different 
thresholds to obtain a linear trend (in which there is no interference from 
background noise) that can be interpolated to the zero threshold to estimate 
the true molecule count per droplet.(40) In this manner, we were able to 
obtain molecular counts per droplet that closely matched the expected value, 
as determined by the maximum possible detection efficiencies (sections 2.4.1 
and 2.4.2) and concentrations (section 2.4.3). Acquisition of single molecule 
data from the droplets with the laser probe focused through the thin layer of 
the continuous, oil phase (see Fig 2.8) was observed to cause a slight decrease 
in signal-to-noise ratio compared to that obtained for data acquisition from a 
fluid filled microfluidic channel (data not shown). However, this was not 
shown to have any effect on the estimation of intra-droplet molecular 




Fig. 2.1: Microfluidic device design A. A droplet moving through a 
microfluidic channel is shown. Inset shows the size of the droplet relative to 
the illumination volume of a standard Confocal Fluorescence Spectroscopy 
(CFS) setup. B. In contrast, elongation of a droplet squeezing through a 
microfluidic constriction is shown. The inset shows the sheet-like 
illumination volume of a Cylindrical Illumination Confocal Spectroscopy 
setup relative to the elongated droplet in the microfluidic constriction. C. The 
multilayered microfluidic device designed for the experiments in this paper is 
shown. A flow focusing geometry was used for droplet generation. The left 
panel shows droplets being generated using a food dye as the discrete phase. 
The rightmost panels show the retractable constriction region in either the 






Fig. 2.2: Testing the microfluidic device A. Retractable constriction in 
action:  Two very different sized droplets can be seen stretching through the 
constriction without breakup. B. Sample single molecule trace data for 
control sample (TOTO®-3 dye only). The discrete phase consisted of 100 nM 
TOTO®-3 dye along with 100 nM Alexa 488 dye (Indicator dye). The red trace 
shows fluorescence signal from the indicator dye, while the black trace shows 
the fluorescence signal from TOTO®-3 dye. C. Similar single molecule trace 
data with the discrete phase consisting of TOTO®-3 labeled, 37 pM Lambda 





Fig. 2.3: Single molecule quantification on the microfluidic device A. 
Data showing the effect of droplet transit time on the mass detection 
efficiency within droplets. The data was obtained using a microfluidic chip 
(Fig 2.1C) with a 200 µm2 constriction. The discrete phase consisted of 1 mM 
TOTO-3, 37 pM Lambda DNA and 100 nM Alexa 488 dye. The number of 
single molecule fluorescent bursts increase with increasing droplet transit 
time through the microfluidic constriction, finally reaching a plateau 
(average value of 312 ± 31.9; red line) at transit times >280 ms. B. SMD-
droplet platform response to changing molecular concentrations. Droplets 
were generated using discrete phase consisting of a range of DNA 
concentrations and passed through a 200 µm2 constriction for single molecule 
detection. C. Manipulation of mass detection efficiency within droplets by 
simply changing the constriction size is demonstrated. As the constriction 
size decreases, larger sections of each droplet pass through the illumination 
volume and hence, mass detection efficiency increases. All the experiments 
were conducted on a CICS setup with detection volume cross section size 64.6 
µm2 and DNA concentrations of 0.37 pM (details of data normalization in 
section 2.4.4). D. The tunable nature of the droplet-CICS platform to attain 
single fluorophore sensitivity is illustrated using a Cy5 molecular beacon 
complementary to a sequence on 16S rRNA from E. coli. The top row shows 
three representative sample droplets from a ‘molecular beacon (MB) only’ 
control sample. The black trace shows single molecule data from the Cy5 dye 
on the MBs. The bottom row shows sample droplets made from the same 
concentration molecular beacon hybridized with a synthetic target DNA. The 
average number of single molecule bursts per droplet in the control sample 
was 0.282 ± 0.11, compared to 9.075 ± 0.76 in the target sample. This 
experiment was conducted on a chip with a constriction cross sectional area 
of 200 µm2 and CICS illumination volume of 14.3 µm2. Each data point 
represents the interpolated y-intercept at zero threshold values from three 
sets of experiments with standard deviation; see details of single molecule 









































































































































































Fig. 2.4: A cross-section of the constriction within the retractable 
valve. Upon pressurization of the top control layer, the actuated valve caused 
the main portion of the channel to close while the smaller constriction 






Fig. 2.5: Schematic diagram of the optical components in our two 





Fig 2.6: Estimation of the size of the CICS illumination volume. Left 
panel: The reflected image of the CICS illumination volume and the 
intensity profile of the image are shown. This image was acquired using the 
633 nm laser on the CICS setup focused on a reflective silicon wafer surface 
and imaged with a CCD camera, after passing through the confocal aperture. 
The width of the illumination volume was measured to be 20.13 μm. Right 
panel: The reflected intensity data from a z-scan conducted to estimate the 
size of the CICS illumination volume along the axis of the laser beam is 
plotted. The X axis shows the location of the laser beam focus relative to the 
surface of the silicon wafer, while the Y axis shows the normalized reflected 







Fig 2.7: Single molecule data analysis. A simple linear interpolation 
using the fluorescence burst counts with the threshold between 90 and 120 
gives a molecule count of 7.38 ± 0.56, which is close to the expected number of 
9.92 molecules per droplet (0.37 pM Toto-labeled lambda DNA within 44.5 pL 
droplets; 50 μm2 constriction within the 64.6 μm2 illumination volume for a 
maximum possible detection efficiency of 100%). This number corresponds to 






Fig 2.8: A high magnification image of a droplet squeezing through a 
20 μm by 10 μm constriction. This lateral view clearly shows the 
continued presence of the continuous phase surrounding the droplet as it is 





Chapter 3: Amplification-free single cell detection in 
droplets 
Rane, Tushar D., et al. "Droplet microfluidics for amplification-free genetic 
detection of single cells." Lab on a Chip 12.18 (2012): 3341-3347. Reproduced 
by permission of The Royal Society of Chemistry 
3.1 Background 
Droplet-based microfluidic systems have introduced otherwise ‘analog’ 
microfluidic systems (i.e. continuous flow microfluidics) to the benefits of the 
‘digital’ operation format. Analogous to the benefits of digital technology in 
electronics, droplet microfluidics allows ‘digital operations’ like mixing 
precise reagent quantities, splitting a reagent into precise small volumes etc. 
possible in microfluidic systems. Such digital operations can be very 
beneficial in biological analyses. For instance, amplification of individual 
DNA molecules by separating them from each other using DNA sample 
splitting into small volumes, i.e. digital PCR, can be used for quantification of 
DNA and sensitive detection of rare mutant DNA present in the background 
of a large number of wild-type DNA(4, 7, 41, 42).   
 At a cellular level, droplets can also be used for confinement and 
manipulation of single cells into small droplets, making them ideal for 
conducting high throughput single cell studies. However, this application of 
droplets is in its infancy with only a select few reports having started 
harnessing this potential of droplet microfluidics. For instance, Huebner et al. 
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demonstrated quantification of protein expression in single cells encapsulated 
within droplets, from a naturally fluorescent protein(20). Joensson et al. 
demonstrated detection of cell-surface biomarkers using enzymatic 
amplification in droplets(43). Boedicker et al. demonstrated analysis of single 
bacterial cells for their susceptibility to antibiotics in droplets, using a 
fluorescent cell viability indicator assay(25). Brouzes et al. developed 
optically-coded droplet assay for high-throughput screening of a drug library 
for its cytotoxic effect against U937 cells(5). Zeng et al. proposed a single cell 
PCR assay for genetic detection using a microfluidic droplet generator 
array(6).  This platform, although capable of high throughput screening, 
requires off-chip PCR reactions and a complex multicolor flow cytometer for 
amplicon detection.  
3.2 Solution 
 In this article we report a droplet microfluidic device that facilitates 
amplification-free genetic detection of single cells. This device offers a simple 
and yet fully integrated approach to include all the assay steps, including cell 
isolation, lysis, probe-target binding and fluorescent detection, performed 
within microfluidic droplets. We exploit the relatively unexplored probe 
hybridization based assays for detection of an intracellular genetic marker of 
interest. Single cell sensitivity is achieved in our platform through a two 
pronged approach. Initially, stochastic confinement of single cells within 
small droplets (pL volume) is used to maintain a low abundance intracellular 
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target of interest from single cells at high concentrations. Cell encapsulation 
in droplets is inherently a probabilistic process, presenting a unique 
challenge for ensuring encapsulation of a single cell in each droplet and hence, 
quantification of target cells present in a sample. However, cell encapsulation 
within droplets has been demonstrated to be a Poisson process in the droplet 
microfluidic literature (44-47). As a result, despite multiple cell encapsulation 
in a small fraction of droplets, the underlying Poisson distribution and hence 
the target cell count in the sample can be estimated. Secondly, the 
microfluidic platform is coupled with highly sensitive confocal fluorescence 
spectroscopy for sensitive detection of target biomolecules from individual 
droplets(33, 48). Simple temperature incubation requirements for cellular 
lysis and hybridization allow us to streamline all the assay steps in a single 
droplet. Our platform utilizes 16S ribosomal RNA (rRNA) as the genetic 
biomarker for pathogen detection. The 16S rRNA gene is often used for 
phylogenetic studies as it is highly conserved between different species of 
bacteria and archaea(49-51). In addition, 16S rRNA is typically present at 
104-105 copies per cell(52). Thus, using 16S rRNA as a surrogate biomarker 
offers the dual benefits of high specificity as well as a relatively large number 
per cell as compared to DNA. Confinement of these molecules within the 
small volume of a droplet, coupled with sensitive fluorescence detection 
readout like confocal fluorescence spectroscopy (39, 48, 53) makes 
amplification-free detection at single cell levels possible. A simple target 
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concentration calculation can illustrate the concentrating power of 
microfluidic droplets. Typical volumes handled by pipettors are in microliters. 
Assuming a single bacterial cell containing 20,000 16S rRNA molecules is 
lysed in a 1L volume, the target 16S rRNA molecule is present at the fM 
concentration, a concentration level that usually necessitates target 
amplification prior to detection. However, if the same cell is lysed while 
confined within a pL-sized droplet, the resulting nM target (Table 3.1) is 
readily detectable, eliminating the need for target amplification. The picoliter 
to nanoliter sized droplets indicated in Table 3.1 can be easily generated 
using flow focusing droplet generators(1). 
In situ detection of 16S rRNA encapsulated in a droplet requires 
fluorescent molecular probes capable of homogeneous detection in a solution 
phase without the need to remove (wash away) free probes. Molecular 
beacons are widely used fluorescence resonance energy transfer (FRET) 
probes that fluoresce upon hybridization with complimentary targets(54). 
Since unhybridized beacons are minimally fluorescent, they form excellent 
probes for homogeneous detection of nucleic acid targets(55, 56). However, 
standard oligonucleotide molecular beacons suffer from the complication of 
negative charge based repulsion as well as the requirement of high salt 
concentrations when used to detect a large target molecule with extensive 
secondary structure like 16S rRNA. Instead, we use a peptide nucleic acid 
(PNA) beacon to carry out intra-droplet 16S rRNA detection. PNA is a 
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synthetic DNA analogue synthesized by attaching nucleic acid bases to a 
peptide backbone. The absence of negative charge on the PNA backbone 
prevents the problems of charge-based repulsion from the target nucleic acid 
as well as removes the requirement for higher salt concentration for effective 
target binding(57). Lower salt concentrations promote denaturation of the 
16S rRNA targets, providing easier access for the probe molecules to bind 
their complementary region on the rRNA(57). 
 The operational procedure of the microfluidic single cell detection 
platform is illustrated in Fig. 3.1. Initially a pathogenic cell sample is mixed 
with PNA beacon. The mixture is diluted and compartmentalized into 
uniform picoliter sized droplets. These droplets then traverse through an 
incubation zone where exposure to a high temperature results in pathogenic 
cell lysis as well as PNA beacon hybridization with target 16S rRNA 
molecules. Thermal lysis of cells is a commonly used cell lysis technique, 
which has been shown to be efficient at cell lysis and post-lysis analysis of 
cellular contents using PCR for a variety of cell types including bacterial(58, 
59) and human cells(60) as well as virii(61). The beacon becomes fluorescent 
once hybridized with a complementary sequence on a conservative site of the 
16S rRNA target, resulting in a substantial increase in fluorescence of the 
droplet containing a pathogenic cell. Consequently, the cell of interest is 
identified and quantitated by detecting the bright fluorescent droplets using 
confocal fluorescence spectroscopy. 
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3.3 Experimental section 
3.3.1 PNA Beacon 
 The PNA beacon sequence used for our experiments is N-BHQ3-E-
GCT-GCC-TCC-CGT-AGG-A-KK-Cy5-C. The probe sequence used in our 
experiments is complementary to the bacterial domain S-D-Bact-0338-a-A-
18(57). In its natural state the beacon folds on itself in solution, so that the 
quencher BHQ3 and the fluorophore Cy5 are in close vicinity with each other, 
leading to effective quenching of Cy5 fluorescence (Fig. 3.1, inset). However, 
when bound to a complementary target, the fluorophore moves away from 
quencher and starts fluorescing. 
3.3.2 Control Targets and Pathogen Cells 
The synthetic target used in the characterization experiments (referred 
to as ‘rRNA mimic’ hereafter) is a 200 bp oligonucleotide target mimicking a 
portion of the E. coli 16S rRNA sequence (5’-CTAGT AGGTG GGGTA 
ACGGC TCACC TAGGC GACGA TCCCT AGCTG GTCTG AGAGG ATGAC 
CAGCC ACACT GGAAC TGAGA CACGG TCCAG ACTCC TACGG GAGGC 
AGCAG TGGGG AATAT TGCAC AATGG GCGCA AGCCT GATGC AGCCA 
TGCCG CGTGT ATGAA GAAGG CCTTC GGGTT GTAAA GTACT TTCAG 
CGGGG-3')(62). The oligonucleotide was synthesized by Integrated DNA 
Technologies (Coralville, Iowa). Two types of control samples were prepared 
including 1) a ‘positive control’ containing synthetic targets hybridized with 
PNA beacon (100nM) in the presence of background human genomic DNA 
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(1g/100L) and 2) a ‘ negative control’ containing PNA beacon (100nM) in 
the presence of background human genomic DNA (1ug/100ul). The synthetic 
target concentration was different for different experiments as indicated in 
the results section. These samples underwent incubation at 65oC for 1 hour 
followed by gradual cooling to room temperature in a thermocycler to promote 
hybridization of the PNA beacon with the synthetic target. These samples 
were then stored at -20oC until the experiments were conducted on the 
microfluidic chips. Prior to the experiments on chip, 10nM Alexa Fluor® 488 
dye was added to these samples as an indicator to visualize the droplet 
boundary and detect the passage of a droplet through the detection region(48). 
Alexa Fluor® 488 exhibits minimal spectral crosstalk with the Cy5 dye 
labeled to the PNA beacon and thus does not interfere with rRNA detection.  
 For the experiments with an actual pathogen sample, we used E. coli 
as a model pathogen. Prior to the experiments, E. coli cells (ER2566 strain, 
New England Biolabs, Inc) were grown overnight at 37oC on a shaker (MaxQ 
2000, Thermo Fisher Scientific Inc.) in an incubator (Napco 8000WJ, Thermo 
Fisher Scientific Inc.). We used M9 minimal media (TEKnova, Inc.) for 
culturing the bacterial cells. E. coli cells from this overnight culture were 
spun down and resuspended in PBS at concentrations required for an 
experiment. For all of our experiments, we maintained the PNA beacon 
concentration constant at 100 nM. The hybridization buffer used for all the 
experiments including those with the synthetic target was maintained at a 
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constant composition of 40% formamide, 100 mM NaCl and 25 mM Tris-HCl. 
10 nM Alexa Fluor® 488 was added as an indicator dye to these cell samples 
before introducing them on the microfluidic chip . 
3.3.3 Design and Fabrication of Microfluidic Device 
 Fig. 3.2 shows the layout of the microfluidic chip used for conducting 
the single cell pathogen detection assay. We used a flow focusing droplet 
generator to produce uniform picoliter volume droplets. As seen from Table 
3.1, smaller droplet sizes lead to higher target concentrations from single 
cells. Hence, the signal to background ratio for this detection platform can be 
tuned by varying the droplet size. The sample droplets produced at the 
droplet generator region are channeled to a droplet ‘incubation zone’ on the 
chip. The chip is designed with two different heights of photoresist. All the 
areas on the chip other than the ‘incubation zone’ are made with 50 m 
photoresist height. The incubation zone is fabricated with 350 m tall layer of 
photoresist to allow droplets to spend sufficient time on chip for completion of 
cell lysis and probe hybridization with target 16S rRNA molecule.  
 The chip was fabricated with polydimethylsiloxane (PDMS) using the 
standard soft lithography technique. Briefly, a silicon wafer was spin coated 
with a 50 m thick layer of SU8-3025 Photoresist (PR) (MicroChem Corp.) 
and patterned through photolithography. This thin PR layer was hard baked 
onto the wafer. Another thick SU8-3050 layer was then spin coated on the 
same wafer and patterned using the second mask to fabricate the incubation 
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zone of the chips. The second layer was also hard baked on the wafer and the 
patterned wafer was then used as a mold to fabricate PDMS chips. 
 To fabricate PDMS structures from the silicon wafer molds, SylgardTM 
184(Dow Corning) base and curing agent were mixed in a 10:1 ratio by 
weight. This mixture was degassed in vacuum and then poured on top on the 
silicon wafer molds. The mixture on the wafers was cured at 80oC for 30 mins. 
The cured PDMS was then peeled off the silicon wafer and individual devices 
were cut out. Access holes for fluid entry were punched into the chips and the 
chips were then bonded to No. 1 coverglass (Fisherfinest) using oxygen 
plasma bonding.  
3.3.4 Optical Detection Setup 
 Confocal fluorescence spectroscopy (CFS) offers the sensitivity as well 
as high speed required for rapid screening of droplets. We used a custom built 
CFS setup for our experiments. The details of a similar setup construction 
were discussed previously(35, 48). The setup is capable of dual laser 
excitation (488 nm and 633 nm) as well as simultaneous dual color detection, 
including the ‘green’ (centered at 520 nm) and ‘red’ (centered at 670 nm) 
wavelength bands. A custom metal plate was designed to act as an interface 
between the microfluidic chip and the CFS setup. This metal plate was 
mounted on a Piezo stage (Thorlabs) to allow precise positioning of the chip 
with respect to the objective on the CFS setup. The metal plate was also used 
to position a peltier heater below the ‘incubation zone’ on the microfluidic 
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chip. The peltier heater was maintained at a fixed incubation temperature 
throughout an experiment on chip. 
3.3.5 Operation of Microfluidic Device   
 The chips were treated with Aquapel (PPG Industries) to render the 
channels hydrophobic prior to each experiment(22). Following this treatment, 
oil phase was introduced onto the chip through the oil inlet and allowed to 
flow on chip for a few minutes to wet the channels with oil phase. The oil 
phase used for our experiments consisted of FC-40 oil (3M) and 2% EA 
surfactant by weight (Raindance Technologies, Inc). 
 An E. coli and PNA beacon mixture was then introduced onto the chip 
through the sample inlet for each experiment. Before initiating droplet 
generation on chip, the chip was placed onto the custom metal plate attached 
to the CFS setup. The chip was held in place using vacuum lines on the metal 
plate. The chip was placed such that the peltier heater on the metal plate was 
located below the incubation zone on the chip. The peltier heater was 
maintained at a constant temperature of 65oC throughout the course of an 
experiment. The excitation laser beam from the CFS setup was focused on 
the fluorescence detection region on the chip. After the chip was ready for 
fluorescence data collection, droplet generation was initiated on chip by 
pressurizing both oil and sample inlets. The droplets took approximately one 
hour to traverse the incubation region on chip before reaching the 
fluorescence detection region. The droplets were imaged after passing 
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through the incubation region for each experiment to estimate the droplet 
size and account for any variations in droplet size between experiments. 
Fluorescence data was then continuously collected from the droplets passing 
the fluorescence detection region on chip while droplets were still being 
generated upstream on the chip. 
3.4 Results and Discussion  
  Prior to our experiments with live cell samples, we conducted some 
tests with the rRNA mimic. The objective of these tests was two-fold: First to 
establish the sensitivity of the assay and second to simulate different cell 
concentrations in a cell sample to test quantification ability of our platform. 
To conduct this assay, PNA beacon was mixed with different concentrations 
of the rRNA mimic in the background of human genomic DNA as described in 
the experimental section. These experiments were conducted on a separate 
microfluidic device discussed in Section 3.6.1. Briefly, this microfluidic device 
is capable of using valves to generate arbitrary sequences of droplets 
generated using two independent samples (positive and negative control 
samples described in the ‘Experimental’ section above).  
 Fig. 3.3 illustrates sample fluorescence spectroscopy traces from two of 
these experiments. Fig. 3.3a indicates fluorescence data collected from an 
artificially generated sequence of one positive droplet per 2 droplets. The 
positive droplet is generated using a sample consisting of PNA beacon 
hybridized with 6.25 nM rRNA mimic in the background of human genomic 
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DNA while the negative droplet is generated using a sample containing PNA 
beacon with human genomic DNA only. This experiment simulates a 
situation in which the cell concentration in a cell sample is such that 
approximately 50% of the droplets are empty while the other 50% have one or 
more cells encapsulated in them. Fig. 3.3b shows similar fluorescence data for 
rRNA mimic concentration of 1.56 nM. In this case, the sequence used was 
one positive droplet per 5 droplets. This experiment simulates a situation in 
which the cell concentration in a cell sample is such that approximately 80% 
of the droplets are empty while the other 20% have one or more cells 
encapsulated in them. The histograms in Fig. 3c and 3d correspond to the 
fluorescence data traces in Fig 3a and Fig 3b respectively. These histograms 
show the distribution of the burst size (sum of photons detected per droplet) 
for a total of 300 droplets for each corresponding condition in Fig. 3.3a and b. 
The histogram shows two distinct peaks indicating two populations of 
droplets i.e. positive droplets with rRNA mimic and negative droplets without 
rRNA mimic. 
 Sequences of droplets as shown in Fig. 3 with different ratio of the 
number of positive droplets to the negative droplets were run for extended 
periods of time and the fluorescence data collected was analyzed to 
differentiate between positive and negative droplets and test the reliability of 
the platform in differentiating between these two populations of droplets for 
long periods of time. This experiment was repeated for two different 
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concentrations of rRNA mimic (6.25 nM and 1.56 nM) hybridized with the 
PNA beacon. The fluorescence data was analyzed to generate burst size for 
each droplet. A burst size threshold was determined to differentiate between 
‘positive’ and ‘negative’ droplets as described in section 3.6.2 in the 
Supplementary section. Three different batches of 100 droplets each were 
analyzed to generate an ‘observed positive droplet count per 100 droplets’ for 
each condition (i.e. positive to negative droplet count ratio) for each rRNA 
mimic concentration. 
The results from this data analysis are plotted in Fig. 3.4. It shows that the 
expected and observed positive droplet count for each condition (i.e. positive 
to negative droplet count ratio) are in excellent agreement with each other for 
both rRNA mimic concentrations tested. These plots thus show that the 
platform can reliably differentiate different positive to negative droplet count 
ratios from each other at close to nanomolar target concentration in positive 
droplets. As seen from Table 3.1, these target concentrations in positive 
droplets correspond to the expected 16S rRNA concentrations obtained in 
picoliter sized droplets following a single pathogen cell lysis within the 
droplet. Thus, the results indicate the capability of our detection platform to 
quantify target cell count in a sample provided the cells are encapsulated in 
droplets with volumes in the picoliter regime. 
We used E. coli as a model pathogen for single cell detection. Initially we 
tested the PNA beacon with E. coli cells in bulk under different temperature 
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conditions to find the best conditions for optimal cell lysis and hybridization 
efficiency (see section 3.6.3). Briefly, we tested E. coli cell incubation with 
PNA beacon at three temperature conditions viz. Room Temperature (RT), 
65oC and 95oC. Fluorescence stemming from PNA beacons hybridized with 
complementary target rRNAs was obtained from each sample using the CFS 
setup. Our results indicate that incubation at RT barely led to cell lysis and 
probe hybridization. However, similar fluorescence signal for both 65oC and 
95oC temperatures indicated similar assay efficiency at these temperatures 
(Fig. 3.8). We used 65oC incubation for on chip experiments to avoid any 
problems associated with droplet evaporation and instability at high 
temperature incubation. We then conducted tests with E. coli cell samples on 
our microfluidic chip (Fig. 3.2). As a first test to estimate the background 
fluorescence from the PNA beacon encapsulated within droplets, we 
generated droplets using a sample containing only PNA beacons without E. 
coli cells. Fig. 3.5a shows the fluorescence signal collected from a few 
representative droplets generated using this sample. As discussed in the 
experimental section, this sample contained an indicator dye (Alexa Fluor® 
488) for easy visualization of droplets in the fluorescence data. The indicator 
dye is present in all the droplets regardless of presence or absence of PNA 
beacon or target cells. Hence, every droplet can be seen as a peak in the 
indicator dye fluorescence data (Green trace). The red trace in Fig. 3.5a 
shows fluorescence signal collected from the PNA beacon (i.e. Cy5 dye on the 
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beacon). In Fig 3.5a, we observe a very small amount of PNA background 
fluorescence in the red trace that is associated with the intrinsic background 
of free PNA beacons resulting from stochastic opening of the beacons due to 
thermal fluctuations. Fig. 3.5b indicates similar fluorescence data from a 
high concentration E. coli cell sample. A standard curve indicating the 
CFU/ml (CFU: Colony Forming Unit) concentration vs OD (Optical Density 
at 600nm) measurement was generated to estimate the CFU/ml 
concentration of an E. coli sample used for an experiment. In this case, the 
droplet size and the starting E. coli concentration lead to a concentration 
estimate of 15.7 CFU/droplet. Although the actual distribution of cells within 
the droplets is expected to be a Poisson distribution, on an average, we expect 
target 16S rRNA from at least one cell to be present in virtually all the 
droplets in this case. The fluorescence data collected from the droplets indeed 
indicates a strong rise in fluorescence from each droplet in the red trace i.e. 
PNA beacon trace, confirming our expectation.  
Finally Fig. 3.6 illustrates the fluorescence data collected from the droplets 
generated using a sample containing low concentration of E. coli cells. The 
droplet size and initial E. coli concentration lead to a concentration estimate 
of 1 CFU per 20 droplets. In this case, we expect a large fraction of droplets to 
be empty with no target E. coli cells while a few droplets are expected to 
contain target E. coli cells. Thus, we expect digital fluorescence signal from 
these droplets i.e. a large number of droplets with weak background 
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fluorescence from the PNA beacon with a few droplets showing strong 
fluorescence signal in the red trace. The trace in Fig. 3.6 indeed matches our 
expectation indicating the feasibility of using our approach to detect 
pathogens from a sample with intact pathogenic cells at single cell level. 
3.5 Conclusion 
In conclusion, we proposed a novel scheme for sequence-specific detection of 
single cells using genetic biomarkers. We demonstrated the functioning of our 
platform with a 16S rRNA mimic target as well as intact E. coli cells as a 
model pathogen. The success of our experiments with a pathogen sample with 
intact pathogenic cells indicates the promise in utilization of our platform 
with clinical samples with appropriate testing and optimization of assay 
conditions. Although the functioning of the platform was demonstrated for 
pathogen detection, the platform is versatile enough to be applied towards 
other single cell studies. 
3.6 Supplementary section 
3.6.1 Device design and fabrication for experiments with 16s rRNA 
mimic  
We designed a dual layer PDMS device for our experiments with the rRNA 
mimic. The schematic illustrating the operation of this device is shown in Fig. 
3.7. The device consisted of one oil inlet and two sample inlets. One of the 
sample inlets took the ‘positive control’ (PNA beacon + rRNA mimic + Human 
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Genomic DNA) as input while the other sample inlet took the ‘negative 
control’ (PNA beacon + Human Genomic DNA) as input, according to the 
description in the article text. Both of these sample inlets are separated from 
the oil flow channel through two valves. These valves are fabricated using 
standard multilayer soft lithography as has been described previously(48). 
The actuation of these valves can controlled using custom software written in 
MatlabTM. Alternating actuation of these valves was used to generate droplet 
trains consisting of different proportions of droplets generated from the 
positive and negative control samples. The droplet train thus generated 
simulates the train of droplets we expect to be generated while working with 
a cell sample i.e. a series of droplets with (positive) and without cells 
(negative) encapsulated in them. These droplet trains are then routed to a 
downstream detection region on chip, where fluorescence detection is 
conducted through Confocal Fluorescence Spectroscopy.  
3.6.2 Fluorescence data analysis for experiments with 16s rRNA 
mimic 
Both the positive and negative control samples being input to the device 
described above in 3.6.1 had an indicator dye (Alexa 488 10nM) added to 
them for identification of the droplet region in the oil background from the 
fluorescence data collected from the droplet train. Custom software written in 
MatlabTM was used for processing the raw fluorescence data. As described in 
the article, our fluorescence setup is capable of dual excitation with a 488nm 
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and a 633nm wavelength laser. The fluorescence collected from the sample 
excited by these lasers is then split into two wavelength bands centered at 
520nm (Green) and 670nm (Red). Fluorescence intensity from these two 
wavelength bands is sensed by two individual avalanche photodiodes and 
converted into photon counts per unit time using custom software written in 
LabVIEW. The fluorescence signal in the green band is due to the 
fluorescence of the indicator dye while the fluorescence in the red band is 
from the Cy5 dye on the PNA beacon. Initially the droplet region for each 
individual droplet is identified from the fluorescence signal trace 
corresponding to the green band by setting a threshold on fluorescence 
intensity. Varying this threshold doesn’t have much effect on identification of 
the droplet region due to uniform fluorescence intensity of the indicator dye 
encapsulated within the droplets. The photons in the red band from the 
region corresponding to each individual droplet were then summed to obtain 
a burst size for each droplet. This burst size was normalized to a standard 
droplet size to overcome any bias due to small size differences in different 
droplets. Since the droplet sequence in the droplet train was known, first 10 
control sample droplets were used to set a threshold for differentiating 
between ‘positive’ and ‘negative’ droplets. Specifically the threshold was set 
at a stringent [burst size mean + 20* (burst size standard deviation)] to 
differentiate between positive and negative droplets. This stringent threshold 
prevented any false positives occurring due to small fluctuations in the 
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fluorescence intensity of ‘negative’ droplets over time. For each different 
droplet train, three batches of 100 droplets each were analyzed to obtain a 
positive droplet count per 100 droplets. The mean and standard deviation 
obtained from this analysis was then plotted as shown in Fig. 3.4 in the 
article.  
3.6.3 Optimizing the incubation temperature for the PNA beacon 
assay in bulk 
Prior to our experiments with E. coli cell samples on chip, we conducted some 
experiments in bulk to optimize the temperature incubation conditions for 
the assay with live cell samples. Briefly we mixed different quantities of 
E.coli cells with PNA beacon and incubated them at different temperatures. 
Fluorescence detection was then conducted on these samples using Confocal 
Fluorescence Spectroscopy (CFS). PNA beacon hybridization with 
complementary target (16S rRNA) released after lysis of the E. coli cells leads 
to increase in fluorescence collected from a sample. We tested three different 
temperatures viz. Room Temperature (RT), 65oC and 95oC. The results shown 
in Fig. 3.8 indicate that the cell lysis and PNA hybridization was inefficient 
at RT incubation. Incubation at 65oC and 95oC on the other hand resulted in 
comparable cell lysis and PNA hybridization efficiency. We used 65oC 
incubation for our experiments on chip to prevent any possible problems with 
droplet evaporation or instability due to high temperature incubation.  
54 
Fig 3.1: Schematic of the droplet assay platform for single cell 
detection. A statistically dilute mixture of pathogenic cells and PNA beacons 
is encapsulated into picoliter sized droplets, which are then incubated at 
elevated temperatures to facilitate cell lysis and beacon-target hybridization. 
PNA beacons encapsulated in a droplet containing a cell start fluorescing 
after hybridization with complementary 16S rRNA targets released from the 
cell. The specific cell of interest is detected and quantified by screening the 





Fig 3.2:  Microfluidic chip design. The top image is the actual mask 
design used for fabricating our microfluidic chip. The chip design consists of 
two different layers fabricated using two different heights of photoresist (50 
µm and 350 µm). The chip features an oil inlet with two sample inlets. The 
chip is capable of generating droplets from a sample, droplet incubation at a 
high temperature (Peltier heater region) and fluorescence detection from the 
droplets using CFS. The bottom left image shows a stream of sample droplets 
generated on an actual chip, while the bottom right image is a photograph of 












Fig 3.3: Fluorescence data collected from the artificially generated 
sequences of positive control (PNA beacon + rRNA mimic + human 
genomic DNA) and negative control (PNA beacon + human genomic 
DNA only) droplets. The fluorescence observed is emitted by the Cy5 dye 
conjugated to the PNA beacon. a) The plot shows fluorescence data from a 
droplet sequence with one positive droplet per two droplets where the 
positive droplets contained 6.25 nM rRNA mimic concentration. The 
fluorescence data shows a clear difference between the positive droplets with 
strong fluorescent bursts and negative droplets with low background 
fluorescent bursts. b) The data shown is similar to subfigure ‘a’ but with the 
positive droplets containing rRNA mimic concentration of 1.56 nM and the 
droplet sequence being one positive droplet per 5 droplets. c and d) The 
histograms show the distribution of the burst size (sum of photons detected 
per droplet) for 300 droplets from each condition observed in the fluorescence 
data traces. Histograms in subfigures ‘c’ and ‘d’ correspond to the 
fluorescence data traces in ‘a’ and ‘b’ respectively. The bimodal nature of both 
histograms indicates clear demarcation between positive droplets with large 
burst size and negative droplets with small burst size. (The x axis has a 
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Fig 3.4: Quantification of positive droplet count in a droplet 
sequence for different artificially generated droplet sequences. For 
each rRNA mimic concentration, different droplet sequences with different 
‘expected’ positive droplet counts were generated and fluorescence data was 
collected as shown in Fig. 3.3. This data was analysed to obtain the ‘observed’ 
positive droplet count for each sequence using burst size thresholding. 
Excellent linearity and close to 1 slope in the relationship between ‘expected’ 
positive droplet count and the ‘observed’ positive droplet count for both rRNA 
mimic concentrations tested indicate the quantification ability of our 
platform. (a: rRNA mimic concentration 6.25nM,  linear fit y=1.0115x-0.1498, 
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Fig 3.5: Fluorescence data collected from droplets with and without 
E. coli cells. The green traces indicate the fluorescence signal collected from 
the indicator dye (Alexa 488) present in all droplets regardless of presence or 
absence of E. coli cells. Each peak in the green trace indicates a droplet 
passing through the detection region of the CFS setup. The corresponding 
time points in the red traces indicate the fluorescence signal collected from 
the PNA beacon present within the same droplet. a) The fluorescence data 
shown here corresponds to droplets generated using a control sample (PNA 
beacon only). b) The fluorescence data shown here corresponds to a high 
concentration E. coli sample. The estimated E. coli sample concentration for 












































































Fig 3.6: Fluorescence data collected from droplets generated using a 
low concentration E. coli sample. Similar to Fig. 3.5, the green trace 
shows fluorescence from the indicator dye while the red trace indicates the 
fluorescence from the PNA beacon encapsulated within the droplets. The E. 
coli concentration for this sample was estimated at 1 CFU per 20 droplets. In 
this case, we expect majority of droplets to have no E. coli cells with a few 
droplets having E. coli cells. The inset shows a zoom in of a small section of 








































Table 3.1: Droplet volume and its effect on the target concentration 
within the droplet: The following table illustrates the concentrating power 
of droplets with respect to single cells. In this table, we assume that an 
intracellular target of interest is present at the concentration of 20000 
targets per cell. This number is well within the range of 16s rRNA count per 
E. coli cell (52), (63). The table shows how the concentration of the same 
number of target molecules (from a single cell) changes from nanomolar to 







Target Molecules per droplet 20000 
 
   Droplet diameter  
(um) 
Droplet volume  
(pL) 
Target concentration in droplet  
(nM) 
15 1.77 1.88E+01 
25 8.18 4.06E+00 
35 22.45 1.48E+00 
50 65.45 5.07E-01 
75 220.89 1.50E-01 
100 523.60 6.34E-02 
1000 523598.78 6.34E-05 
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Fig. 3.8: Effect of incubation temperature on the cell lysis and PNA 




































Chapter 4: Continuous Flow Digital Loop-Mediated 
Isothermal Amplification (LAMP) Reaction for Digital 
Nucleic Acid Detection 
4.1 Introduction 
Digital PCR (polymerase chain reaction) is rapidly becoming the technique of 
choice for ultra-sensitive quantification of nucleic acid molecules present in 
biological samples (7-9, 64, 65). Digital PCR involves breaking down a 
biological sample mixed with PCR reagents into a large number of individual 
reactions such that each reaction contains either one copy or no copies of the 
target nucleic acid. As PCR is run in parallel on all these reactions through 
thermocycling, an accurate molecular count of a nucleic acid of interest 
present in the biological sample can be obtained through simple counting of 
positive PCR reactions from the total pool of reactions. 
Since the first demonstration of this concept in a 96 well plate format (41), a 
variety of microfluidic platforms have been proposed for practical 
implementation of the digital PCR technique. These platforms can be broadly 
classified into two different types. One type involves microfabrication of a 
large array of micro-wells on a substrate (4, 66, 67). This format is capable of 
real-time digital PCR monitoring. However, the sample volume that can be 
analyzed and the well size are fixed by the microfabricated design. Any 
change in sample volume or individual reaction volume (well size) requires a 
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change in microfluidic design. The second type involves generation of a large 
number of tiny droplets (nanoliter to picoliter sized) from the sample mixed 
with PCR reagents(7, 8). Each of the individual droplets then functions as an 
independent reaction container. Similar to the micro-well format, however, 
commercial instruments available for conducting this type of analysis can 
typically process fixed sample volumes with fixed droplet size. Furthermore, 
the analysis workflow for droplet-based analysis is fragmented and requires 3 
separate instruments/devices for completion of analysis viz. 1) A droplet 
generator instrument 2) A thermocycler and 3) A droplet reader instrument 
to detect reaction outcome from droplets. This mode of analysis reduces 
potential for higher throughput due to idle time on two of the three 
instruments while one instrument is processing the samples to be analyzed.  
Implementing the droplet-based digital nucleic acid analysis workflow on a 
single sample-to-answer device can overcome the issues mentioned above. On 
such a device, all three steps of analysis viz. droplet generation, droplet 
incubation as well as droplet detection are performed on the same device in a 
continuous flow manner. Continuous flow operation implies that there is no 
idle time involved in the sample processing workflow and the speed at which 
fluorescence can be reliably detected from droplets is the only rate limiting 
step limiting the throughput of this system. Secondly delivery of small 
sample plugs separated by immiscible oil phase plugs as has been reported in 
the past (25, 68) can be used to deliver any sample volume that needs to be 
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processed for a particular sample. This sample volume could range from a few 
tens of nanoliters to virtually any large volume that needs to be processed 
without any loss of sample in the process. 
Despite this potential for improved throughput, larger sample volume 
processing capability and hence, wider dynamic range, implementing 
continuous flow digital PCR in droplet format is difficult due to the need for 
thermocycling. Attempts have been made in the past to realize digital PCR in 
a continuous flow format. However, these attempts have had limited success 
in terms of target nucleic acid quantification (23, 69). 
Loop-mediated isothermal amplification (LAMP) is a great alternative to 
PCR for nucleic acid amplification. LAMP functions through auto-cycling 
strand displacement DNA synthesis. LAMP through its simple requirement 
for single temperature incubation is very suitable for implementation in a 
continuous flow format. Furthermore, since LAMP uses a set of 4 different 
primers recognizing six independent sequences on a target nucleic acid, it can 
also provide better specificity than PCR (70, 71). 
The schematic shown in Fig. 4.1a illustrates the simple functioning scheme of 
the device we designed for continuous flow digital nucleic acid detection. A 
sample to be analyzed is mixed with LAMP reagents and then digitized into 
tiny picoliter-sized droplets on to the device. The image shown in Fig. 4.1b as 
well as supplementary video 1 shows the droplet generation process on the 
device. The droplets then flow to an incubation region where they are exposed 
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to temperature suitable for the LAMP reaction. The image shown in Fig. 4.1c 
and supplementary video 2 show droplets in this region of the device. Finally 
these droplets move to a downstream detection region on the device, where 
fluorescence detection is conducted on these droplets using confocal 
fluorescence spectroscopy. All three steps required for analysis occur 
simultaneously on the device. As a result, the throughput of the device is only 
limited by the speed at which fluorescence can be detected from the droplets. 
4.2 Experimental section  
Device Fabrication: An image of the whole microfluidic device is included 
in Fig. 4.6. The devices were fabricated using polydimethylsiloxane (PDMS) 
as the structural material. To avoid evaporation of droplets during transit 
through the incubation region, we devised a fabrication scheme to fabricate 
thin PDMS devices. Initially the molds for the devices were fabricated on 
4inch Si wafers using standard photolithography technique with SU8-3025 
(MicroChem Corp.) as the structural material. Initially a relatively thick 
layer of PDMS [Sylgard 184(Ellsworth Adhesives), 10:1 base to curing agent 
ratio] is coated on a blank wafer at a slow spin speed of 100 rpm on a spin 
coater (Laurell Technologies, Corp). This layer is cured at 80oC for 10 min. 
While the thick PDMS layer is being cured, a thin layer of PDMS (6:1 base to 
curing agent ratio) is the spin coated on the device mold at 350rpm. This thin 
layer of PDMS is cured at 80oC for 6 min. A rectangular piece, large enough 
to cover the whole device area, is then cut out from the cured thick PDMS 
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layer. This rectangular piece is partially bonded to the cured thin PDMS 
layer on the device mold by baking at 80oC for 5 min. Finally the bonded 
thick and thin layers are peeled off the mold. The thick layer just acts as a 
support to allow for manipulation of the thin layer. Access holes are then 
punched on the device at the input and output ports. The thin layer is then 
bonded to thickness #1 cover glass (Ted Pella, Inc) using standard O2 plasma 
treatment. The thick layer being partially bonded to the thin layer, can then 
be easily peeled off without breaking the bond between the thin layer and the 
coverglass. Small cubes of PDMS (10:1 base to curing agent ratio) with holes 
punched at the center are then bonded to the thin PDMS layer using O2 
plasma treatment. Finally another thickness #1 coverglass is bonded to the 
thin PDMS layer, effectively sandwiching this layer between two pieces of 
coverglass in the incubation region on the device. Images of the actual device 
can be seen in Fig. 4.6.  
Materials: The following reagents were used for LAMP reactions on and off-
chip: Betaine (Sigma-Aldrich Co., LLC), MgSO4 (New England Biolabs), ROX 
reference dye (Life Technologies), dNTPs (Life Technologies), BSA (New 
England Biolabs), Calcein (Anaspec, Inc), Manganese Chloride (Sigma-
Aldrich Co., LLC), EvaGreen dye (Biotium Inc), Bst 2.0 WarmStart DNA 
Polymerase and isothermal reaction buffer (New England Biolabs). A typical 
reaction mixture consisted of 1X isothermal reaction buffer, 0.8M Betaine, 
7mM MgSO4 , 25µM Calcein, 0.75mM Manganese Chloride, 0.25µM ROX 
77 
reference dye, 0.1mg/mL BSA, 1.4mM dNTPs and 0.32 U/µL BST WarmStart 
DNA Polymerase. For experiments with EvaGreen, Calcein and Manganese 
chloride were replaced with 0.5X EvaGreen dye where 1X is the 
manufacturer recommended concentration. 
The primers for the experiments in this article were designed to be specific to 
a region on the 16s rRNA gene for Neisseria Gonorrhoeae. The primers were 
designed using the LAMP primer design software PrimerExplorer. For the 
experiments with synthetic target, a double stranded target was generated 
using fusion PCR and then purified from the gel band specific to the target 
after running electrophoresis on the PCR product. For the experiments with 
genomic DNA, DNA extracted from Neisseria Gonorrhoeae (Strain FA1090, 
ATCC® 700825™) was purchased from ATCC®. The base sequences of 
primers used for LAMP experiments are as follows 
F3: 5- ATC CTG GCT CAG ATT GAA CG -3 
B3: 5- ATA TCG GCC GCT CGG ATA -3 
FIP: 5- GCC ACC CGA GAA GCA AGC TTC TTT TGG CGG CAT GCT TTA 
CAC AT -3 
BIP: 5- TAC CGG GTA GCG GGG GAT AAT TTT CTG CTT TCC CTC TCA 
AGA CG -3 
LoopF: 5- TGC TGC CGT CCG ACT TG -3 
LoopB: 5- CTG ATC GAA AGA TCA GCT AAT ACC G -3 
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The base sequence of the target region flanked by the primers F3 and B3 is 
5- ATC CTG GCT CAG ATT GAA CGC TGG CGG CAT GCT TTA CAC ATG 
CAA GTC GGA CGG CAG CAC AGG GAA GCT TGC TTC TCG GGT GGC 
GAG TGG CGA ACG GGT GAG TAA CAT ATC GGA ACG TAC CGG GTA 
GCG GGG GAT AAC TGA TCG AAA GAT CAG CTA ATA CCG CAT ACG 
TCT TGA GAG GGA AAG CAG GGG ACC TTC GGG CCT TGC GCT ATC 
CGA GCG GCC GAT AT -3   
For all experiments, the final concentration of all primers in the reaction 
mixture was kept constant at 1) 0.2µM for F3, B3 2) 1.6uM for FIP and BIP 
and 3) 0.8uM for LoopF and LoopB respectively. The oil phase used for 
experiments on-chip consisted of FC40 (3M) with 5% perfluoropolyether-
polyethyleneglycol surfactant (RAN Biotechnologies, Inc) by weight 
Device operation: Reagents (oil phase and sample) were delivered to the 
device through custom assembled flow controllers with flow feedback (IDEX 
Health and Science, LLC). For the duration of an experiment, the device was 
mounted on a platform designed such that the incubation region on the 
device was placed on a custom peltier heater assembly. This peltier heater 
assembly was used to maintain the incubation region on the device at a 
temperature of 63C suitable for the LAMP reaction. Fluorescence was 
continuously detected from droplets passing through the detection region on 
the device by a custom built confocal fluorescence spectroscopy setup. The 
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optical setup is capable of dual excitation (488nm and 552nm) as well as dual 
band detection (506-534nm and 608-648nm).  
4.3 Results and Discussion  
Reliable quantification with digital LAMP reaction requires assay readout 
with good signal to background ratio (SBR). We compared two different assay 
outcome indicators for the LAMP assay viz. 1) DNA binding dye EvaGreen® 
and 2) A Calcein dye based indicator (71). The details of the experiments are 
included in section 4.5.1. Briefly, EvaGreen indicates a positive LAMP 
reaction through increased fluorescence resulting from the binding of the dye 
to the large amount of double stranded DNA generated by the LAMP reaction. 
Calcein dye is non-fluorescent when bound with Manganese ions. However, 
large amount of DNA generated during LAMP reaction results in generation 
of pyrophosphate as a byproduct, which sequesters Manganese from Calcein, 
resulting in return of the dye to its original fluorescence. We tested both 
readouts for SBR under different conditions using the synthetic dsDNA 
target containing a base sequence specific to Neisseria Gonorrhoeae (Fig. 4.7, 
4.8, 4.9 and 4.10). Our results indicate that the maximum SBR possible with 
EvaGreen was approx. 2 whereas the maximum SBR possible with Calcein 
was approx. 6.5. 
We then tested both of these assay outcome indicators on the droplet device 
(Fig. 4.1). To conduct this test, a low concentration of the synthetic target was 
mixed with LAMP reagents and then processed on the droplet device. Figures 
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4.2 and 4.3 show a sample digital fluorescence signal obtained from droplets 
using the two different detection techniques. In both cases, an indicator dye 
(ROX) is encapsulated in the droplets. The fluorescence channel 
corresponding to this dye shows steady fluorescence intensity across droplets 
whereas assay readout specific fluorescence channel shows characteristic 
digital signal with droplet intensities varying between two different levels. 
Calcein-based detection clearly shows much stronger difference between 
positive droplets (positive LAMP reaction) and negative droplets (negative 
LAMP reaction). As data is collected from a large number of droplets, the two 
droplet populations (positive and negative) can be easily separated from each 
other in both cases as long as the positive droplet population is a significant 
fraction of the total droplet population. However, for droplet populations with 
rare positive droplets, it was not possible to reliably threshold the droplet 
intensity data to identify positive droplets from the droplet population with 
EvaGreen based readout due to low SBR. So for all subsequent experiments 
we used Calcein-based readout as the detection technique.   
We then tested the capability of the continuous flow device to function for 
long periods of time while processing samples with different target 
concentrations. Fig. 4.4 shows average droplet intensity data for different 
target concentrations. The data corresponding to each target concentration is 
obtained from a population of 100000 droplets each. Each droplet has two 
data points associated with it 1) A Blue data point indicated average Calcein 
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fluorescence intensity and 2) A Green data point indicating average ROX 
flu0rescence intensity. As expected for all different target concentrations, the 
ROX fluorescence intensity shows minimal variation whereas the Calcein 
fluorescence intensity shows two distinct populations.  
Target quantification from the droplet intensity data requires proper 
separation of the two populations of droplets (positive and negative) from 
each other. We tested two different techniques to conduct this separation 1) 
Standard thresholding with a fixed manually specified threshold and 2) 
Automated clustering using expectation maximization algorithm in Matlab. 
For thresholding analysis, a threshold approximately centered between the 
two peaks in the droplet intensity histograms was used whereas for 
automated clustering, two gaussians were fit to the histogram data using 
default fitting conditions in Matlab (Details in section 4.5.2). The positive 
droplet fraction identified for different input target concentrations using 
these two techniques is plotted against the expected target concentration in 
Fig. 4.5. The data points follow a characteristic exponential curve predicted 
by the Poisson distribution of target molecules within droplets. 
4.4 Conclusion 
In summary, we demonstrated a continuous flow digital nucleic acid sensing 
system using LAMP reaction as a means of nucleic acid amplification. Using 
this system, we obtained throughputs on the order of million droplets per 110 
minutes. With an average drop volume of 10pL, this corresponds to 
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processing of 10uL of sample volume per 110mins. Considering that a 
continuous flow system is the only format with the possibility of delivery of 
small reaction volumes per sample sub micro liter, a sample volume of 100nL 
per sample would imply that our device is capable of processing 100 samples 
per 110 mins. Furthermore, the throughput of this system is only limited by 
the speed at which fluorescence can be detected from droplets reliably. Since 
we are operating in a conservative region where the transit time per droplet 
is ~1-2msec per droplet, there is plenty of room to further enhance the 
throughput, making this an attractive alternative to the traditional digital 
PCR workflow for digital nucleic acid sensing. On the other hand, 
applications which require rare molecule sensing from large volumes of a 
biological sample can benefit from the capability of this device to screen as 
large a volume as required due to continuous flow format of operation. 
4.5 Supplementary section 
4.5.1 LAMP assay indicator evaluation 
Evaluation experiments to estimate signal to background ratios from the 
LAMP assay indicators under different conditions were done in a tube format. 
In one set of experiments, EvaGreen was used as the assay indicator dye. The 
assay conditions were kept the same as described in Materials and Methods 
section in the main article, except that the BSA concentration used was 
0.01mg/mL and the EvaGreen concentration was varied between 0.5X to 5X 
where 1X is the recommended concentration from the manufacturer. The 
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positive controls consisted of 2.15e7 copies/mL concentration synthetic target. 
The LAMP reactions were assembled with 20µL final volume and incubated 
in PCR strips on a thermocycler at 63oC for 1hr. Following incubation, the 
reaction mixtures were manually pipetted into a glass bottom 384 well plate 
and fluorescence was detected from the wells using a Typhoon 9410 Variable 
Mode Imager (GE Healthcare). The outcome of the reactions was also verified 
through gel electrophoresis as shown in Fig. 4.8. We observed that the signal 
to background ratio (positive to negative control fluorescence ratio) varied 
between 1.7 to 1.95 for EvaGreen concentration varying between 0.5X to 2X. 
No positive amplification reaction was observed for higher concentrations of 
the EvaGreen dye. Similar evaluation experiment was conducted for the 
Calcein based LAMP assay indicator. The Calcein concentration was kept 
fixed at 25µM while the Manganese chloride concentration was varied 
between 0nM to 2000nM. The analysis steps were the same as indicated for 
the EvaGreen experiment described earlier. We observed that the signal to 
background ratio (positive to negative control fluorescence ratio) in this case 
varied between ~1 to 6.7 for Manganese Chloride concentration varying 
between 0nM to 1000nM (Fig. 4.9). No amplification was observed for 
2000nM Manganese Chloride concentration as indicated by gel 
electrophoresis results in Fig. 4.10 
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4.5.2 Droplet data analysis 
Droplet fluorescence was detected from the device using a confocal 
fluorescence spectroscopy setup capable of dual excitation (488nm and 
552nm) as well as dual band detection (506-534nm and 608-648nm). Since all 
samples tested on the device included ROX as an indicator dye, ROX 
fluorescence thresholding was used to identify droplets from a fluorescence 
data trace. The droplets collected from the fluorescence data traces were 
filtered to remove droplets with very short (<0.5ms) and very long transit 
times (>5ms), indicative of satellite droplets and merged droplets respectively, 
from data analysis. Average fluorescence intensity of all the filtered droplets 
was then calculated. The average fluorescence intensity data was then either 
1) thresholded with a constant threshold to separate the populations of 
positive and negative droplets or 2) clustered into positive and negative 
droplet populations using expectation maximization algorithm implemented 
in Matlab through the function ‘gmdistribution.fit’. An example of population 
identification using both techniques is shown in Fig. 4.11. Using this 
population data a positive droplet fraction from the total droplet population is 
estimated. From each experiment, an image of droplets is analyzed to 
estimate the volume of the droplets for that particular experiment. This 
volume estimate was used to estimate the known target molecule 
concentration per droplet for each experiment.  The droplet volume varied 
around ~8pL for all the experiments.    
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Fig. 4.1 Droplet microfluidic device for continuous flow digital LAMP 
analysis a) A schematic showing three steps of digital LAMP analysis that 
are conducted on the droplet microfluidic device b) An image of the droplet 
generation region on the microfluidic device c) An image of the droplet 










Fig. 4.2 Sample digital LAMP signal from droplets with an EvaGreen 
readout. Blue trace: EvaGreen fluorescence signal, Green trace: ROX 
(indicator dye) fluorescence signal. The inset shows individual droplets in the 
fluorescence data traces. The indicator dye fluorescence intensity can be seen 
uniform across droplets whereas the EvaGreen fluorescence intensity varies 
between two levels: high intensity indicating positive LAMP reaction and low 
























































































Fig. 4.3 Sample digital LAMP signal from droplets with a Calcein 
based readout. Blue trace: Calcein fluorescence signal, Green trace: ROX 
(indicator dye) fluorescence signal. The inset shows individual droplets in the 
fluorescence data traces. The indicator dye fluorescence intensity can be seen 
uniform across droplets whereas the Calcein fluorescence intensity varies 
between two levels: high intensity indicating positive LAMP reaction and low 






































































Fig. 4.4 Average droplet fluorescence intensity data from large 
droplet populations for different target concentrations. Each droplet 
has two data points associated with it. A blue data point indicating average 
Calcein fluorescence intensity and a corresponding green data point 
indicating average ROX intensity. Data from a population of 100000 droplets 
is shown for each target concentration. The ROX intensity shows minimal 
variability across droplets whereas the Calcein intensity varies between two 
levels as expected from Fig. 4.3. The fraction of the positive droplet 










Fig. 4.5 Target nucleic acid quantification with digital LAMP. The plot 
of the positive droplet fraction against the expected target concentration in 
copies per droplet shows an exponential relationship predicted by Poisson 
distribution. Both thresholding and clustering approaches for positive droplet 
identification agree well for higher target concentrations. However, clustering 


































Fit: y = 1-exp(-0.1882*x)
R2: 0.9949
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Fig. 4.6 Microfluidic device used for droplet experiments. The left 
panel shows the thin structure of the device while the right panel indicates 






























Fig. 4.8 Gel verification of LAMP reaction outcome for various 
EvaGreen concentrations.  
Top row (Negative controls). 1: 100bp ladder, 2-5: 0.5X-5X EvaGreen 
concentrations with RT (Room temperature) incubation, 6-11: 0.5X-5X 
EvaGreen concentrations with 63oC incubation.  
Bottom row (Positive controls). 1: 100bp ladder, 2-5: 0.5X-5X EvaGreen 
concentrations with RT incubation, 6-11: 0.5X-5X EvaGreen concentrations 
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Fig. 4.9 Effect of Manganese chloride concentration on LAMP signal 

















Fig. 4.10 Gel verification of LAMP reaction outcome for various 
Manganese Chloride concentrations.  
Top row (Negative controls). 1: 100bp ladder, 2-7: 250nM, 500nM, 750nM, 
1000nM, 2000nM and 0nM Manganese Chloride concentrations respectively 
with 63oC incubation  
Bottom row (Positive controls). 1: 100bp ladder, 2-5: 2-7: 250nM, 500nM, 
750nM, 1000nM, 2000nM and 0nM Manganese Chloride concentrations 
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Fig. 4.11 Two different techniques for separation of positive and 
negative droplet clusters from a droplet population. The two 
histograms indicate the droplet intensity data from the same droplet 
population with the insets showing a zoomed in version of the histogram. The 
histogram on top is separated into negative (blue) and positive (green) droplet 
populations using automated clustering using expectation maximization 
algorithm whereas the histogram on bottom is separated into the positive and 







Chapter 5: A Barcode-Free Combinatorial Screening 
Platform for Matrix Metalloproteinase Screening 
5.1 Introduction 
Matrix metalloproteinases (MMPs) are a family of enzymes involved in a 
plethora of biological functions. Through their activity against biological 
molecules like proteinases, latent growth factors, cell-surface receptors, 
growth factor binding proteins etc, they are able to regulate a number of 
biological processes (72). Furthermore, this family also plays an important 
role in pathological conditions like cancer, arthritis, psoriasis, pulmonary 
emphysema and endometriosis (73). It is, thus, critical to infer the presence of 
particular subtypes of MMP family in biological samples for better 
understanding of their role in pathological processes. Short FRET peptide 
substrates can be used to sense MMPs through their cleavage activity. 
However their relative non-specificity demands sophisticated mathematical 
techniques like Proteolytic Activity Matrix Analysis (PrAMA) (74) to infer the 
presence of a specific set of MMPs based on the cleavage signature of an 
unknown biological sample against a panel FRET peptide substrates. 
Functioning of techniques like this requires large datasets of individual 
purified MMP cleavage signatures against a large panel of peptide substrates, 
generating which can be extremely costly and time consuming through the 
standard 96 well plate workflow. 
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Droplet microfluidics holds tremendous promise for high throughput 
analysis of biological samples. The power of droplet microfluidics is evident 
from the scientific literature harnessing this versatile platform for a variety 
of applications like single cell analysis (75), single molecule analysis (76), 
particle generation (77), and enzyme kinetics analysis (78). This technology 
has really matured in digital analysis of individual biological samples at 
single molecule level (9, 76, 79). However the potential of this technology to 
address the needs of combinatorial screening applications by replacing 
standard biochemical assays conducted in a multi-well plate format (µL 
regime) to the droplet format (nL-pL regime) still remains unattained. 
A variety of droplet-based schemes have been proposed by other 
research groups to suit the needs of combinatorial screening applications. 
Brouzes et al proposed a scheme for high-throughput screening of single cells 
through high-speed electrocoalescence of a reagent droplet library with cell 
sample droplets(75). Despite high-speed operation, this scheme is practically 
limited to a small number of reagent-sample combinations due to the need for 
a composition identifying unique barcode in each droplet. Furthermore, the 
reagent and sample droplet volumes are fixed resulting in fixed sample to 
reagent ratio in each droplet. Another scheme proposed by Abate et al 
provides an alternative through the picoinjection technology. This technology 
is capable of injecting small quantities of individual reagents into droplets at 
high speeds. However, picoinjector technology is also limited by the need for 
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unique barcodes and reagent quantity control is only possible with pressure 
and flow rate variation, both of which cannot be varied for each individual 
droplet. (80). Picoinjector technology has been applied to MMP screening 
against FRET substrates (81). However, due to the limitations discussed 
above the multiplexing capacity of these demonstrations is limited to small 
number of unique MMP-substrate combinations, albeit with large number of 
repeats of each condition. 
We proposed an alternative strategy in recent past to overcome the 
limitations of these technologies (82). This strategy combines the control 
offered by microfluidic valves with the high throughput capacity of droplets. 
Barcode-free, continuous flow operation of this strategy implies unlimited 
potential screening capacity on a single device with precise composition 
control over each individual droplet. In this article we demonstrate the true 
potential of this technology using MMP screening as a sample application. A 
droplet based scheme using valves has also been proposed by Jambovane et 
al for MMP screening (83). However, application of imaging as a detection 
mechanism severely limits the throughput of this scheme both from the point 
of view of data acquisition as well as processing. A simple modification to a 
continuous flow format of operation can completely change the throughput 
capacity of a single device as demonstrated in this article. 
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5.2 Solution 
A schematic of the device we designed for this application is illustrated in Fig 
5.1. The device features a central channel with an oil phase input at the 
upstream end, followed by a reagent injection region, an incubation region 
and a fluorescence detection region respectively as one moves downstream. 
The device also has twelve individual reagent inputs. We also included 
‘pressure relief’ channels on this device, to decouple the dependence of droplet 
size generated on the device from the changing flow resistance of the 
incubation region. The valves corresponding to the pressure relief channels 
are opened during reagent injection and droplet displacement operations on 
the device. 
The device operation sequence is illustrated in Fig 5.1. The most 
upstream reagent input is dedicated to dispensing reaction buffer into 
droplets. For every droplet generated on the device, initially a buffer droplet 
is dispensed in the central channel. As all reagents are constantly 
maintained under pressure, opening the valve corresponding to a particular 
reagent results in release of a reagent droplet into the central channel. The 
valve opening time as well as the pressure magnitude applied to the reagents 
can be used to control the volume of the reagent dispensed into the central 
channel. After using this mechanism to dispense a buffer droplet, this droplet 
is moved in front of the input corresponding to the next reagent to be injected, 
using flow of oil phase from the oil input to the central channel, and the 
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injection of next reagent is completed. This sequence of steps can be repeated 
as many times as desired to inject up to 12 reagents in each droplet using 
this device. After a complete reaction mixture droplet is assembled, this 
droplet is moved to the downstream incubation region. The length of the 
incubation region can be modified to achieve desired incubation time of the 
droplets on the device. Following incubation, the droplets move to a 
fluorescence detection region where they are interrogated by a confocal 
fluorescence spectroscopy system for the reaction outcome. All three steps of 
device operation can be seen in the supporting videos included with this 
thesis (supplementary videos 3, 4 and 5).  
This scheme of combinatorial droplet generation has a few salient 
features which set it apart from other droplet microfluidic platforms 
described above. Under this scheme up to 12 different reagents can be 
injected into a reagent droplet at various independently controlled 
proportions. The device can operate in a completely automated manner 
through execution of a predetermined valve actuation sequence. This 
automation also implies that various reaction mixtures can be generated in a 
predetermined order as desired. This feature also provides the device with 
the ability to generate exactly as many repeats of a reaction mixture as 
desired. Simultaneous operation of all three steps i.e. droplet generation, 
incubation as well as fluorescence detection implies that this device has 
virtually unlimited screening capacity. Even at a very conservative estimate 
112 
of ten different reagent concentrations for each reagent in a droplet, a single 
device is capable of producing a trillion different droplet compositions. Most 
importantly, since the order of droplets is maintained throughout the device, 
droplets are automatically spatially coded, precluding the need for 
composition identifying unique barcodes.  
We designed a microfluidic device to execute the workflow proposed in 
Fig 5.1. The details of device fabrication can be found in section 5.4.1. The 
device was then tested for its capability to generate various combinations of 
input reagents in a predetermined sequence using fluorescent dyes as 
reagents. In our first test, we generated all possible combinations of four 
different concentrations of three different fluorescent dyes on our microfluidic 
device (Fig 5.2). Each white square in the collage in Fig 5.2 includes three 
images of a droplet taken with red, green and blue filters from top to bottom 
respectively (details in sections 5.4.2). A progressive sequence of changing 
droplet compositions can be seen as one moves from left to right in each row, 
beginning with increasing concentrations of individual dyes followed by all 
combinations of pairs of dyes followed by all combinations of triplets of dyes. 
This mode of operation, however, is inherently limited in screening 
capacity by the space available on the device in the incubation region. The 
true potential of our scheme lies in the continuous flow mode of operation 
wherein all the steps of droplet generation, incubation and detection are 
occurring simultaneously on the device in synchronization with each other. 
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To test this mode of operation, we generated a sequence of droplets on the 
device using two different fluorescent dyes (Alexa Fluor 488 and Alexa Fluor 
546, hereafter Alexa488 and Alexa546 respectively). The sequence consisted 
of a gradient of Alexa488 followed by a gradient of Alexa546 followed by four 
different fixed intensities of Alexa 488 dye with a gradient of Alexa 546 dye 
at each fixed intensity of Alexa 488 dye. The two data traces in Fig 5.3 show 
two repeats of this droplet sequence. The bar chart at the bottom of Fig 5.3 
shows the mean and standard deviation of each droplet’s fluorescence 
intensity in the sequence over ten repeats of the droplet sequence. The data 
traces show the ability of our scheme to independently control the 
concentration of different components in droplets and sense the effect of this 
varying concentration in a serial manner. As designed the sequence of 
droplets is constantly maintained throughout the device resulting in 
fluorescence data collection from the droplets, exactly in the order that they 
were generated. The presence of strongly fluorescent droplets right next to 
weakly fluorescent droplets in a channel indicates minimal carryover of 
material from droplet to droplet. Finally the small error bars in the bar chart 
indicate repeatable and robust operation of the device without any human 
intervention. 
An important characteristic of a combinatorial reaction generation 
system like ours is the reagent concentration dynamic range of the system. 
The upper end of this range is fixed by the input reagent concentration. The 
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response time of the valves used in our scheme as well as the minimum 
pressure that can be applied to a reagent for reliable injection puts a lower 
limit on the smallest reagent volume that can be injected into a droplet. 
However, this limitation theoretically doesn’t limit the lower end of the 
reagent concentration dynamic range as the buffer droplet size can always be 
made as large as necessary to achieve the required concentration. Practically 
however we observed that large volume droplets due to their long length tend 
to breakup during transit through the incubation region on the device. Given 
these constraints we were able to achieve a maximum dilution of 6 parts per 
1000 on our device (section 5.4.4). This number is however limited to our 
current device design as well as the oil-surfactant system used in our 
experiments. An increase in channel height in the incubation region, to 
decrease droplet length, as well as choice of a modified oil-surfactant system 
for better droplet stability may further reduce the dilution limit we were able 
to achieve without droplet breakup on our device. 
We then tested the applicability of our droplet system for screening of 
Matrix Metalloproteinases (MMPs) against a variety of peptide substrates on 
our device for their specificity and activity. The peptide substrates used are 
short peptide sequences labeled with a fluorophore (5-FAM) and a quencher 
(QXLTM520) on either ends. In the presence of an MMP, the peptide sequence 
is cleaved resulting in separation of the fluorophore from the quencher and a 
consequent increase in the fluorophore’s fluorescence. The rate of increase in 
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fluorescence of an MMP-substrate sample can then serve as a proxy for the 
activity of the MMP against the peptide substrate.  
Fig 5.4 shows data traces obtained from two repeats of a droplet sequence 
containing various combinations of MMPs and substrates. The data trace in 
the top panel indicates fluorescence emitted by the fluorophore on the peptide 
substrates. However, for a droplet sequence with an unknown outcome (as 
against a fluorescent dye dilution series), it can be difficult to estimate the 
position of each droplet in the whole long sequence as well as to ensure that 
the device is operating robustly without any unwanted merging/breakup of 
droplets. So we also included some ‘beacon’ droplets in the droplet sequence, 
generated through different dilutions of a fluorescent dye different from the 
fluorescent dye on the MMP substrates. These droplets are indicated in the 
data trace from the Alexa546 channel. The known repeating pattern of these 
droplets allows us to easily discern repeats of a droplet sequence from the 
data. Furthermore, their predetermined location in the droplet sequence 
allows us to ensure that the device is operating in a robust manner without 
any unwanted merging/breakup of droplets as any unwanted 
merging/breakup would result in a change in the position of a beacon droplet 
in the whole sequence. It should be noted that these beacon droplets are not 
limited by different fluorescence intensities that can be easily distinguished 
by the detection system similar to fluorescence intensity based barcodes. The 
possibility of varying intensities, varying count as well as varying spacing 
116 
between beacon droplets provides for virtually unlimited possible beacon 
droplets marking different positions in an extremely long droplet sequence. 
We then compared the substrate cleavage rates for various MMP-
substrate combinations we observed on our device against cleavage rates we 
observed in off-chip experiments. Some representative results are indicated 
in Fig 5.5 while others are included in Fig 5.8. Our comparison indicates that 
the cleavage rates of enzymes MMP1, MMP2 and MMP9 matched across 
platforms fairly well for various substrates. However, the substrate cleavage 
rates for MMP8 and MMP13 were consistently low on the device when 
compared with cleavage rates in off-chip experiments. Interaction of proteins 
with oil-surfactant system used in droplet devices has been reported in 
literature (84, 85). Our results indicate that the oil-surfactant system we 
used interacts with MMP8 and MMP13, reducing their activity. Some 
solutions have been proposed in the literature to engineer better surfactants 
with substantially reduced interaction with proteins (84, 85). These solutions 
can potentially make this platform suitable for a broad range of enzymatic 
screening. As a proof of principle of screening large number of enzyme-
substrate combinations on a single device, we generated a droplet train 
consisting of 650 unique droplet compositions (data shown in section 5.4.6). 
The activity patterns from two repeats of this sequence shows excellent 
similarity. We, however, did observe that following long term operation of the 
device the hydrophobic treatment wears off resulting in more sticking of 
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droplet contents to the channel surface. Superhydrophobic treatments have 
been proposed in literature to fabricate antifouling surfaces. Integration of 
these surfaces with our device design can potentially increase the time span 
for which a device can function without significant channel surface fouling.  
5.3 Conclusion 
In summary, we demonstrated a droplet device for combinatorial screening 
applications without the need for composition identifying unique barcodes. 
We expect this format of droplet devices to increase the applicability of 
droplet microfluidics to applications requiring the capability of rapid 
heterogenous reaction generation. 
5.4 Supplementary section 
5.4.1: Microfluidic device fabrication 
The microfluidic devices for our experiments were fabricated using standard 
multilayer soft-lithography techniques. The fluidic layer mold for the devices 
was fabricated through dual layer photolithography. Initially a layer of SPR-
220 7.0 (MicroChem Corp.) photoresist is patterned on a 4 inch silicon wafer. 
This positive photoresist was used to generate the channel regions on the 
device to be compressed by the control layer. Following this step, a layer of 
SU8-3025 (MicroChem Corp.) was patterned on the same wafer to generate 
the rest of the fluidic layer network on the device. An independent control 
layer mold was prepared on a separate silicon wafer by patterning a single 
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layer of SU8-3025 on the wafer. These molds were then used to fabricate 
devices using multi-layer soft lithography. Initially a ~1mm thick layer of 
polydimethylsiloxane (Sylgard Elastomer 184, Ellsworth Adhesives, 6:1 base 
to curing agent ratio) was spin-coated on the control layer mold. This layer 
was partially cured in an oven at ~80°C for 5-6 minutes. The PDMS 
membrane on the mold was then peeled off and trimmed to prepare for 
alignment with the fluidic layer. A thin layer of PDMS was spin coated on the 
fluidic layer mold and partially cured in the oven at ~80°C for 3-4 minutes. 
The PDMS membrane from the control layer mold was then aligned with the 
fluidic layer using a stereoscope. These two layers were allowed to bond for 
10 minutes at ~80°C. Following this, ~50g of PDMS (10:1 base to curing 
agent ratio) was poured on these two layers to form the thick body of the 
device. This thick PDMS layer was allowed to cure for at least 25 minutes at 
~80°C. The devices were then peeled off the mold and holes were punched at 
the input and output ports. The devices were bonded to Thickness #1 cover 
glass (Ted Pella, Inc.) using oxygen plasma treatment. Before use, the devices 
were treated with Aquapel (PPG Industries) to render the fluidic channels on 
the device hydrophobic. 
5.4.2: Materials 
We used a ‘MMP Substrate Sampler kit’ (Anaspec, Inc Catalog#: 71170) as a 
source of MMP substrates for our experiments. This kit consists of 16 
substrates (SB1-SB16), all of which consist of short peptide sequences labeled 
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with the fluorophore 5-FAM and quencher QXLTM520. The exact sequences of 
peptides from this kit included in our experiments are appended below this 
section. The kit also included a fluorescence reference standard (5-FAM-Pro-
Leu-OH), which was used to generate standard curves correlating 
fluorescence intensity with substrate concentration. A ‘Matrix 
Metalloproteinase (MMP) Multipack-1’ (Enzo Life Sciences, Catalog #: BML-
AK013-0001) was used as a source of MMPs for our experiments. This kit 
consists of active recombinant MMP catalytic domains. We used the 
fluorescent dyes Alexa Fluor 350, Alexa Fluor 488 and Alexa Fluor 647 (Life 
Technologies) as indicator dyes for the experimental results shown in Fig 5.2. 
The input concentrations of these three dyes used for experimental results in 
Fig 5.2 were 25uM, 10uM and 10uM respectively. Alexa Fluor 546 was used 
in the form of an oligo labeled with the dye as an indicator dye for our 
experiments including this dye. All the reagents including fluorescent dyes 
were diluted to the required concentrations with the reaction buffer included 
with the MMP substrate sampler kit. 10ug/mL of BSA was added to the 
reaction buffer to prevent adsorption of reagents to device and tubing walls. 
The oil phase for our experiments consisted of FC-40 (3M) and 1H, 1H, 2H, 
2H-Perfluoro-1-octanol (SigmaAldrich) (4:1 v/v). The surfactant oil phase 
consisted on FC40 with 2% fluorosurfactant (RAN Biotechnologies) by weight. 
Input reagent concentrations for various experiments 
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The input dye concentrations used for the image in Fig 5.2 were Alexa350: 
25uM, Alexa488: 10uM and Alexa647: 10uM. Four different concentrations of 
these dyes generated in droplets from each of these inputs were 0X, 0.1X, 
0.2X and 0.3X where X is the original input concentration of each dye. 
The input dye concentrations used for data in Fig 5.3 were Alexa488: 50nM 
and Alexa546: 50nM. Five different concentrations of each dye apparent in 
droplet format from Fig 5.3 were 0X, 0.1X, 0.2X, 0.3X and 0.4X where X is the 
original input concentration of each dye 
For the experimental results in Fig 5.4 and 5.5, the input concentration of all 
MMPs was 5ng/uL while the concentration of all substrates was 5uM. 1X 
MMP concentration in droplets for these figures refers to 1ng/uL 
concentration while 1X substrate concentration refers to 1uM concentration. 
For the experimental results in Fig 5.8, the input concentration of all MMPs 
was 7.5ng/uL while the concentration of all substrates was 7.5uM. 1X MMP 
concentration in droplets for these results refers to 1ng/uL concentration 
while 1X substrate concentration refers to 1uM concentration. 
For the experimental results in section 5.4.6, the input concentration of all 
MMPs was 7.5ng/uL while the concentration of all substrates was 7.5uM. 1X 
MMP concentration in droplets for these results refers to 0.5ng/uL 
concentration while 1X substrate concentration refers to 0.5uM concentration. 
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Peptide substrate sequences: 
SB2: QXL520TM -Pro-Leu-Ala-Leu-Trp-Ala-Arg-Lys(5-FAM)-NH2 
SB3: QXL520 TM -Pro-Leu-Gly-Cys(Me)-His-Ala-D-Arg-Lys(5-FAM)-NH2 
SB4: 5-FAM-Pro-Leu-Ala-Nva-Dap(QXL520 TM)-Ala-Arg-NH2 
SB5: 5-FAM-Pro-Leu-Gly-Leu-Dap(QXL520 TM)-Ala-Arg-NH2 
SB8: QXL520 TM -Arg-Pro-Lys-Pro-Leu-Ala-Nva-Trp-Lys(5-FAM)-NH2 
SB9: QXL520 TM -Arg-Pro-Leu-Ala-Leu-Trp-Arg-Lys(5-FAM)-NH2 
SB11: 5-FAM-Pro-Cha-Gly-Nva-His-Ala-Dap(QXL™520)-NH2 
SB12: 5-FAM-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(QXL520 TM)-NH2 
SB15: QXL520 TM -γ-Abu-Pro-Gln-Gly-Leu-Dab(5-FAM)-Ala-Lys-NH2 
5.4.3: Experimental protocol 
5.4.3.1 On-chip experiments 
A set of solenoid valves was used to control the on/off status of the valves on 
the device. Initially, all the reagent inputs on the device were primed with 
the respective reagent. Any residual reagents in the central channel following 
this process were flushed out using the oil phase. Following this, the valve 
actuation sequence corresponding to the reagent combinations to be 
generated on the device was executed by a computer. The valve actuation 
sequence for each droplet consisted of the following steps 1) Buffer droplet 
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generation 2) Droplet displacement in front of other reagent inputs for 
reagent injection 3) Droplet displacement to the incubation region through 
injection of oil phase in the central channel 4) Further displacement of 
droplet in the incubation channel through injection of a surfactant oil phase 
in the central channel. 5) Closing all valves on the device for dissipation of 
pressure in the central channel. After ensuring proper operation of the device 
on a microscope, the device is moved to a fluorescence detection setup. The 
fluorescence detection setup we used for our experiments is capable of dual 
channel excitation (488nm, 552nm) as well as dual band detection (506-
534nm and 608-648nm). The detection volume of the fluorescence detection 
setup was placed at the detection region of the device for continuous sensing 
of fluorescence from droplets passing that region. The device was maintained 
at room temperature for all the experiments.  
5.4.3.2 Off-chip experiments 
For off-chip experimental results used in Fig 5.5 and 5.8, MMP and substrate 
concentrations identical to those being compared against in the droplet 
format were generated in 20uL reactions in a 96 well plate format. The 
fluorescence from the 96 well plate with these reaction mixtures was then 




5.4.3.3 Data Analysis on-chip experiments 
Fluorescence data obtained from droplet sequences generated on chip was 
further processed through custom software written in Matlab. This software 
identified various droplets in a data trace and generated various statistics 
obtained from the data collected from each droplet. The average droplet 
fluorescence intensity identified by this software for each droplet was then 
used to estimate MMP activity rates shown in Fig 5.5 and 5.8. Each repeat of 
a droplet sequence consisted of substrate only controls for each substrate type 
and concentration. The average fluorescence intensity of a substrate-only 
control droplet was subtracted from the average fluorescence intensity of a 
MMP-substrate combination droplet (with same substrate concentration) and 
this intensity difference was converted to substrate concentration difference 
using the standard curve in section 5.4.5. The substrate concentration 
difference thus obtained was then divided by the droplet transit time on the 
device (~12min) to estimate MMP activity rates for that particular MMP-
substrate combination. 
5.4.3.4 Data Analysis off-chip experiments 
For a fair comparison between on-chip and off-chip experiments, MMP 
activity rate was estimated from off-chip experiments in a manner similar to 
on-chip experiments. The fluorescence intensity reading from a substrate 
only control sample was subtracted from a MMP-substrate combination 
reaction for the same substrate concentration at the same time point (12mins 
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after injection of enzyme into the reaction mixture). The difference in 
fluorescence intensities was again converted to substrate concentration 
difference, using the standard curve for off-chip experiments in section 5.4.5. 
This substrate concentration difference was then divided by the time for 
which the enzyme was added to the reaction mixture (12 min) to estimate 
MMP activity rate for that particular MMP-substrate combination. 
5.4.4: Determining maximum reagent dilution on device 
To generate maximum reagent dilution on the device, we tested the smallest 
reagent injection possible on our device. To conduct this experiment we 
generated various dilutions of Alexa Fluor 546 dye on our device. The Alexa 
Fluor 546 input was maintained under a low pressure of 1psi while the buffer 
input was maintained at a high pressure of 10psi. We then generated a 
droplet sequence which included droplets containing Alexa Fluor 546 
injections generated using valve opening times of 0.0125, 0.05, 0.0875, 0.125, 
0.1625, 0.2, 0.2375 and 0.275 seconds for the valve corresponding to the Alexa 
Fluor 546 input. We also included a buffer-only droplet at the beginning of 
the droplet sequence as well as an Alexa Fluor 546 droplet without any 
dilution at the end of the sequence. Fluorescence data collected from four 
repeats of this droplet sequence can be seen in Fig 5.6. We observed that a 
valve opening time of 0.0875 seconds was necessary to observe reliable 
injection of reagent into the droplets. The maximum dilution of the dye 
obtained for this valve opening time was 0.0066X, calculated as the ratio of 
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the average fluorescence intensity of the droplet corresponding to 0.0875 
second valve opening time to the average fluorescence intensity of the 
undiluted Alexa Fluor 546 droplet at the end of the droplet sequence. 
5.4.5 Fluorescence standard curve  
Various concentrations (2, 1, 0.5, 0.25, 0.125, 0.0625, 0.03125 and 0.015625 
µM) of the fluorescence reference standard included in the MMP substrate 
sampler kit were used to generate a standard curve relating fluorescence 
intensity with substrate concentration. To generate the standard curve for 
the optical setup used with the microfluidic device, a train of droplets was 
generated using different concentrations of the reference standard for 
fluorescence measurement to closely mimic the experimental conditions on 
the device. Excellent linear relation was observed between reference standard 
concentration and the measured fluorescence intensities (Fig 5.7).  
Similarly fluorescence intensities of the same set of concentrations of 
the reference standard were measured on the CFX96 Real-Time PCR 
detection system used for fluorescence monitoring from off-chip experiments. 
The plot of the measured fluorescence intensities against the corresponding 
reference standard concentrations shows linear relation between the two 
variables (Fig 5.7). 
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5.4.6 Long droplet sequence generation on device 
As a proof of principle, we generated a large sequence of droplets containing 
650 unique MMP-substrate combinations on a single device. Average 
fluorescence intensities obtained from two repeats of droplets corresponding 
to each unique combination are shown in the two matrices in Fig 5.9. Plots of 
measured fluorescence intensities from different MMP-substrate 
combinations against each other for different repeats show good linear 
correlation indicating repeatable operation of the device over long periods of 
time (Fig 5.10). 
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Fig 5.1 MMP screening platform. Step 1: Droplet assembly through 
microfluidic valve (thin black colored channels) controlled injection of desired 
MMP(s) and substrate(s) in a buffer droplet Step 2: Incubation of assembled 
MMP-substrate droplets in the incubation channel on the device. Step 3: 
Serial interrogation of droplets through Confocal Fluorescence Spectroscopy 
while preserving the order of generation, precluding the need for a barcode to 






Fig 5.2 A series of fluorescent droplets generated on a single device: 
Each white square contains three images of a single droplet collected using 
DAPI, FITC and Cy5 filter sets on a fluorescence microscope from the bottom 
to top respectively. The droplets represent all possible combinations of four 
different intensities of three different fluorescent dyes (Alexa350, Alexa488 






Fig 5.3 Droplet composition control and serial droplet fluorescence 
detection on the device: The two data traces show two repeats of a 
sequence of 24 droplets generated on the device. The green trace indicates 
fluorescence from the Alexa488 channel (506-534nm) while the orange trace 
indicates fluorescence from the Alexa546 channel (608-648nm). The 
fluorescence data indicates the capability of the device to independently 
control the concentration of different reagents in individual droplets. The plot 
on the bottom indicates average fluorescence of each individual droplet in the 
sequence. The error bars indicate the standard deviation in average 
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Fig 5.4 MMP-substrate assay on device: The two data traces indicate 
fluorescence obtained from two repeats of a sequence of droplets containing 
different MMP-substrate combinations. The FAM channel indicates 
fluorescence from the FRET-peptide substrates cleaved by different MMPs. 
Alexa546 dye is used to insert a few ‘beacon’ droplets (Green peaks in 
Alexa546 channel) into the droplet sequence without interfering with the 
assay channel. The presence of beacon droplets in the sequence at 
predetermined positions with respect to other droplets can be used as an 
indicator of proper operation of the device without any unwanted droplet 
merging/splitting. The fluorescence from the non-beacon droplets in the 
Alexa546 channel is due to bleeding of some fluorescence from the FAM 








































Fig 5.5 MMP activity comparison between on and off-chip 
experiments: The cleavage rates of different MMP types against different 
substrates estimated from corresponding droplets on the device are compared 
against cleavage rates estimated for same reaction conditions from off-chip 
experiments. (MMP1_1: MMP1 at 1X concentration, SB9_2_chip: Substrate 






























































































































Fig 5.6 Largest reagent dilution generated on the device: Left panel: 
The data trace indicates four repeats of a sequence of droplets generated to 
test the largest reagent (Alexa Fluor 546) dilution that can be produced on 
our device. Each sequence ends with an undiluted reagent droplet to indicate 
the scale of dilution. Right panel: Average fluorescence intensities of the 
droplets in the sequence shown in the left panel. Error bars indicate standard 



























































































Fig 5.7 Standard curves. Left panel: The data trace on top shows four 
repeats of a droplet sequence generated on device with different 
concentrations of fluorescent substrate reference standard. The average 
fluorescence intensity data extracted from this droplet sequence is plotted 
against the known reference standard concentrations in the droplets in the 
bottom plot to generate a standard curve for on-chip experiments. Right 
panel: A plot of measured fluorescence intensity (on the CFX96 Real-Time 
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Fig 5.8 MMP activity comparison between on and off-chip 
experiments: (MMP1_chip: MMP1 at 1X concentration on-chip, 




















































































Fig 5.9 Average measured droplet fluorescence intensities from two 
repeats of 650 unique MMP-substrate combinations. The numbers on 
both axes indicate concentrations (1:1X concentration, 2: 2X concentration 



































































































Fig 5.10 Average fluorescence intensities measured from different 
repeats for each unique MMP-substrate combination plotted against 
each other: good linear correlation indicating repeatable operation of the 


















































y = 0.965x + 1.18e+05
R2 = 0.939













































y = 1.07x + 9.47e+04
R2 = 0.957
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Chapter 6: Microfluidic platform for on-demand generation 
of spatially indexed combinatorial droplets 
Zec, Helena, Tushar D. Rane, and Tza-Huei Wang. "Microfluidic platform for 
on-demand generation of spatially indexed combinatorial droplets." Lab on a 
Chip12.17 (2012): 3055-3062. Reproduced by permission of The Royal Society 
of Chemistry 
6.1 Background 
Droplet microfluidic platforms are in the early stages of revolutionizing high 
throughput and combinatorial sample screening for bioanalytical 
applications(1, 2, 86, 87). Droplet-based systems have many advantages over 
conventional microtiter techniques for combinatorial screening applications. 
Microfluidic droplets function as miniaturized reaction containers consist of 
pico or nanolitre volumes, thereby facilitating reduced reagent consumption 
and background noise(87). Furthermore, carrier fluid shields each droplet, 
mitigating the problems of absorption onto solid surfaces and contamination. 
The high surface area to volume ratio of droplets also facilitates shorter heat 
and mass transfer times, leading faster reaction kinetics in droplets(1, 19). 
  Recent publications in the microfluidic domain boast high throughput 
capability of their respective droplet-based platforms. Compartmentalization 
of many small droplets allows isolation of interfering molecules into separate 
volumes, thereby facilitating digital analysis of biological entities. Several 
examples have been demonstrated including: droplet platforms for high 
throughput single copy DNA amplification(21, 69, 88), droplet platforms for 
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high throughput single cell screening(20, 22, 89) as well as droplet platforms 
for single organism screening(90, 91). These droplet platforms are capable of 
high resolution screening of the biological contents at the level of the 
fundamental unit. However, they are limited to the analysis of a single 
sample under a homogeneous reagent condition. 
 The aforementioned droplet platforms are incapable of addressing the 
needs of numerous applications which require high degrees of multiplexing as 
well as high-throughput analysis of multiple samples. Some examples include 
genetic fingerprinting for forensics(92), single nucleotide polymorphism 
(SNP) analysis for crop improvement and domestication(93), genotyping 
required for identification of genes associated with common diseases(94) and 
generation of a blood donor genotype database for better matching between 
recipient and donor to prevent adverse transfusion reactions(95). All these 
applications require multiplexed screening of a single sample with a panel of 
reagents (or markers) and rapid screening of a large number of samples to 
generate the required databases.   
  In recent years, there have been attempts to expand the capacity of 
droplet platforms for the analysis of a biological or chemical sample with 
multiple reagents. One of the well-tested platforms has been the droplet 
platform developed by RainDance Technologies, for massively parallel PCR 
enrichment for DNA sequencing(96). This platform involves a multistep 
approach with generation of a large library of PCR reagent droplets by a 
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microchip, followed by merging of these reagent droplets with sample 
droplets generated from a DNA sample on a second device. These sample-
reagent hybrid droplets are then collected in standard PCR tubes for 
thermocycling, followed by fluorescence detection and sequencing. In this 
platform, the content of each individual droplet is unknown and is decoded 
only by offline nucleic acid sequencing. Therefore, it cannot be applied to 
other applications that require real-time detection(87). A solution to this 
problem is to associate a unique optical-code with each reagent prior to 
mixing with the sample(5). However, an optical-coding scheme based on 
fluorescence intensity is practically limited to a small number of ‘codes’ due to 
the small allowable number of fluorophores without spectral crosstalk and 
the limited dynamic range of the optical detection setup being used(87). 
Furthermore, the electrocoalescence technique used in such platforms for 
droplet merging is susceptible to errors of no fusion caused by an excess of 
droplets of a reagent or unintended fusion of more than two droplets due to 
highly stringent synchronization requirements(97). A recent article 
demonstrated a picoinjector which can overcome this problem and be used to 
add controlled volumes of multiple reagents to sample droplets using 
electromicrofluidics(98). However, similar to droplet platforms discussed 
earlier, the content of each individual droplet is unknown unless a barcode is 
included in each individual droplet. 
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Alternatively, a series of articles adopted a cartridge technique for 
increasing the throughput of the droplet platform(99). This technique 
involves generation of an array of reagent plugs in a capillary (cartridge), 
which are sequentially introduced to a simple microfluidic device for merging 
with a single substrate. The reagent plugs can be further digitized into 
smaller droplets prior to merging with the sample. As the length of the 
capillary can be very long, the number of reagents to screen against the 
sample is virtually limitless. This technique has been applied to many 
applications including protein crystallization(99) and study of bacterial 
susceptibility to antibiotics(25). Although the aforementioned droplet and 
cartridge platforms are capable of high throughput and multiplexed analysis, 
they are still limited to screening of a single sample at a time. Recently, a 
microfluidic platform was proposed for combinatorial chemical synthesis in 
picolitre droplets, where droplets of one library of reagents were fused at 
random with droplets containing a different set of reagents(97). This platform 
has the potential of generating a large set of possible combinations of 
different reagents. However, as afore-discussed, the unknown identity of the 
compounds within individual droplets precludes its use for many screening 
applications that require real-time detection. 
Here we present a droplet platform capable of on-demand generation of 
nanolitre droplets of combinational mixtures of samples and reagents, needed 
for biochemical screening applications that require multiplexing and high-
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throughput capability. On-demand droplet generation and manipulation 
using pneumatic valves has been demonstrated by other groups in the 
past(100-102). However, these platforms have focused on generating multiple 
reagent combinations using fixed number of inputs to the device, severely 
limiting the number of possible sample-reagent combinations being generated 
on the device. The droplet platform reported in this article uses a linear array 
of sample plugs as an input to the device, removing the limitation imposed by 
the number of inputs to the device. Initially, a preformed linear array of 
sample plugs separated by a carrier fluid is flowed from the cartridge into the 
microfluidic device, wherein each plug is digitized by a pneumatic valve into 
smaller sample daughter droplets. The volume of the resulting daughter 
droplet can be precisely controlled by varying the valve opening time and the 
back pressure on the cartridge containing sample plugs. The daughter 
droplets are then directly injected with reagents in a synchronization-free 
manner. The microfluidic design features a robust fusion module which 
exploits local channel geometry for synchronization-free injection of reagents 
into each sample daughter droplet. After reagent injection into a sample 
droplet, our microfluidic device introduces additional carrier fluid containing 
surfactant to the channel containing the sample-reagent hybrid droplet array 
to prevent unwanted merging of these droplets on the device. In the proposed 
microfluidic device, droplets are indexed by their layout in a 1D array, 
enabling the identification of the contents of each droplet by spatial indexing. 
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Spatial indexing as a means for identification of droplet content obviates the 
need for a limiting optical barcoding scheme. 
6.2 Materials and Methods 
6.2.1 Serial Sampling Loading System 
 The sample library was generated using a custom-designed Serial 
Sample Loading System (SSL). Fig 6.2 is a schematic illustrating the 
functioning of the SSL system. Briefly, the SSL system was designed to be 
compatible with Costar 96-well plates (Corning). Initially the wells on a 
Costar 96-well plate are filled with the samples and the carrier fluid to be 
used for generating the sample plug array. An Aquapel (PPG Industries) 
treated silica capillary is then attached to a capillary adapter on the SSL 
system, which is also connected to a positive pressure input. A sample well is 
then interfaced with the capillary through the capillary adapter. Application 
of positive pressure to the sealed sample well for a controlled amount of time 
is then used to drive a sample plug from the well into the capillary. This 
sequence of steps is then repeated to load alternating sample and carrier 
fluid plugs into the capillary (Fig. 6.2b). More detailed information on the 
structure and operation of different components of the SSL system can be 
found in the section 6.5.4.  
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6.2.2 Fabrication of the Master Molds for the Microfluidic Device 
 The fluidic layer on the microfluidic device features five different 
heights of microfluidic channels (Fig. 6.3b and c). As a result, the fluidic mold 
consists of five different layers of photoresist. The fluidic channel heights in 
these five different photoresist layers were expected to be 25 µm, 50 µm, 100 
µm, 200 µm and 360 µm. The photoresist used for the 25 um layer was SPR 
220-7.0 (Rohm & Haas), while the rest of the layers were fabricated using 
SU-8 3050 (MicroChem). Fabrication was performed using standard 
photolithography techniques. Briefly, a SPR 220-7.0 layer was spin coated on 
a 4 inch silicon wafer. This layer was patterned using photolithography and 
hard baked to generate a rounded channel cross section, required for effective 
valve closure, as has been described earlier(36). For all other layers, SU-8 
3050 was spin-coated on the wafer and patterned using standard 
photolithography, excluding the developing step. This technique was found to 
be very effective in preventing generation of bubbles and non-uniform coating 
of photoresist on the wafer due to the presence of features from earlier layers 
on the wafer. A single developing step for all four SU-8 3050 layers was used 
to remove excess photoresist on the wafer (Fig 6.7). The control layer for the 
microfluidic device on the other hand consisted of microfluidic channels of a 
single height. As a result, the mold fabrication for the control layer was 
relatively simpler, with a single layer of SU-8 3050 photoresist, 50 µm in 
height.  
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6.2.3 Microfluidic Device Fabrication 
  The microfluidic devices were fabricated using multilayer soft 
lithography techniques(36). The protocol differed slightly from our standard 
protocol(33, 34, 48)  due to the need for proper functioning of push-down 
valves(103) while accommodating tall features (up to 360 µm) on the fluidic 
layer. The thickness of the polydimethylsiloxane (PDMS) membrane 
separating the control layer and the fluidic layer in a microfluidic device 
needs to be less than ~50 µm, for complete valve closure at reasonable 
pressure (~30 PSI). However, the presence of fluidic regions as tall as 360 µm 
on the fluidic layer mold precluded the possibility of covering the entire 
fluidic layer mold with PDMS, while maintaining the thickness of the PDMS 
layer to a value less than 50 µm in the regions of the device containing valves. 
To overcome this problem, a modified three-layer fabrication process was 
developed. Detailed description of the fabrication process is included in 
section 6.5.2.  
6.2.4 Capillary–to–Chip Interface 
 Following the microfluidic device fabrication, a silica capillary was 
attached to the ‘capillary inlet’ on the microfluidic device (Fig. 6.3b). The 360 
µm tall channel region at the capillary inlet accommodates a silica capillary 
with an OD of 360µm. A 10 mm section of silica capillary is inserted 
horizontally into this tall channel on the device until it is flush with the 200 
µm tall fluidic channel on the device. To seal the capillary to the chip and 
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prevent leakage, PDMS was dispensed around the capillary at the interface 
between the capillary and the device. The PDMS tended to crawl into the 360 
µm channel and surround the capillary, effectively sealing the capillary-to-
chip connection. The final assembly was baked for at least 2 hours at 80ºC 
before usage.  
6.2.5 Device control 
 All the inputs on the device were kept under constant pressure, with 
independent input pressure for 1) carrier fluid input, 2) all four reagent 
inputs and 3) carrier fluid with surfactant input. The pressure applied to the 
capillary input was controlled directly by the pressure controller used for the 
SSL system. All the valves on the device were controlled by an array of off-
chip solenoid valves, as has been demonstrated earlier(34). We developed 
Matlab (Mathworks, Natick MA) software for computer control of the valve 
array. This software allowed us to execute a predetermined sequence of valve 
actuation with independent time control for each actuation. The opening of a 
valve corresponding to an input on the device led to the release of a droplet of 
fluid from that inlet into a central channel on the device. The volume of this 
droplet could be controlled through variation of the opening time of the valve. 
6.2.6 Reagents  
 All the devices and capillaries were treated with Aquapel to render 
their surface hydrophobic. The testing of our platform was performed using 
food dyes (Ateco, Glen Cove, NY) to mimic different samples and reagents for 
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easy visualization. The carrier fluid used to maintain the separation between 
sample plugs consisted of a perfluorocarbon (FC-3283) and a non-ionic 
fluorous-soluble surfactant (1H,1H,2H,2H-Perfluoro-1-octanol) mixed in a 
ratio of 8:1 by volume. The carrier fluid with surfactant consisted of FC-40 
(3M) and 2% ‘EA’ surfactant (Raindance Technologies) by weight. 
6.2.7 Sample plug and droplet volume estimation 
 We estimated the volume of sample plugs and sample droplets 
generated using the SSL system and the microfluidic device respectively. 
This volume estimation was performed by processing the images of these 
sample plugs or droplets using the software ImageJ(104). Specifically, for 
sample plug volume estimation, a series of sample (blue food dye) plugs were 
generated in a silica capillary using the SSL system. A colour image of these 
plugs was taken against the while background of a ‘letter’ sized sheet of 
paper using a standard Digital Single-Lens Reflex (DSLR) camera. This 
image was imported in ImageJ and the length scale was set to true length 
using the known length of the letter sized paper in the image. The lengths of 
the sample plugs were then manually measured for each plug using the 
‘Measure’ function in ImageJ. The plug lengths could be converted to plug 
volumes with the known cross sectional area of the capillary. 
 For sample droplet volume estimation, we generated droplets made of 
blue food dye using one of the four reagent inlets on the microfluidic device, 
until the whole incubation region on the device was full of droplets. The 
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whole device was then imaged using a DSLR camera. The image was 
imported in ImageJ and cropped to obtain an image of the incubation region 
on the device. This image was then converted to a binary image using colour 
thresholding to identify droplets over the background image. An estimate of 
the droplet area for each droplet in the image was then obtained using the 
‘Analyze Particles’ function. This analysis was limited to particle areas larger 
than a lower threshold to exclude any particles and occasional satellite 
droplets from the analysis. The droplet areas thus estimated were then 
converted to droplet volume using the known depth of the incubation channel 
region (200 µm). 
6.3 Results and Discussion  
6.3.1 Overall Work Flow 
 Fig 6.1 is a schematic illustrating the functioning of the platform. 
Initially a cartridge (capillary) is loaded with a library of sample plugs 
forming a serial sample plug array: plugs are separated from each other by 
an immiscible carrier fluid. This cartridge is interfaced with a microfluidic 
device featuring multichannel architecture and pneumatic microvalves. The 
microfluidic device digitizes sample plugs into smaller daughter droplets on. 
Each sample daughter droplet then moves to the downstream fusion region 
where a specific reagent is injected into the sample daughter droplet. The 
reagent droplets are injected into the sample daughter droplet through 
controlled actuation of valves corresponding to the reagent inlets. Supp. 
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Video 6 shows this sequence of events. No strict synchronization or droplet 
detection module is necessary for fusion of sample and reagent to occur as the 
sample droplet is elongated in the fusion area (Supp. Video 7), exploiting the 
local channel geometry. The resulting sample-reagent droplet undergoes 
mixing and travels downstream to the incubation region on the device. After 
reagent injection, additional carrier fluid containing surfactant is released 
into the central channel on the device to stabilize sample-reagent hybrid 
droplets. The sequence of droplets is maintained throughout the device, 
precluding the need for a complicated barcoding scheme to identify the 
contents of each individual droplet. 
6.3.2 Capillary-to-Chip Interface 
 Our prototype platform necessitated the capillary-to-chip interface 
design to allow for sample plug introduction on chip. This objective presented 
a unique challenge, since proper functioning of the platform requires smooth 
transition of sample plugs from the large ID of the capillary to shallow 
channels on the device in the valve regions. There have been demonstrations 
of capillary-to-chip interfaces in the past for introducing sample plugs from a 
capillary to a microfluidic device. However, the devices used don’t face this 
problem as they typically feature large channels with a valve-less design(25, 
99). The capillary interface we designed (Fig. 6.3b and c) between the 
capillary and microfluidic chip was found to be effective in minimizing plug 
break up as plugs moved from the high ID (200 µm) of the capillary to the 
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shallow channels on chip (25 µm). This transition consisted of 5 different 
channel sections with gradually reducing channel heights of 360 µm, 200 µm, 
100 µm, 50 µm and 25 µm. This gradual transition minimizes the shear 
stress on the sample plug as it traverses from a capillary to the shallow 
channels on the chip, preventing its breakup in transit. 
6.3.3 Droplet uniformity using mechanical valve based droplet 
generation 
 We examined the performance of the mechanical valves on our 
microfluidic device for their capability to control the droplet size generated. 
To conduct this experiment, we primed the incubation channel on the device 
with the carrier fluid. We then used one of the reagent inlets on the device for 
generating droplets made of blue-colored food dye into the incubation channel 
region. The two parameters which could be used to control the droplet size 
generated from a reagent inlet are 1) Input pressure to the reagent inlet 
(Preagent) and 2) The opening time of the valve corresponding to the reagent 
inlet (Topen). Initially, we fixed the value of Preagent and generated droplets on 
the device for different values of Topen. Droplet generation was continued for 
each condition tested, until the incubation region on the device was 
completely full of droplets. We then estimated the volume for all these 
droplets using the image processing technique discussed in the ‘Materials 
and Methods’ section. The mean and standard deviation of fifty droplets 
generated for each condition was plotted against Topen in Fig. 6.4b. This 
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experiment was repeated for three different fixed values of Preagent. As 
expected, the linear relationship between droplet volume and Topen indicates 
excellent and predictable control of the device over droplet volume. Small 
standard deviation observed on the droplet volume also indicates excellent 
droplet uniformity for identical droplet generation conditions. This result is 
very important to ensure the capability of the device to generate droplets of 
various compositions on-demand. 
6.3.4 Sample Digitization  
 We examined the capability of our device to digitize a set of sample 
plugs being supplied to the device into smaller sample daughter droplets. To 
conduct this experiment, we generated a set of sample plugs into a silica 
capillary using the SSL system. These sample plugs were delivered to the 
microfluidic device through the capillary inlet, under pressure provided by 
the pressure controller on the SSL system. For this experiment, the repeating 
sequence of steps executed on the device was as following: 1) Generate small 
droplet from a sample plug in the central channel, 2) Move the droplet 
towards incubation region with carrier fluid 3) Release small amount of 
carrier fluid with surfactant in the central channel. Repeating this set of 
steps led to generation of an array of sample droplets generated through 
digitization of sample plugs on the device. Examples of unmerged sample 
daughter droplets are shown in Fig. 6.6a (Sample droplets A, B, C and D). 
The order of the sample plugs in the capillary is consistently maintained on 
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the device, even after the digitization operation. One shortcoming of this 
operation is the generation of non-uniform droplets towards the beginning 
and the end of the sample plugs. This is because the valve actuation sequence 
is continuously executed without any sensing of sample plug arrival on the 
device. However, the sample droplet uniformity is maintained throughout the 
rest of the sample plug. As the droplets generated on the device are stabilized 
with surfactant, undesirable merging of non-uniform droplets originating 
from the front- or back-end of plugs is avoided on the device.  
6.3.5 Generation of droplets of combinatorial mixtures 
 In this section we demonstrate proof-of-concept generation of 
combinatorial mixtures from sample plugs and reagent droplets on our device. 
For discernibility, we chose to use different food dye solutions to simulate 
different samples and reagents. Fig. 6.5 shows how reagent injection 
operations are performed in the fusion region on our device (also shown in 
Supp. Video 6). First, a sample plug travels from the capillary on to the 
microfluidic device. This plug is then chopped into a smaller sample daughter 
droplet. This droplet is then moved to the downstream fusion zone through 
release of carrier fluid in the central channel on the device. As every single 
input on the device is controlled with an individual valve, the device 
functions like an assembly line with complete temporal and spatial control 
over every single operation, as against typical droplet generating devices 
where the carried fluid flow is continuous. This level of control also implies 
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that the operation of the device can be paused and resumed with a completely 
new valve actuation sequence, on demand without affecting the existing 
droplets on the device. None of the droplet devices reported in literature so 
far has this capability to the best of our knowledge. A reagent droplet is then 
injected directly into the sample daughter droplet (Fig. 6.5a). The volume of 
reagent solution injected into the sample droplet can be controlled through 
variation of the opening time for the valve corresponding to the reagent inlet. 
Supp. Video 7 provides a close-up view to how reagent injection is performed. 
The fusion zone is designed such that the sample daughter droplet is 
sufficiently elongated within a region, which overlaps with all the injection 
ports of the interrogating reagents. This elongated droplet state removes the 
need for strict positioning accuracy requirements on the sample droplet for 
reliable injection of reagent into the sample droplet. In addition to 
demonstrating injection of a single reagent in a sample droplet, we have 
demonstrated injection of up to four reagents into a single sample droplet as 
shown in Fig. 6.5b. The concept of droplet elongation to aid reagent injection 
can be easily scaled to accommodate tens of reagent inlets, if desired. 
 After reagent injection, the sample-reagent droplet is driven further 
downstream with the help of carrier fluid. Following this, a small plug of 
carrier fluid with surfactant is released in the central channel for stabilizing 
the droplets in the incubation region. Using this scheme we can 
simultaneously take advantage of a surfactant-free zone in one area of the 
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chip to promote sample-reagent merging while deliberately using surfactant 
in another area to increase droplet stability and prevent unwanted droplet 
merging. 
 Fig. 6.6 demonstrates the reliability of the fusion mechanism on our 
device. Fig. 6.6a is a table of 16 different sample-reagent combinations 
generated on a single chip through all possible merging combinations of four 
different sample daughter droplets (A: blue, B: yellow, C: green, D: water) 
with four different reagents (Reagent 1: orange, Reagent 2: water, Reagent 3: 
blue, Reagent 4: yellow) with the condition of merging exactly one sample 
with one reagent.  
 The micrographs in Fig. 6.6b show a repeating sequence of the sample-
reagent hybrid droplets in the incubation region of the chip. The chip is 
operated such that the sample daughter droplets are merged with a repeating 
sequence of four different reagents. As a result a repeating sequence of four 
possible combinations generated through mixing a single sample with four 
different reagents can be seen in each individual micrograph. Once a sample 
plug is exhausted, the sample daughter droplets generated from the next 
incoming sample plug start merging with the same repeating sequence of 
reagents generating a repeating sequence of a new set of four different 
sample-reagent combinations in the incubation region on the chip. 
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 The droplet monodispersity as well as the uniform spacing between 
droplets is clearly visible in these micrographs. The inset in Fig. 6.6b displays 
zoomed-in view of these micrographs of the incubation region illustrating two 
repeats of each sequence in the incubation region. These images also 
demonstrate the capability of the device to maintain the order in which 
droplets are generated, throughout the incubation region on the device. We 
have demonstrated 16 combinations in this instance, but by employing 
multiple (2, 3 or 4) reagent merging with sample daughter droplets, as 
demonstrated in Fig. 6.5b, many more combinations can be generated using 
our prototype device. 
6.4 Conclusion 
 In summary, we have demonstrated a platform capable of preparing 
droplets from combinational mixtures of a large number of samples and 
reagents. This is accomplished by synchronization-free and detection-free 
fusion of sample daughter droplets and reagents. A key benefit of this 
architecture is the ability to scale this device to analyze N samples against M 
reagents (N x M) where N can range from hundreds to thousands without 
accompanying increase in device complexity. Additional reagent set 
multiplexing can be accomplished analogously by introducing linear arrays of 
reagent set plugs similar to sample introduction. Furthermore, this design 
allows for spatial indexing, by maintaining the sequence of droplets from 
generation throughout incubation, precluding the need for barcoding. 
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 This platform presents a novel design with several important 
components: a unique SSL system which uses pressure to inject uniform 
volumes of sample into a capillary directly from an industry standard multi-
well plate. This capillary is then interfaced with a microfluidic device using a 
novel capillary-to-chip connection. The microfluidic device is capable of 
combinatorial screening operations. Robust synchronization-free reagent 
injection is performed on the device based on a design which capitalizes on 
droplet elongation in the fusion zone on the device. In our prototype design 
up to 4 reagent droplets can be fused with a single sample droplet. However, 
by employing the same concept many more reagent inlets can be introduced 
on chip to perform merging operations. In addition, we have demonstrated a 
technique for reagent injection in droplets that capitalizes on controlling 
droplet surface chemistry by controlling surfactant concentration at different 
regions on the chip. That is, we have demonstrated a surfactant-free 
environment in the fusion zone on the device, thereby promoting reagent 
injection in sample droplets while the droplets are stabilized by surfactant in 
the incubation region.   
 For the microfluidic chip design, several areas can be explored to 
further enhance the operation of the chip. To make the transition of sample 
plugs from a capillary to the microfluidic device more gradual a 
photolithography process employing a grayscale mask could be used. This 
approach can generate very gradual reduction in channel cross section from a 
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large capillary to shallow microfluidic channels on the device as against the 5 
step reduction demonstrated in the current version of the device. 
Furthermore, reagents may be loaded in cartridge format to further enhance 
multiplexing capabilities. We expect the platform described here to be a 
promising candidate for combinatorial screening applications using droplet 
microfluidics.  
6.5 Supplementary section 
6.5.1 Mold Fabrication 
The work flow used for fabricating the fluidic layer mold is illustrated in Fig 
6.7. The mold consists of five different layers of photoresist with heights of 25 
µm, 50 µm, 100 µm, 200 µm and 360 µm. The photoresist used for the 25 µm 
layer was SPR 220-7.0 (Rohm & Haas), while the rest of the layers were 
fabricated using SU-8 3050 (MicroChem). Initially a 25um tall SPR 220-7.0 
layer was spin coated on a silicon wafer. This layer was patterned using 
photolithography and hard baked to generate a rounded channel cross section, 
required for effective valve closure. Rest of the layers were fabricated by 
stacking and patterning multiple layers of SU-8 3050 on the wafer. All the 
steps required for standard photolithography (Soft Bake, Exposure and Post 
Exposure Bake) are conducted for each layer of SU-8 3050, except the 
developing step. This step is conducted in common for all layers after the last 
SU-8 layer is patterned to remove excess unexposed photoresist from the 
wafer (Fig 6.7). This technique was found to be very effective in preventing 
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generation of bubbles and non-uniform coating of photoresist on the wafer 
due to the presence of features from earlier layers on the wafer.  
6.5.2 Device Fabrication and Operation 
The microfluidic device for our experiments was fabricated using multilayer 
soft lithography technique. Standard dual layer microfluidic devices with 
push-down valves fabricated using polydimethylsiloxane (PDMS) require 
shallow fluidic channels to make sure the layer of PDMS between the fluidic 
and control layer is sufficiently thin (~50um) for complete closure of valves at 
low pressures (<30psi). The requirement of shallow fluidic channels is 
incompatible with our chip design. So we developed a modified fabrication 
process for our device. This modified soft lithography process is outlined in 
Fig 6.8. For this modified fabrication process, three different batches of 
PDMS were mixed. These varied in composition, and base to crosslinking 
agent ratios of 15:1, 10:1 and 6:1 were used, respectively. These batches were 
thoroughly mixed and degassed prior to use for device fabrication. The control 
layer mold was spin coated with a thick layer (~1 mm) of 6:1 PDMS and 
baked at 80oC for 7 mins. A thin layer of 15:1 PDMS was spin coated on the 
fluidic layer mold. The device was designed such that the valve regions on the 
device were placed in areas surrounded by shallow fluidic channels, ensuring 
uniform coverage of these regions with a thin layer of PDMS. The PDMS on 
the fluidic layer mold was then baked at 80oC for 6 minutes. The PDMS was 
removed from the control layer mold and the control layer was cut to the 
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exact size of the valve regions on the device, while not covering any channels 
higher than 50 µm on the device (Fig 6.8). The control layer PDMS pieces 
were aligned with baked PDMS layer on the fluidic layer mold under a 
stereoscope. The fluidic layer mold with the aligned control layer was baked 
at 80oC for 20 mins to promote adhesion between the control layer and the 
fluidic layer. Following this, 49.5 g of 10:1 PDMS was poured on the fluidic 
layer mold, covering all features on the fluidic layer mold with a 3-4 mm 
thick layer of PDMS. The fluidic layer mold was then baked for at least 30 
minutes at 80oC. Following this, the PDMS was removed from the fluidic 
layer mold and individual devices were cut. Fluidic access holes were then 
punched into the device and the device was bonded to a coverglass through 
oxygen plasma treatment. 
6.5.3 Fusion Zone design 
An important aspect of our microfluidic device is the robust synchronization-
free fusion mechanism. This mechanism utilizes the cross-sectional area of 
the central channel on the microfluidic device for the merging operation. Fig 
6.9 demonstrates the design criteria of the fusion region on our device. In our 
current design, the dimensions of the fusion zone, defined as the distance 
between the first and last reagent inlet (3800 m), height (50 µm) and width 
(100 m) of the central channel determine the volume of the fusion zone (19 
nL). This volume of the fusion zone corresponds to the minimum volume of 
the sample daughter droplet, such that the droplet spans the entire length of 
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all the reagent injection sites on the chip. As a result, the sample daughter 
droplet position doesn’t need to be finely controlled to inject different 
reagents in it. If there is a need for smaller reaction volumes, the cross-
sectional area of the central channel can be modified to reduce the minimum 
volume of the sample daughter droplet required. For instance, reducing the 
fusion zone channel height from 50 m to 10 m will results in reduction in 
minimum required droplet volume from 19 nL to 3.8 nL (Fig 6.9). A similar 
approach can be used to accommodate more than four reagent inlets on the 
chip. 
6.5.4 Serial Sample Loading System  
6.5.4.1 Background 
High throughput sample processing is a critical requirement for a large 
number of industries. Some examples include the agricultural, 
pharmaceutical and biotechnological industries(105). As a result, there is a 
constant drive for innovation in sample processing techniques, supporting 
these industries. One major breakthrough in this domain has been the 
application of various robotic sample handling techniques, to improve the 
speed of sample processing as well as to reduce the volume of reagents used 
per reaction. Although the robotic systems have become incredibly fast at 
sample processing operations, they are typically limited to operating with 
standard multi-well (96, 384 and 1536 well) plates. As a result, the typical 
sample volume consumption is on the order of microliters per reaction for 
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such systems(105). Recent advances in the microfluidic domain show promise 
in overcoming this limitation of the robotic systems. Droplet-based 
microfluidic systems have been shown to be capable of performing 
biomolecular screening with sample volumes as low as picoliters(1, 5, 8, 48, 
69). However, introducing a large number of samples on a miniature 
microfluidic device is difficult since it is impractical to have hundreds to 
thousands of sample inlets to a single microfluidic device. Furthermore, the 
tubing used for supplying the samples to such a microfluidic device would 
already consume orders of magnitude more sample than is required for the 
actual analysis on the microfluidic device. So, there is a need for an efficient 
way to transport a large number of samples to a microfluidic device. Ideally 
such a sample transport system would be flexible enough to supply variable 
number of samples to a microfluidic device without any modifications in the 
transport system or the device. 
The ‘plug-in cartridge’ technique developed by the Whitesides 
group(106) provides an elegant solution to the problem of introducing a large 
number of reagents on a microfluidic device through a single inlet. Under this 
approach, a series of sample plugs are loaded into a capillary, with air 
bubbles present between sample plugs acting as spacers. This capillary is 
connected to a microfluidic device, for serial delivery of these sample plugs. 
However, in this approach, the sample plugs are constantly in contact with 
the capillary inner surface, leading to the problem of cross contamination 
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between plugs(106). Another modification of this approach developed by the 
Ismagilov group(107) utilizes an immiscible carrier fluid instead of an air 
bubble to act as a spacer between sample plugs. The carrier fluid in this 
approach preferentially wets the inner surface of the capillary, thus 
preventing direct contact between sample plugs and the capillary surface. As 
a result, the problem of cross contamination between sample plugs is 
eliminated. The carrier fluids typically used for generating these sample plug 
arrays are fluorinated oils, which also reduce the problem of reagents leaking 
from sample plugs into the carrier fluid due to their low solubility for most 
reagents(107).  
Although this approach is promising, the current techniques used 
under this approach for generating the ‘sample plug cartridges’ have some 
issues which need to be resolved. The common technique of using a syringe 
pump for aspirating sample plugs from a sample well(99, 108, 109) in a 
multi-well plate can be extremely slow. Another technique of using vacuum 
for aspirating a sample plug can be much faster(106). However, this 
technique can only provide a maximum driving pressure of 1 atm (~15 psi). 
As a result, the driving force may not be sufficient to load large numbers of 
sample plugs into a capillary due to the increasing fluidic resistance of the 
capillary with the introduction of sample plugs. Furthermore, both these 
techniques require the free end of the capillary to be attached to either a 
syringe or a vacuum source, thus excluding the possibility of operating this 
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sample loading system in sync with the operations on a downstream 
microfluidic device. This can be a major setback to throughput as the 
possibility of conducting assays in continuous flow manner on microfluidic 
devices, as has been demonstrated earlier(110), is precluded. 
To overcome these issues, we conceptualized and fabricated a sample 
plug loading system, which utilizes positive pressure for loading sample plugs 
from an industry standard multi-well plate to a capillary. Fig 6.10 shows a 
schematic illustrating the working principle of this system. A critical 
component of this system is a ‘capillary adapter’ which acts as an interface 
between a capillary, to be used for holding the sample plug array, and a 
multi-well plate used for holding samples. As shown in the schematic, the 
capillary adapter can be sealed with a sample well on the multi-well plate, 
creating a temporary pressure chamber in the sample well. In this sealed 
mode, the capillary attached to the capillary adapter is immersed in the 
sample present in the well. The pressure input on the capillary adapter can 
then be used to apply pressure to the sample in the well for a controlled 
amount of time. As a result, a small plug of sample is pushed from the well 
into the capillary. The size of this plug can be controlled by varying the input 
pressure and the pressure application time. Repeating this process with 
multiple sample wells can be used to generate an array of sample plugs in the 
capillary. As is clear from Fig 6.10, this whole sample plug loading process 
only requires one end of the capillary to be engaged, while the other end of 
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the capillary is free to be interfaced with a downstream microfluidic device, 
where further operations can be carried out with the sample plug array. 
Fig 6.11 shows a detailed model of the capillary adapter we designed in 
the CAD software ‘Solidworks’ (Solidworks Corp.). The wider backside of the 
adapter with the three large holes is used to bolt the capillary adapter to a 
stable support. The narrower front side is the actual functioning head of the 
capillary adapter. The functioning head consists of three disc shaped recesses 
on three sides (top, left and right), which are used to seat three NanoPorts 
(Idex Health and Science). The NanoPorts can be used to make a leak free 
connection with different types of tubing. The NanoPort on the top side is 
used to attach the capillary to the capillary adapter. The NanoPort on left 
side is used to attach the pressure supply line to the capillary adapter, while 
the NanoPort on the right side can be used to gauge pressure in the sample 
well, if required. All these NanoPorts holding locations on the capillary 
adapter have holes drilled in the center and routed to the bottom of the 
capillary adapter, as shown in the bottom view (Fig 6.11). When in use, the 
capillary goes through the straight hole drilled from the top of the capillary 
adapter to the bottom side. The bottom side of the capillary adapter has a 
disc shaped recess and a protruding circle. The disc shaped recess holds a 
silicone sealing ring, which is used to temporarily seal the capillary adapter 
with a sample well on a 96-well plate. The protruding circle acts as a 
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centering feature, which is used for centering the capillary adapter into a 
sample well.  
Our assembled Serial Sample Loading (SSL) platform is shown in Fig 
6.12.  All the components of the SSL platform are attached to an aluminum 
breadboard for support. A vertical stainless steel post bolted to the aluminum 
breadboard provides strong support structure for the capillary adapter. The 
capillary adapter is bolted to an angle bracket, which can slide on the post. 
This assembly allows us to manipulate the height of the capillary adapter 
from the aluminum base, as required. The capillary adapter is fixed at a 
suitable height to leave sufficient space for an assembly for XYZ motion of a 
96-well plate below it. To control the cost of the pilot system, we chose to keep 
the motion of the 96-well plate in the XY plane manual by using simple rails. 
However, these rails can be easily replaced with a motorized XY stage for 
automated motion of the 96-well plate. Controlled motion of the 96-well plate 
in the Z dimension, however, is critical for providing a reproducible seal 
between the capillary adapter and a sample well. So the motion in the Z-
dimension was motorized. Typical linear translation stages are ill-suited for 
this application due to the limitation on the load supported by these stages 
along the direction of travel. Hence, a Motorized Lab Jack was used for 
automated motion of the 96-well plate in the Z dimension. Fig 6.12 also 
shows an Electronic Pressure Controller, which can control the pressure 
applied to a sample well through the capillary adapter. 
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6.5.4.2 Materials and Methods 
The capillary adapter was designed in Solidworks (Solidworks Corp.) and 
then fabricated at the Physical Sciences Machine Shop at Johns Hopkins 
University. The capillary adapter was fabricated using stainless steel as 
substrate, to prevent corrosion due to contact with biological samples and 
buffers. All other structural components for the SSL system were purchased 
from Thorlabs (Newton, NJ). A Motorized Lab Jack (L490MZ/M, Thorlabs) 
was purchased to use for computer controlled vertical motion of the 96-well 
plate in the SSL system. The electronic pressure controller used with the SSL 
system was purchased from Alicat Scientific Inc. (Tucson, AZ).  The pressure 
controller used is a dual valve pressure controller (PCD-100PSIG-D-PCV03), 
which eliminates the need for bleed ports and relief valves typically required 
for pressure control in a closed volume. NanoPorts (N-124H, N-333 and N-
125H Idex Health and Science) were bonded to the capillary adapter at the 
three ports according to the instructions provided by Idex. The sealing ring 
attached to the bottom of the capillary adapter was fabricated using a silicone 
septum (Corning). The ring shape was punched out of the silicone septum 
using hole punches (3/8” and 13/64” hole diameter, McMaster). The capillary 
adapter was designed to be compatible with Costar 96-well plates (Corning). 
The Motorized Lab Jack and the Electronic Pressure Controller were 
interfaced with a computer through USB ports. Custom software written in 
LabVIEW (National Instruments), allowed us to control the motion of the 96 
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well-plate in the vertical direction, as well as the pressure applied to a 
sample well through the capillary adapter.  
The sample loading experiments were conducted using Silica Capillary 
Tubing (Polymicro Technologies). The capillaries were treated with 
AquapelTM (PPG Industries) before an experiment, to render the inner surface 
of the capillary hydrophobic. The samples used for most experiments were 
food dyes (Ateco, Glen Cove, NY), unless specified otherwise. The carrier fluid 
used for separating sample plugs from each other was a mixture of FC-3283 
(3M) and 1H,1H,2H,2H-Perfluoro-1-octanol (Sigma-Aldrich Co.) in the ratio 
of 8:1 by volume. For these experiments, the Aquapel treated capillary was 
completely filled with the carrier fluid first. Following this, a sample well on 
the 96-well plate was manually aligned with the capillary adapter. The 
LabVIEW software then raised the 96-well plate in vertical direction, to seal 
the sample well with the capillary adapter. The same software was then used 
to apply the desired pressure profile to the sample well for the desired 
amount of time. Following this, the 96-well plate was lowered by the 
LabVIEW software. We then manually aligned another well containing the 
carrier fluid with the capillary adapter. The same sample plug loading steps 
were then used to load a carrier fluid plug into the capillary. This alternating 
sequence of sample and carrier fluid plug loading was repeated until the 
desired number of sample plugs was loaded into the capillary. 
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For the experiments which required sample plug volume estimation, 
we used a 1 m long silica capillary with a 200 µm inner diameter (ID). The 
sample used for these experiments was a single food dye. A series of 12 
sample plugs separated by carrier fluid was loaded into the capillary using 
the steps described above. This capillary was then placed on the white 
background of a ‘letter’ sized sheet of paper and imaged using a Digital 
Single-Lens Reflex (DSLR) camera. The camera was placed such that the 
whole letter sized paper was included in the camera’s field of view. The image 
was then imported in ImageJ (104) for plug volume estimation. Length scale 
was set in the image using the known length of the letter sized sheet of paper. 
Following this, the length of each sample plug was measured by manually 
drawing a line marking the length of the plug in ImageJ. This measured 
length, along with the known cross sectional area of the capillary was then 
used to estimate the plug volume for each sample plug. The plug volume data 
from the last 10 sample plugs for each loading condition was then used for 
the data analysis. 
6.5.4.3 Results 
One of the first critical tests of our SSL platform was to determine its 
capability to provide significantly higher driving pressure than vacuum (~15 
psi) for sample plug loading in a capillary. To conduct this test, we first 
attached a silicone sealing ring to the capillary adapter, as described in the 
‘Materials and Methods’ section. The NanoPorts for the capillary and 
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pressure gauge on the capillary adapter were plugged using plugs (Idex 
Health and Science). The electronic pressure controller was connected to an 
input pressure supply of 95 psi from a Nitrogen cylinder. A sample well on a 
Costar 96-well plate, was then sealed with the capillary adapter using the 
SSL system. The LabVIEW software was then used to raise the pressure in 
the sealed sample well to different peak pressure values (10, 20, 30, 40 and 
50 psi). Fig 6.13 shows a plot of the pressure in the sample well, sensed by 
the pressure controller, for these 5 different tests. The pressure plot for each 
test consists of 3 distinct regions: Rising phase (the pressure in the sample 
well is raised from zero to peak value during this phase), Peak pressure 
phase (pressure in the sample well is maintained at peak value during this 
phase) and Decline phase (pressure in the sample well is reduced from peak 
to zero psi during this phase). The duration of each of these phases can be 
controlled using the LabVIEW software. All these phases were fixed at 
duration of 5 sec each for the plots shown in Fig 6.13. The pressure plots 
demonstrate that the pressure controller can easily maintain a peak pressure 
of 50 psi in the sealed sample well as commanded. Thus, proving that our 
SSL system can provide substantially higher driving pressures than a 
vacuum based system for sample plug loading in a capillary. The pressure 
controller we used was factory calibrated to a maximum pressure of 50 psi. 
Hence, we couldn’t test the SSL system for pressures higher than 50 psi. 
Furthermore, Fig 6.13 also demonstrates that the pressure controller can 
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control the timing of the ‘Rising’ and ‘Peak pressure’ phases very precisely. 
The duration of the ‘Decline’ phase, however, being a passive process driven 
by the pressure difference between the sealed sample well and the 
atmosphere, depends to some extent on the peak pressure value.    
We then tested the capability of the SSL system to load a series of 
sample plugs into a capillary. Initial testing was conducted using food dyes as 
samples for easy visibility. A silica capillary was loaded with alternate plugs 
of different food dyes and carrier fluid using the SSL system. Fig. 6.14a 
shows a micrograph of the silica microcapillary with a few food dye sample 
plugs. The micrograph shows excellent uniformity of plugs, the ability of the 
SSL system to keep sample plugs separate from each other, as well as the 
capability to load sample plugs without breakup into the capillary. We then 
tested the sample plug loading scheme with a biologically relevant sample in 
the form of a ‘PicoGreen’ (Life Technologies) stained Lambda DNA (Promega) 
sample. The Lambda DNA was present at a concentration of 2ug/ml 
concentration in the sample. Biological samples provide additional challenge 
to the sample plug loading process due to the lack of any visual feedback 
during sample plug loading. Food dyes are easily visible and their plug 
uniformity can be easily discerned during the loading process. However, most 
biological samples being transparent, it is difficult to differentiate them from 
the transparent carrier fluid. The variation in plug size is solely dependent 
on the repeatability of the SSL system. We thus loaded these Lambda DNA 
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sample plugs into a silica capillary essentially blindly and then obtained a 
fluorescence image (Fig. 6.14b) of the silica capillary using a Typhoon 9410 
Variable Mode Imager (GE Healthcare). The fluorescent Lambda DNA plugs 
can be clearly seen over the dark background of the interspersed carrier fluid 
plugs. Excellent uniformity of plug loading, despite lack of visual feedback is 
also clearly evident from this image. The ultimate purpose of the SSL system 
is delivery of a large array of sample plugs to a microfluidic device for further 
processing. So, as a proof of principle, we also demonstrated interfacing of a 
capillary with a simple microfluidic device (Fig. 6.14c). A series of sample 
plugs made from food dye using the SSL system, were then delivered from 
the capillary to the microfluidic device. Excellent transition of sample plugs 
from the capillary to the microfluidic device without break-up can be clearly 
seen from the image in Fig. 6.14c. 
We then conducted more rigorous testing of the SSL platform to 
determine its capability to maintain sample plug uniformity, as well as 
control the sample plug size as desired. To conduct these experiments, we 
loaded a series of twelve sample plugs made of the same food dye into a 1m 
long silica capillary for each set of sample plug loading conditions, as 
described in the ‘Materials and Methods’ section. The sample plug volume 
estimated from the last ten sample plugs was used to estimate the mean and 
standard deviation of the plug volume for each loading condition. These 
values were then used for the plots shown in Fig. 6.15 and 6.16.  
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The sample plug volume depends on a few factors: 1) Peak pressure (Ppeak) 
applied, 2) duration of the ‘Rising’ and ‘Decline’ phases of pressure 
application and 3) the duration (Tpeak) of the Peak pressure phase. All these 
parameters can be precisely controlled in the SSL system with our LabVIEW 
software. We decided to vary the intuitive factors like Ppeak and Tpeak to 
control the sample plug volume. Initially, we held Ppeak constant and varied 
Tpeak to estimate the sample plug volume generated for different Tpeak values. 
This experiment had two objectives: First to estimate the variation in plug 
volume for a fixed set of loading conditions and second to estimate the 
relationship between plug volume and Tpeak for a fixed value of Ppeak. Fig. 6.15 
shows a plot of sample plug volume vs Tpeak for three different values of Ppeak 
(0.5, 1 and 1.5 psi). The linear relation between plug volume and Tpeak for 
each individual Ppeak value demonstrates the capability of the SSL system to 
precisely control the plug volume in a predictable manner, through the 
variation of the duration of the ‘Peak pressure’ phase. Furthermore, the plug 
size variation indicated by the error bars is fairly low with a maximum 
coefficient of variation of approx. 7% for all but two smallest plug volumes 
generated, where we were approaching the lower limit of the operation of the 
electronic pressure controller. We expect the system performance, in terms of 
plug volume variability, to improve as the motion of the 96 well plate is 
automated in the horizontal plane too, as the overlap of the sample well wall 
with the sealing ring of the capillary adapter can be reproduced across the 
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area of the 96 well plate, providing a reproducible seal for every single 
sample plug loading step. 
Varying Tpeak to control plug volume can be beneficial for smaller plug 
volumes. However, as the plug volume increases, Tpeak can quickly increase, 
reducing the speed at which sample plugs can be loaded in a capillary. For 
larger plug volumes, it would be beneficial to raise the peak pressure, to 
achieve larger plug volume in the same amount of time. Fig 6.16 shows a plot 
of the sample plug volume vs Ppeak for a fixed value of Tpeak (1 sec). This plot 
shows another linear relationship between sample plug volume and Ppeak, 
providing an alternative predictable way to vary the sample plug volume 
through variation of the peak pressure applied to the sample well. The value 
of Ppeak here is only limited by the pressure at which the seal between the 
sample well and the capillary adapter breaks down. This result, thus 
illustrates a limitation of applying vacuum to load sample plugs in a capillary, 
which can be overcome with the use of the SSL system. Although, the 
vacuum level can be controlled with a regulator, the driving pressure cannot 
be greater than 1 atm(~15psi), limiting the speed at which large sample plugs 
can be loaded in a capillary. 
One limitation of the SSL system is its dependence on the fluidic 
resistance of the capillary for maintaining the uniformity of sample plug 
volume for the same sample plug loading conditions. However, as more and 
more sample plugs are loaded into the capillary, the fluidic resistance of the 
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capillary increases, gradually reducing the sample plug volume over the 
course of loading of sample plugs. This effect is illustrated in Fig 6.17a. In 
this figure, the sample plug volume data is normalized by the plug volume of 
the first sample plug generated for each loading condition. The normalized 
sample plug volume is then plotted against the sample plug number in the 
loading sequence. As seen from the plot, for three independent loading 
conditions (Ppeak: 1 psi, Tpeak: 1.5, 2 and 2.5 sec), we observe a consistent 
gradual reduction in the sample plug volume as the number of sample plugs 
in the capillary increases.  
This problem can be avoided through pressure compensation for the 
changing fluidic resistance of the capillary. We observed the sample plug 
volume reduce by approx. 15% for the 10th sample plug loaded into a capillary 
for all the three conditions shown in Fig 6.17a. So we did simple linear peak 
pressure (Ppeak) increase for each sample plug in the loading sequence to 
compensate for the 17% (1/0.85) increase in the fluidic resistance over the 
course of loading 10 sample plugs in the capillary. The normalized sample 
plug volumes for this modified loading scheme with the same starting point 
as the three conditions shown in Fig 6.17a, are plotted in Fig 6.17b. These 
plots demonstrate that a simple compensation scheme can avoid gradual 
reduction in sample plug volume with increasing number of sample plugs, 
further improving the sample plug uniformity of the SSL system.  
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In the future versions of the SSL system, the compensation scheme can 
be further improved by devising a mathematical model of the changing fluidic 
resistance in the capillary and incorporating it in the LabVIEW software, to 
automatically compensate for the changing fluidic resistance by varying the 
peak pressure (Ppeak) applied to the sample well for each consecutive sample 
plug being loaded into the capillary. Alternatively, an imaging based 
technique can be used to detect the appearance of the edge between a sample 
plug and the carrier fluid at a particular distance from the end of capillary 
immersed in the sample solution, to provide feedback for computer control of 
the pressure controller. This approach can enable very accurate metering of 
sample plug volume for each sample plug despite changing fluidic resistance 
in the capillary.  
6.5.4.4 Discussion  
In conclusion, we have devised a new technique for serial delivery of a large 
number of samples to a microfluidic device, directly from a standard multi-
well plate. Our SSL system differs from similar techniques developed by 
other research groups in the past, in the application of positive pressure as a 
driving force for the loading of a series of sample plugs into a capillary for 
direct delivery to a microfluidic device. The SSL system can be used for rapid 
sample plug loading into a capillary with the only rate limiting step being 
movement of the multi-well plate, to load samples from different sample 
wells. We demonstrated the functioning of the SSL system as well as its 
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capability to precisely control the sample plug volume. Since the SSL system 
engages only one end of the capillary in sample plug loading, it can be 
directly interfaced with a downstream microfluidic device for its operation in 
synchronization with the microfluidic device. In its current form, the SSL 
system was designed for loading sample plugs into a single capillary. 
However, the design can be easily extrapolated for simultaneous loading of 
sample plugs in multiple capillaries from a row of sample wells. We expect 
the SSL system to be instrumental in further improvement in the throughput 




Fig 6.1 Schematic of the sample screening platform Step 1: A cartridge 
is loaded with a library of sample plugs separated by an immiscible carrier 
fluid. This cartridge is interfaced with a microfluidic device. Step 2: On-
demand digitization of incoming sample plugs into smaller daughter droplets. 
The volume of individual daughter droplets can be controlled by valve 
opening time and back pressure on the cartridge. Step 3: By exploiting the 
cross sectional area of the central channel, the sample daughter droplet is 
stretched in the “Fusion Region”. This approach allows for robust, 
synchronization-free injection of up to four reagents simultaneously directly 
into the daughter droplet. The volume of reagent injected is controlled 
through modulation of back pressure and valve opening time corresponding 
to the reagent inlet. Step 4: Once sample and reagent have been combined 
into one droplet, the droplets are stabilized with carrier fluid containing 
surfactant to prevent unwanted droplet coalescence downstream. Step 5: 
Sample-reagent droplets travel to an incubation channel. Step 6: The sample-
reagent droplets are incubated while maintaining their sequence in 
downstream incubation channels. This approach allows for droplet 
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Fig 6.2 ‘Serial Sample Loading’ (SSL) system a) Schematic: A custom 
SSL system was designed which employs positive pressure to inject a sample 
plug into a microcapillary from a standard multi-well plate. A custom 
capillary adapter in the SSL system provides an interface between a 
microcapillary and a multi-well plate. This adapter can seal a well on the 
multi-well plate, thus generating a temporary pressure chamber inside the 
sample well. A pressure input on the adapter can then be used to apply 
controlled pressure to the fluid inside the sample well. This positive pressure 
drives a small plug of sample from the well into the microcapillary. Following 
this, the seal is broken and the multi-well plate is moved to seal another 
sample well with the capillary adapter. This sequence of steps is repeated to 
generate a sample library into the microcapillary. b)  An image of a food dye 
sample plug array generated using the SSL system. Each sample plug is 







Fig 6.3: Microfluidic Device Design a) Photograph of a prototype device. 
The microfluidic device has a multichannel architecture: 1) The central 
channel with fusion region and incubation region (purple), 2) Capillary inlet, 
3) Reagent inlets: reagent 1 (pink), reagent 2 (orange), reagent 3 (green), 
reagent 4 (turqoise) and surfactant oil inlet (yellow). The valves on the device 
(V1-V7) are indicated by a turquoise dye. b) A scan of the capillary inlet 
region, indicating the height difference between different sections of the 
capillary inlet to facilitate smooth sample plug transition from the large ID of 







Fig 6.4 Control of droplet volume and droplet uniformity using 
mechanical valve based droplet generation a) Micrograph of the 
incubation region on the microfluidic device filled with reagent droplets 
generated using sequentially increasing valve opening times (Ton = 0.3, 0.4, 
0.5, 0.6, 0.7, 0.8 seconds) for a fixed back pressure on the reagent inlet 
(Preagent= 5 psi). This resulted in a linear array of repeats of a sequence of six 
droplets, with each droplet increasing in volume. b) A plot of droplet volume 
versus the valve opening time (Ton) for a valve corresponding to a reagent 
inlet for three different values of back pressures applied to the reagent inlet 
(Preagent= 2.5, 5 and 7.5 psi). The droplet volumes plotted are an average of 
volumes estimated from 50 droplets for each condition. The error bars in the 







Fig 6.5 Demonstration of reagent injection in sample daughter 
droplets merging with reagents a) Time series of images indicating 
reagent injection into sample daughter droplets at the ‘Fusion zone’ on the 
device. A sample daughter droplet (yellow) is released from the capillary inlet 
and is halted in the ‘Fusion zone’ by actuating a valve upstream which 
controls carrier fluid injection into the central channel on the device. A 
reagent (blue) is released and injected directly into the sample droplet. The 
elongated configuration of the sample daughter droplet in the ‘Fusion zone’ 
ensures robust reagent injection operation on the device without the need for 
precise sample droplet positioning. b) A series of photographs demonstrating 























Fig 6.6 Photographs of the incubation region indicating multiplexing 
capability of the device a) Table with micrographs indicating 
combinatorial mixture droplets generated on the device using four different 
samples [Sample A (blue), Sample B (yellow), Sample C (green), Sample D 
(water)] and four different reagents [Reagent 1 (orange), Reagent 2 (water), 
Reagent 3 (light blue), Reagent 4 (yellow)]. Droplets 1A-4A, 1B-4B, 1C-4C, 
and 1D-4D are each generated from a combination of the sample and reagent 
in the corresponding column and row respectively. For example, Droplet 1A is 
the combination of sample A with reagent 1. b) Left panel shows four 
different micrographs showing repeating sequences of sample daughter 
droplets generated from a single sample plug merged with four different 
reagents on a single device. The right panel shows zoomed in version of a 
small section of the micrographs from the left panel for easy visualization of 
the droplet sequence. The droplet identification codes in this panel are the 
same as those used in subfigure a. Note: The sequence of droplets seems to be 
going in opposite direction in alternate channels due to the changing 







Fig 6.7 Microfabrication Process with Single Developing Step: Four 
consecutive layers of SU8 photoresist are spin coated and patterned on a 
single silicon wafer using photolithography. Each layer undergoes all 
standard photolithography steps like soft bake (SB), exposure and post-
exposure bake (PEB). However, the developing step is conducted in common 






Fig 6.8 Modified microfluidic device fabrication: The process flow used 
for fabrication of our microfluidic devices to accommodate tall channels in the 
fluidic layer while maintaining the functionality of push-down valves. (6:1, 






Fluidic layer mold Control layer mold
Spin Coat 15:1 PDMS Spin Coat 6:1 PDMS
Align control layer over
the fluidic layer mold
Pour 10:1 PDMS over the 
whole fluidic layer mold
and bake.
Peel off the cured PDMS 
after bake
Bond the PDMS chip 
with a coverglass to seal 
the channels 
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Fig 6.9 Fusion zone design for robust reagent injection in sample 






Fig 6.10 A schematic illustrating the working principle of the sample 
plug loading system. This positive pressure based sample loading system 
involves interfacing a capillary with a sample well through a capillary 
adapter. The capillary adapter can be used to seal a sample well from a 
multi-well plate, creating a temporary pressure chamber in the sample well. 
Application of pressure to this sealed sample well through the capillary 
adapter leads to introduction of a sample plug from the sample well into the 
capillary. 





















liquidSample Sample Sample Sample
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Fig 6.11 Different views of a CAD model of the capillary adapter 
actually used for fabrication of the capillary adapter: The wider 
backside of the adapter with the three large holes is used to bolt the capillary 
adapter to a stable support. The narrower front side is the actual functioning 







Fig 6.12 A photograph of the actual assembled Serial Sample Loading 
(SSL) system: The SSL system features a custom made capillary adapter to 
interface a capillary with the multi-well plate, a Motorized Lab Jack for 
vertical motion of the multi-well plate and an Electronic Pressure Controller 



















Fig 6.13 A plot of pressure variation in the sample well over time, for 
different peak pressures (10, 20, 30, 40 and 50 psi) applied to the 
sample well. The pressure variation is sensed by the Electronic Pressure 
Controller in the SSL system. Each individual plot shows three distinct 
phases of pressure application to the sample well: 1) Rising phase (The 
pressure is raised from zero to peak pressure during this phase), 2) Peak 
pressure phase (Pressure is maintained at its peak value during this phase) 
and 3) Decline phase (The pressure is reduced from peak pressure to zero 
during this phase). The duration of all these phases was maintained constant 
at 5 sec each for all the plots in the figure. The plots demonstrate precise 
timing and pressure control of the SSL system in the sample well. 
Furthermore, the plots also demonstrate that peak pressure of up to 50 psi 


























Fig 6.14 Micrographs demonstrating capability of the SSL system to 
load uniform sample plugs into a capillary: a) The micrograph shows a 
series of sample plugs in the form of different food dyes loaded into a 
capillary by the SSL system. b) This micrograph shows a fluorescence image 
of a series of sample plugs made from PicoGreen stained Lambda DNA, 
loaded into a capillary by the SSL system. The capillary loaded with these 
sample plugs was imaged using a Typhoon 9410 Variable Mode Imager and 
the false color was added to the fluorescence intensity image using ImageJ. c) 
A photograph of a simple microfluidic chip interfaced with a capillary. The 
image shows transition of a series of sample plugs generated using the SSL 










Fig 6.15 Plots showing the linear relationship between sample plug 
volume and the duration of the peak pressure phase (Tpeak) for 
three different fixed values of peak pressure (Ppeak: 0.5, 1 and 1.5 
psi) applied. Each data point shows the mean and standard deviation of the 































Fig 6.16 Plot showing the linear relationship between the sample 
plug volume and the peak pressure (Ppeak) applied for a fixed 
duration of the peak pressure phase (Tpeak: 1 sec). Each data point 
shows the mean and standard deviation of the volume of ten sample plugs 



























Fig 6.17 Sample plug volume variation with plug number Left) Plot 
showing the gradual reduction of sample plug volume as the number of 
sample plugs loaded into a capillary increases for three loading conditions 
(Ppeak: 1 psi, Tpeak: 1.5, 2, 2.5 sec). The sample plug volume is normalized by 
the volume of the first sample plug loaded into the capillary for each sample 
plug loading condition. Right) A plot of Sample plug volume versus the plug 
number in the sequence in which sample plugs are loaded in a capillary, with 
peak pressure (Ppeak) compensation to overcome the increase in fluidic 
resistance of the capillary with each additional plug being loaded into the 
capillary. The gradual plug volume reduction observed in the left figure is 
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Chapter 7: Conclusion and Future directions 
In conclusion, this thesis contributed a set of tools using droplet microfluidic 
technology with applications including single cell analysis, single molecule 
analysis, pathogen detection and high throughout combinatorial screening. 
The technology developed in the second chapter demonstrated single 
molecule sensing and quantification within individual droplets. This sensitive 
technique when coupled with single cell encapsulation in droplets can be used 
for ultra-sensitive and high throughput molecular expression analysis from 
single cells. The continuous flow sample-to-answer devices developed in 
chapters three and four provide an alternative to the current fragmented 
droplet digital PCR workflow which requires three separate instruments for 
target nucleic acid sensing at single molecule level. Further development of 
these continuous flow devices for delivery of multiple samples in a serial 
manner will make this analysis workflow a viable alternative to current 
commercially available droplet digital PCR instruments with the added 
flexibility of screening virtually any range of sample volumes desired. Finally 
the technology developed in chapters five and six provides a solution for 
performing high-throughput screening operations using droplet microfluidics. 
Further development of this technology for increased throughput and 
continuous flow PCR capabilities can make this an attractive technology for 




1. Teh SY, Lin R, Hung LH, Lee AP. Droplet microfluidics. Lab Chip. 2008 
Feb; 8(2): 198-220.  
2. Huebner A, Sharma S, Srisa-Art M, Hollfelder F, Edel JB, Demello AJ. 
Microdroplets: A sea of applications? Lab Chip. 2008 Aug; 8(8): 1244-1254.  
3. Kobayashi I, Uemura K, Nakajima M. Formulation of monodisperse 
emulsions using submicron-channel arrays. Colloids Surf Physicochem Eng 
Aspects. 2007 3/15; 296(1-3): 285-289.  
4. Ottesen EA, Hong JW, Quake SR, Leadbetter JR. Microfluidic digital PCR 
enables multigene analysis of individual environmental bacteria. Science. 
2006 Dec 1; 314(5804): 1464-1467.  
5. Brouzes E, Medkova M, Savenelli N, Marran D, Twardowski M, Hutchison 
JB, Rothberg JM, Link DR, Perrimon N, Samuels ML. Droplet microfluidic 
technology for single-cell high-throughput screening. Proc Natl Acad Sci U S 
A. 2009 Aug 25; 106(34): 14195-14200. PMCID: PMC2732882.  
6. Zeng Y, Novak R, Shuga J, Smith MT, Mathies RA. High-performance 
single cell genetic analysis using microfluidic emulsion generator arrays. Anal 
Chem. 2010 Apr 15; 82(8): 3183-3190. PMCID: PMC2859697.  
7. Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, 
Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC, Kitano TK, 
Hodel MR, Petersen JF, Wyatt PW, Steenblock ER, Shah PH, Bousse LJ, 
Troup CB, Mellen JC, Wittmann DK, Erndt NG, Cauley TH, Koehler RT, So 
AP, Dube S, Rose KA, Montesclaros L, Wang S, Stumbo DP, Hodges SP, 
Romine S, Milanovich FP, White HE, Regan JF, Karlin-Neumann GA, 
Hindson CM, Saxonov S, Colston BW. High-throughput droplet digital PCR 
system for absolute quantitation of DNA copy number. Anal Chem. 2011 Nov 
15; 83(22): 8604-8610. PMCID: PMC3216358.  
8. Zhong Q, Bhattacharya S, Kotsopoulos S, Olson J, Taly V, Griffiths AD, 
Link DR, Larson JW. Multiplex digital PCR: Breaking the one target per color 
barrier of quantitative PCR. Lab Chip. 2011 Jul 7; 11(13): 2167-2174.  
9. Baker M. Digital PCR hits its stride. Nat Meth. 2012 print; 9(6): 541-544.  
10. Fallah-Araghi A, Baret JC, Ryckelynck M, Griffiths AD. A completely in 
vitro ultrahigh-throughput droplet-based microfluidic screening system for 
protein engineering and directed evolution. Lab Chip. 2012 Mar 7; 12(5): 882-
891.  
11. Zheng B, Roach LS, Ismagilov RF. Screening of protein crystallization 
conditions on a microfluidic chip using nanoliter-size droplets. J Am Chem 
Soc. 2003 Sep 17; 125(37): 11170-11171.  
222 
12. Shestopalov I, Tice JD, Ismagilov RF. Multi-step synthesis of 
nanoparticles performed on millisecond time scale in a microfluidic droplet-
based system. Lab Chip. 2004 Aug; 4(4): 316-321.  
13. Nie Z, Li W, Seo M, Xu S, Kumacheva E. Janus and ternary particles 
generated by microfluidic synthesis: Design, synthesis, and self-assembly. J 
Am Chem Soc. 2006 Jul 26; 128(29): 9408-9412.  
14. Hwang DK, Dendukuri D, Doyle PS. Microfluidic-based synthesis of non-
spherical magnetic hydrogel microparticles. Lab Chip. 2008 Oct; 8(10): 1640-
1647.  
15. Choi CH, Jung JH, Rhee YW, Kim DP, Shim SE, Lee CS. Generation of 
monodisperse alginate microbeads and in situ encapsulation of cell in 
microfluidic device. Biomed Microdevices. 2007 Dec; 9(6): 855-862.  
16. Song H, Ismagilov RF. Millisecond kinetics on a microfluidic chip using 
nanoliters of reagents. J Am Chem Soc. 2003 Nov 26; 125(47): 14613-14619. 
PMCID: PMC1769313.  
17. Chiu DT, Lorenz RM. Chemistry and biology in femtoliter and picoliter 
volume droplets. Acc Chem Res. 2009 May 19; 42(5): 649-658. PMCID: 
PMC2684575.  
18. Nie Z, Xu S, Seo M, Lewis PC, Kumacheva E. Polymer particles with 
various shapes and morphologies produced in continuous microfluidic 
reactors. J Am Chem Soc. 2005 Jun 8; 127(22): 8058-8063.  
19. Song H, Chen DL, Ismagilov RF. Reactions in droplets in microfluidic 
channels. Angew Chem Int Ed Engl. 2006 Nov 13; 45(44): 7336-7356. PMCID: 
PMC1766322.  
20. Huebner A, Srisa-Art M, Holt D, Abell C, Hollfelder F, deMello AJ, Edel 
JB. Quantitative detection of protein expression in single cells using droplet 
microfluidics. Chem Commun (Camb). 2007 Mar 28; (12)(12): 1218-1220.  
21. Kumaresan P, Yang CJ, Cronier SA, Blazej RG, Mathies RA. High-
throughput single copy DNA amplification and cell analysis in engineered 
nanoliter droplets. Anal Chem. 2008 May 15; 80(10): 3522-3529.  
22. Clausell-Tormos J, Lieber D, Baret JC, El-Harrak A, Miller OJ, Frenz L, 
Blouwolff J, Humphry KJ, Koster S, Duan H, Holtze C, Weitz DA, Griffiths 
AD, Merten CA. Droplet-based microfluidic platforms for the encapsulation 
and screening of mammalian cells and multicellular organisms. Chem Biol. 
2008 May; 15(5): 427-437.  
23. Schaerli Y, Wootton RC, Robinson T, Stein V, Dunsby C, Neil MA, French 
PM, Demello AJ, Abell C, Hollfelder F. Continuous-flow polymerase chain 
reaction of single-copy DNA in microfluidic microdroplets. Anal Chem. 2009 
Jan 1; 81(1): 302-306.  
223 
24. Beer NR, Wheeler EK, Lee-Houghton L, Watkins N, Nasarabadi S, Hebert 
N, Leung P, Arnold DW, Bailey CG, Colston BW. On-chip single-copy real-
time reverse-transcription PCR in isolated picoliter droplets. Anal Chem. 2008 
Mar 15; 80(6): 1854-1858.  
25. Boedicker JQ, Li L, Kline TR, Ismagilov RF. Detecting bacteria and 
determining their susceptibility to antibiotics by stochastic confinement in 
nanoliter droplets using plug-based microfluidics. Lab Chip. 2008 Aug; 8(8): 
1265-1272. PMCID: PMC2612531.  
26. Schmitz CH, Rowat AC, Koster S, Weitz DA. Dropspots: A picoliter array 
in a microfluidic device. Lab Chip. 2009 Jan 7; 9(1): 44-49.  
27. Castro A, Williams JG. Single-molecule detection of specific nucleic acid 
sequences in unamplified genomic DNA. Anal Chem. 1997 Oct 1; 69(19): 3915-
3920.  
28. de Mello AJ. Seeing single molecules. Lab Chip. 2003 May; 3(2): 29N-34N.  
29. Li H, Zhou D, Browne H, Balasubramanian S, Klenerman D. Molecule by 
molecule direct and quantitative counting of antibody-protein complexes in 
solution. Anal Chem. 2004 Aug 1; 76(15): 4446-4451.  
30. Neely LA, Patel S, Garver J, Gallo M, Hackett M, McLaughlin S, Nadel M, 
Harris J, Gullans S, Rooke J. A single-molecule method for the quantitation of 
microRNA gene expression. Nat Methods. 2006 Jan; 3(1): 41-46.  
31. Yeh HC, Chao SY, Ho YP, Wang TH. Single-molecule detection and probe 
strategies for rapid and ultrasensitive genomic detection. Curr Pharm 
Biotechnol. 2005 Dec; 6(6): 453-461.  
32. Yeh HC, Ho YP, Shih I, Wang TH. Homogeneous point mutation detection 
by quantum dot-mediated two-color fluorescence coincidence analysis. Nucleic 
Acids Res. 2006 Mar 3; 34(5): e35. PMCID: PMC1390686.  
33. Puleo CM, Yeh HC, Liu KJ, Wang TH. Coupling confocal fluorescence 
detection and recirculating microfluidic control for single particle analysis in 
discrete nanoliter volumes. Lab Chip. 2008 May; 8(5): 822-825.  
34. Puleo CM, Wang TH. Microfluidic means of achieving attomolar detection 
limits with molecular beacon probes. Lab Chip. 2009 Apr 21; 9(8): 1065-1072.  
35. Liu KJ, Wang TH. Cylindrical illumination confocal spectroscopy: 
Rectifying the limitations of confocal single molecule spectroscopy through 
one-dimensional beam shaping. Biophys J. 2008 Sep 15; 95(6): 2964-2975. 
PMCID: PMC2527274.  
36. Unger MA, Chou HP, Thorsen T, Scherer A, Quake SR. Monolithic 
microfabricated valves and pumps by multilayer soft lithography. Science. 
2000 Apr 7; 288(5463): 113-116.  
224 
37. Yeh HC, Ho YP, Shih I, Wang TH. Homogeneous point mutation detection 
by quantum dot-mediated two-color fluorescence coincidence analysis. Nucleic 
Acids Res. 2006 Mar 3; 34(5): e35. PMCID: PMC1390686.  
38. Diehl F, Li M, He Y, Kinzler KW, Vogelstein B, Dressman D. BEAMing: 
Single-molecule PCR on microparticles in water-in-oil emulsions. Nat 
Methods. 2006 Jul; 3(7): 551-559.  
39. Liu KJ, Wang TH. Cylindrical illumination confocal spectroscopy: 
Rectifying the limitations of confocal single molecule spectroscopy through 
one-dimensional beam shaping. Biophys J. 2008 Sep 15; 95(6): 2964-2975. 
PMCID: PMC2527274.  
40. Huang B, Wu H, Bhaya D, Grossman A, Granier S, Kobilka BK, Zare RN. 
Counting low-copy number proteins in a single cell. Science. 2007 Jan 5; 
315(5808): 81-84.  
41. Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci U S A. 1999 
Aug 3; 96(16): 9236-9241. PMCID: PMC17763.  
42. Lun FM, Chiu RW, Allen Chan KC, Yeung Leung T, Kin Lau T, Dennis Lo 
YM. Microfluidics digital PCR reveals a higher than expected fraction of fetal 
DNA in maternal plasma. Clin Chem. 2008 Oct; 54(10): 1664-1672.  
43. Joensson HN, Samuels ML, Brouzes ER, Medkova M, Uhlen M, Link DR, 
Andersson-Svahn H. Detection and analysis of low-abundance cell-surface 
biomarkers using enzymatic amplification in microfluidic droplets. Angew 
Chem Int Ed Engl. 2009; 48(14): 2518-2521.  
44. Baret JC, Miller OJ, Taly V, Ryckelynck M, El-Harrak A, Frenz L, Rick C, 
Samuels ML, Hutchison JB, Agresti JJ, Link DR, Weitz DA, Griffiths AD. 
Fluorescence-activated droplet sorting (FADS): Efficient microfluidic cell 
sorting based on enzymatic activity. Lab Chip. 2009 Jul 7; 9(13): 1850-1858.  
45. Clausell-Tormos J, Lieber D, Baret JC, El-Harrak A, Miller OJ, Frenz L, 
Blouwolff J, Humphry KJ, Koster S, Duan H, Holtze C, Weitz DA, Griffiths 
AD, Merten CA. Droplet-based microfluidic platforms for the encapsulation 
and screening of mammalian cells and multicellular organisms. Chem Biol. 
2008 May; 15(5): 427-437.  
46. Koster S, Angile FE, Duan H, Agresti JJ, Wintner A, Schmitz C, Rowat 
AC, Merten CA, Pisignano D, Griffiths AD, Weitz DA. Drop-based microfluidic 
devices for encapsulation of single cells. Lab Chip. 2008 Jul; 8(7): 1110-1115.  
47. Shim JU, Olguin LF, Whyte G, Scott D, Babtie A, Abell C, Huck WT, 
Hollfelder F. Simultaneous determination of gene expression and enzymatic 
activity in individual bacterial cells in microdroplet compartments. J Am 
Chem Soc. 2009 Oct 28; 131(42): 15251-15256.  
48. Rane TD, Puleo CM, Liu KJ, Zhang Y, Lee AP, Wang TH. Counting single 
molecules in sub-nanolitre droplets. Lab Chip. 2010 Jan 21; 10(2): 161-164.  
225 
49. Lane DJ, Pace B, Olsen GJ, Stahl DA, Sogin ML, Pace NR. Rapid 
determination of 16S ribosomal RNA sequences for phylogenetic analyses. 
Proc Natl Acad Sci U S A. 1985 Oct; 82(20): 6955-6959. PMCID: PMC391288.  
50. Fuhrman JA, Davis AA. Widespread archaea and novel bacteria from the 
deep sea as shown by 16S rRNA gene sequences. Mar Ecol Prog Ser. 1997; 
150: 275-285.  
51. Ludwig W, Schleifer KH. Bacterial phylogeny based on 16S and 23S rRNA 
sequence analysis. FEMS Microbiol Rev. 1994 Oct; 15(2-3): 155-173.  
52. Zwirglmaier K, Ludwig W, Schleifer KH. Recognition of individual genes 
in a single bacterial cell by fluorescence in situ hybridization--RING-FISH. 
Mol Microbiol. 2004 Jan; 51(1): 89-96.  
53. Wang TH, Peng Y, Zhang C, Wong PK, Ho CM. Single-molecule tracing on 
a fluidic microchip for quantitative detection of low-abundance nucleic acids. 
J Am Chem Soc. 2005 Apr 20; 127(15): 5354-5359.  
54. Tyagi S, Kramer FR. Molecular beacons: Probes that fluoresce upon 
hybridization. Nat Biotechnol. 1996 Mar; 14(3): 303-308.  
55. Tyagi S, Kramer FR. Molecular beacons: Probes that fluoresce upon 
hybridization. Nat Biotechnol. 1996 Mar; 14(3): 303-308.  
56. Zhang CY, Chao SY, Wang TH. Comparative quantification of nucleic 
acids using single-molecule detection and molecular beacons. Analyst. 2005 
Apr; 130(4): 483-488.  
57. Xi C, Balberg M, Boppart SA, Raskin L. Use of DNA and peptide nucleic 
acid molecular beacons for detection and quantification of rRNA in solution 
and in whole cells. Appl Environ Microbiol. 2003 Sep; 69(9): 5673-5678. 
PMCID: PMC194960.  
58. Yang J, Liu Y, Rauch CB, Stevens RL, Liu RH, Lenigk R, Grodzinski P. 
High sensitivity PCR assay in plastic micro reactors. Lab Chip. 2002 Nov; 
2(4): 179-187.  
59. Waters LC, Jacobson SC, Kroutchinina N, Khandurina J, Foote RS, 
Ramsey JM. Microchip device for cell lysis, multiplex PCR amplification, and 
electrophoretic sizing. Anal Chem. 1998 Jan 1; 70(1): 158-162.  
60. Wilding P, Kricka LJ, Cheng J, Hvichia G, Shoffner MA, Fortina P. 
Integrated cell isolation and polymerase chain reaction analysis using silicon 
microfilter chambers. Anal Biochem. 1998 Mar 15; 257(2): 95-100.  
61. Lee WC, Lien KY, Lee GB, Lei HY. An integrated microfluidic system 
using magnetic beads for virus detection. Diagn Microbiol Infect Dis. 2008 
Jan; 60(1): 51-58.  
226 
62. Brosius J, Palmer ML, Kennedy PJ, Noller HF. Complete nucleotide 
sequence of a 16S ribosomal RNA gene from escherichia coli. Proc Natl Acad 
Sci U S A. 1978 Oct; 75(10): 4801-4805. PMCID: PMC336208.  
63. Hoshino T, Yilmaz LS, Noguera DR, Daims H, Wagner M. Quantification 
of target molecules needed to detect microorganisms by fluorescence in situ 
hybridization (FISH) and catalyzed reporter deposition-FISH. Appl Environ 
Microbiol. 2008 Aug; 74(16): 5068-5077. PMCID: PMC2519275.  
64. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, Spina 
CA, Woelk CH, Richman DD. Highly precise measurement of HIV DNA by 
droplet digital PCR. PLoS One. 2013; 8(4): e55943. PMCID: PMC3616050.  
65. Heredia NJ, Belgrader P, Wang S, Koehler R, Regan J, Cosman AM, 
Saxonov S, Hindson B, Tanner SC, Brown AS, Karlin-Neumann G. Droplet 
digital PCR quantitation of HER2 expression in FFPE breast cancer samples. 
Methods. 2013 Jan; 59(1): S20-3.  
66. Heyries KA, Tropini C, Vaninsberghe M, Doolin C, Petriv OI, Singhal A, 
Leung K, Hughesman CB, Hansen CL. Megapixel digital PCR. Nat Methods. 
2011 Jul 3; 8(8): 649-651.  
67. Shen F, Du W, Kreutz JE, Fok A, Ismagilov RF. Digital PCR on a 
SlipChip. Lab Chip. 2010 Oct 21; 10(20): 2666-2672. PMCID: PMC2948063.  
68. Zec H, Rane TD, Wang T. Microfluidic platform for on-demand generation 
of spatially indexed combinatorial droplets. Lab on a Chip. 2012; 12(17): 
3055-3062.  
69. Kiss MM, Ortoleva-Donnelly L, Beer NR, Warner J, Bailey CG, Colston 
BW, Rothberg JM, Link DR, Leamon JH. High-throughput quantitative 
polymerase chain reaction in picoliter droplets. Anal Chem. 2008 Dec 1; 
80(23): 8975-8981. PMCID: PMC2771884.  
70. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino 
N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids 
Res. 2000 Jun 15; 28(12): E63. PMCID: PMC102748.  
71. Tomita N, Mori Y, Kanda H, Notomi T. Loop-mediated isothermal 
amplification (LAMP) of gene sequences and simple visual detection of 
products. Nat Protoc. 2008; 3(5): 877-882.  
72. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell 
behavior. Annu Rev Cell Dev Biol. 2001; 17: 463-516. PMCID: PMC2792593.  
73. Amalinei C, Caruntu ID, Giusca SE, Balan RA. Matrix metalloproteinases 
involvement in pathologic conditions. Rom J Morphol Embryol. 2010; 51(2): 
215-228.  
74. Miller MA, Barkal L, Jeng K, Herrlich A, Moss M, Griffith LG, 
Lauffenburger DA. Proteolytic activity matrix analysis (PrAMA) for 
227 
simultaneous determination of multiple protease activities. Integr Biol 
(Camb). 2011 Apr; 3(4): 422-438. PMCID: PMC3173501.  
75. Brouzes E, Medkova M, Savenelli N, Marran D, Twardowski M, 
Hutchison JB, Rothberg JM, Link DR, Perrimon N, Samuels ML. Droplet 
microfluidic technology for single-cell high-throughput screening. Proc Natl 
Acad Sci U S A. 2009 Aug 25; 106(34): 14195-14200. PMCID: PMC2732882.  
76. Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, 
Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC, Kitano TK, 
Hodel MR, Petersen JF, Wyatt PW, Steenblock ER, Shah PH, Bousse LJ, 
Troup CB, Mellen JC, Wittmann DK, Erndt NG, Cauley TH, Koehler RT, So 
AP, Dube S, Rose KA, Montesclaros L, Wang S, Stumbo DP, Hodges SP, 
Romine S, Milanovich FP, White HE, Regan JF, Karlin-Neumann GA, 
Hindson CM, Saxonov S, Colston BW. High-throughput droplet digital PCR 
system for absolute quantitation of DNA copy number. Anal Chem. 2011 Nov 
15; 83(22): 8604-8610. PMCID: PMC3216358.  
77. Song H, Chen DL, Ismagilov RF. Reactions in droplets in microfluidic 
channels. Angew Chem Int Ed Engl. 2006 Nov 13; 45(44): 7336-7356. PMCID: 
PMC1766322.  
78. Song H, Ismagilov RF. Millisecond kinetics on a microfluidic chip using 
nanoliters of reagents. J Am Chem Soc. 2003 Nov 26; 125(47): 14613-14619. 
PMCID: PMC1769313.  
79. Zhong Q, Bhattacharya S, Kotsopoulos S, Olson J, Taly V, Griffiths AD, 
Link DR, Larson JW. Multiplex digital PCR: Breaking the one target per color 
barrier of quantitative PCR. Lab Chip. 2011 Jul 7; 11(13): 2167-2174.  
80. Abate AR, Hung T, Mary P, Agresti JJ, Weitz DA. High-throughput 
injection with microfluidics using picoinjectors. Proc Natl Acad Sci U S A. 
2010 Nov 9; 107(45): 19163-19166. PMCID: PMC2984161.  
81. Chen CH, Miller MA, Sarkar A, Beste MT, Isaacson KB, Lauffenburger 
DA, Griffith LG, Han J. Multiplexed protease activity assay for low-volume 
clinical samples using droplet-based microfluidics and its application to 
endometriosis. J Am Chem Soc. 2013 Feb 6; 135(5): 1645-1648. PMCID: 
PMC3566300.  
82. Zec H, Rane TD, Wang TH. Microfluidic platform for on-demand 
generation of spatially indexed combinatorial droplets. Lab Chip. 2012 Sep 7; 
12(17): 3055-3062.  
83. Jambovane S, Kim DJ, Duin EC, Kim SK, Hong JW. Creation of stepwise 
concentration gradient in picoliter droplets for parallel reactions of matrix 
metalloproteinase II and IX. Anal Chem. 2011 May 1; 83(9): 3358-3364.  
84. Holtze C, Rowat AC, Agresti JJ, Hutchison JB, Angile FE, Schmitz CH, 
Koster S, Duan H, Humphry KJ, Scanga RA, Johnson JS, Pisignano D, Weitz 
228 
DA. Biocompatible surfactants for water-in-fluorocarbon emulsions. Lab Chip. 
2008 Oct; 8(10): 1632-1639.  
85. Roach LS, Song H, Ismagilov RF. Controlling nonspecific protein 
adsorption in a plug-based microfluidic system by controlling interfacial 
chemistry using fluorous-phase surfactants. Anal Chem. 2005 Feb 1; 77(3): 
785-796. PMCID: PMC1941690.  
86. Pompano RR, Liu W, Du W, Ismagilov RF. Microfluidics using spatially 
defined arrays of droplets in one, two, and three dimensions. Annu Rev Anal 
Chem (Palo Alto Calif). 2011; 4: 59-81.  
87. Guo MT, Rotem A, Heyman JA, Weitz DA. Droplet microfluidics for high-
throughput biological assays. Lab Chip. 2012 Feb 9.  
88. Beer NR, Hindson BJ, Wheeler EK, Hall SB, Rose KA, Kennedy IM, 
Colston BW. On-chip, real-time, single-copy polymerase chain reaction in 
picoliter droplets. Anal Chem. 2007 Nov 15; 79(22): 8471-8475.  
89. Baret JC, Miller OJ, Taly V, Ryckelynck M, El-Harrak A, Frenz L, Rick C, 
Samuels ML, Hutchison JB, Agresti JJ, Link DR, Weitz DA, Griffiths AD. 
Fluorescence-activated droplet sorting (FADS): Efficient microfluidic cell 
sorting based on enzymatic activity. Lab Chip. 2009 Jul 7; 9(13): 1850-1858.  
90. Shi W, Qin J, Ye N, Lin B. Droplet-based microfluidic system for 
individual caenorhabditis elegans assay. Lab Chip. 2008 Sep; 8(9): 1432-
1435.  
91. Shi W, Wen H, Lu Y, Shi Y, Lin B, Qin J. Droplet microfluidics for 
characterizing the neurotoxin-induced responses in individual caenorhabditis 
elegans. Lab Chip. 2010 Nov 7; 10(21): 2855-2863.  
92. Sobrino B, Brion M, Carracedo A. SNPs in forensic genetics: A review on 
SNP typing methodologies. Forensic Sci Int. 2005 Nov 25; 154(2-3): 181-194.  
93. Gupta PK, Rustgi S, Mir RR. Array-based high-throughput DNA markers 
for crop improvement. Heredity (Edinb). 2008 Jul; 101(1): 5-18.  
94. Ragoussis J. Genotyping technologies for genetic research. Annu Rev 
Genomics Hum Genet. 2009; 10: 117-133.  
95. Veldhuisen B, van der Schoot CE, de Haas M. Blood group genotyping: 
From patient to high-throughput donor screening. Vox Sang. 2009 Oct; 97(3): 
198-206.  
96. Tewhey R, Warner JB, Nakano M, Libby B, Medkova M, David PH, 
Kotsopoulos SK, Samuels ML, Hutchison JB, Larson JW, Topol EJ, Weiner 
MP, Harismendy O, Olson J, Link DR, Frazer KA. Microdroplet-based PCR 
enrichment for large-scale targeted sequencing. Nat Biotechnol. 2009 Nov; 
27(11): 1025-1031. PMCID: PMC2779736.  
229 
97. Theberge AB, Mayot E, El Harrak A, Kleinschmidt F, Huck WT, Griffiths 
AD. Microfluidic platform for combinatorial synthesis in picolitre droplets. 
Lab Chip. 2012 Mar 7; 12(7): 1320-1326.  
98. Abate AR, Hung T, Mary P, Agresti JJ, Weitz DA. High-throughput 
injection with microfluidics using picoinjectors. Proc Natl Acad Sci U S A. 
2010 Nov 9; 107(45): 19163-19166. PMCID: PMC2984161.  
99. Li L, Mustafi D, Fu Q, Tereshko V, Chen DL, Tice JD, Ismagilov RF. 
Nanoliter microfluidic hybrid method for simultaneous screening and 
optimization validated with crystallization of membrane proteins. Proc Natl 
Acad Sci U S A. 2006 Dec 19; 103(51): 19243-19248. PMCID: PMC1748211.  
100. Zeng S, Li B, Su X, Qin J, Lin B. Microvalve-actuated precise control of 
individual droplets in microfluidic devices. Lab Chip. 2009 May 21; 9(10): 
1340-1343.  
101. Guo F, Liu K, Ji X, Ding H, Zhang M, Zeng Q, Liu W, Guo S, Zhao X. 
Valve-based microfluidic device for droplet on-demand operation and static 
assay. Appl Phys Lett. 2010 12/06; 97(23): 233701-3.  
102. Wang H, Liu K, Chen KJ, Lu Y, Wang S, Lin WY, Guo F, Kamei K, Chen 
YC, Ohashi M, Wang M, Garcia MA, Zhao XZ, Shen CK, Tseng HR. A rapid 
pathway toward a superb gene delivery system: Programming structural and 
functional diversity into a supramolecular nanoparticle library. ACS Nano. 
2010 Oct 26; 4(10): 6235-6243. PMCID: PMC2992838.  
103. Melin J, Quake SR. Microfluidic large-scale integration: The evolution of 
design rules for biological automation. Annu Rev Biophys Biomol Struct. 
2007; 36: 213-231.  
104. Abramoff MD, Magalhaes PJ, Ram SJ. Image processing with ImageJ. 
Biophotonics International. 2004; 11: 36-42.  
105. Mayr LM, Bojanic D. Novel trends in high-throughput screening. Curr 
Opin Pharmacol. 2009 Oct; 9(5): 580-588.  
106. Linder V, Sia SK, Whitesides GM. Reagent-loaded cartridges for 
valveless and automated fluid delivery in microfluidic devices. Anal Chem. 
2005 Jan 1; 77(1): 64-71.  
107. Chen DL, Ismagilov RF. Microfluidic cartridges preloaded with nanoliter 
plugs of reagents: An alternative to 96-well plates for screening. Curr Opin 
Chem Biol. 2006 Jun; 10(3): 226-231. PMCID: PMC1764868.  
108. Zheng B, Ismagilov RF. A microfluidic approach for screening 
submicroliter volumes against multiple reagents by using preformed arrays of 
nanoliter plugs in a three-phase liquid/liquid/gas flow. Angew Chem Int Ed 
Engl. 2005 Apr 22; 44(17): 2520-2523. PMCID: PMC1766320.  
230 
109. Adamson DN, Mustafi D, Zhang JX, Zheng B, Ismagilov RF. Production 
of arrays of chemically distinct nanolitre plugs via repeated splitting in 
microfluidic devices. Lab Chip. 2006 Sep; 6(9): 1178-1186. PMCID: 
PMC1851925.  
110. Zhang Y, Ozdemir P. Microfluidic DNA amplification--a review. Anal 






Tushar D. Rane 05/25/14 
Name Date of this version 
Education History: 




Mentor: Dr. Jeff TH 
Wang 
Johns Hopkins 






B. Tech 2004 
Mechanical 
Engineering 
Indian Institute of 
Technology, Bombay 
Professional experience: 
Research Internship Summer, 2003 
Tata Research Development 
and Design Centre, Pune, 
India 
Scholarships: 
 Siebel Scholar Class of 2014 (Awarded to 85 students at the top of their class based 
on academic performance and leadership from 17 top graduate programs every year) 
 Indian Institute of Technology, Bombay, Heritage Fund Scholarship (2001-2004, 
awarded to approximately 100 students with limited family income every year, based 
on academic performance) 
Peer-Reviewed Journal Publications 
1) Rane, T. D., Zec, H. C., Puleo, C., Lee, A., & Wang, J. T. H. (2012). Droplet microfluidics for 
amplification-free genetic detection of single cells. Lab on a Chip, 12(18), 3341-3347 
2) Zec, H. C.*, Rane, T. D.*, & Wang, J. T. H. (2012). Microfluidic platform for on-demand 
generation of spatially indexed combinatorial droplets. Lab on a Chip, 12(17), 3055-3062 
232 
3) Rane, T. D.*, Zec, H. C.*, & Wang, T. H. (2012). A Serial Sample Loading System Interfacing 
Multiwell Plates with Microfluidic Devices. Journal of Laboratory Automation, 17(5), 370-377 
4) Liu, K. J., Rane, T. D., Zhang, Y., & Wang, T. H. (2011). Single-Molecule Analysis Enables 
Free Solution Hydrodynamic Separation Using Yoctomole Levels of DNA. Journal of the 
American Chemical Society, 133(18), 6898-6901 
5) Rane, T. D.*, Puleo, C. M.*, Liu, K. J., Zhang, Y., Lee, A. P., & Wang, T. H. (2010). Counting 
single molecules in sub-nanolitre droplets. Lab on a Chip,10(2), 161-164 
6) Izawa, J., Rane, T., Donchin, O., &Shadmehr, R. (2008). Motor adaptation as a process of 
reoptimization. The Journal of Neuroscience, 28(11), 2883-2891 
7) Rane, T. D., Dewri, R., Ghosh, S., Chakraborti, N., &Mitra, K. (2005). Modeling the 
recrystallization process using inverse cellular automata and genetic algorithms: Studies using 
differential evolution. Journal of phase equilibria and diffusion, 26(4), 311-321 
8) Diedrichsen, J., Hashambhoy, Y., Rane, T., &Shadmehr, R. (2005). Neural correlates of reach 
errors. The Journal of neuroscience, 25(43), 9919-9931 
(*: These authors contributed equally to this article) 
Peer-Reviewed Conference Articles 
1) H.C. Zec, T.D. Rane, P. Ma, T.H. Wang (2013). Parallelization of fission and fusion operations 
for high throughput generation of combinatorial droplets. IEEE 27th International Conference 
on Micro Electro Mechanical Systems 
2) Tushar D Rane, Helena C. Zec, Tza-Huei Wang (2013) A multiplexed microfluidic droplet 
platform for matrix metalloproteinase screening. The 17th International Conference on 
Miniaturized Systems for Chemistry and Life Sciences(MicroTAS) 
3) H.C. Zec, T.D. Rane, W.C. Chu, V.W. Wang, T.H. Wang (2013). A microfluidic droplet 
platform for multiplexed single nucleotide polymorphism analysis of an array plant genomic 
DNA samples. IEEE 26th International Conference on Micro Electro Mechanical Systems 
4) K.J. Liu, T.D. Rane, Y. Zhang, C. Beh, D.J. Shin, T.H. Wang (2012). An Integrated Platform 
for Single Molecule Free Solution Hydrodynamic Separation Using Yoctomoles of DNA and 
Picoliter Samples. ASME 10th International Conference on Nanochannels, Microchannels and 
Minichannels (ICNMM) 
5) Helena Zec, Tushar D. Rane, Wen-Chy Chu & Jeff Wang. (2012) Multiplexed Screening Of A 
Large Library Of Biological Samples Through On-Demand Droplet Generation And Fusion. 
Proceedings of the ASME 10th International Conference on Nanochannels, Microchannels, and 
Minichannels (ICNMM) 
6) Rane T. D., Zec H., Puleo C., Lee A. P., & Wang T. H. (2011) High-throughput single-cell 
pathogen detection on a droplet microfluidic platform. IEEE 24th International Conference 
on Micro Electro Mechanical Systems 
7) Tushar Rane, Chris Puleo, Helena Zec, Kelvin Liu, Yi Zhang, Abraham Lee & Tza-Huei 
Wang (2009) Analyte Detection in Droplets: One Molecule at a Time. 13th International 
Conference on Miniaturized Systems for Chemistry and Life Sciences(MicroTAS) 
8) C.M. Puleo, H.C. Yeh, K.J. Liu, T. Rane, T.H. Wang (2008). Coupling evaporation-based, 
microfluidic concentration and confocal fluorescence spectroscopy. IEEE 21st International 
Conference on Micro Electro Mechanical Systems 
9) Izawa J., Rane T., Donchin O., & Shadmehr R. (2006) Changing the noise in dynamics of 
reaching predictably changes control of reaching. Advances in Computational Motor Control 
Patent Applications 
 U.S. Patent App. 13/147,742: ‘MICROFLUIDIC SOLUTION FOR HIGH-THROUGHPUT, 
DROPLET-BASED SINGLE MOLECULE ANALYSIS WITH LOW REAGENT 
CONSUMPTION’ Inventors: Jeff T.H. Wang, K.J. Liu, C.M. Puleo, T.D. Rane 
 U.S. Patent App. 13/708,510: ‘SYSTEM AND METHOD FOR SCREENING A LIBRARY OF 
SAMPLES’ 
Inventors: Jeff T.H. Wang, H.C. Zec, T.D. Rane, W.C. Chu 
233 
Service and Leadership 
Spring 2005 Teaching assistant for ‘Computational Modeling Lab’ 
Spring 2006 Teaching assistant for ‘Computational Modeling Lab’ 
Spring 2007 Teaching assistant for ‘Learning Theory’ class 
Fall 2009 Teaching assistant for ‘Microfabrication Lab’ 
Spring 2010 Teaching assistant for ‘Systems Bioengineering II’ 
Spring 2013 Teaching assistant for ‘Biosensing and BioMEMS’ class 
Fall 2011-Spring 2013 Volunteer consultant for the ‘Study Consulting’ program at Johns 
Hopkins University 
 
